Abstract
The catalytic, enantioselective, cyclization of phenols with electrophilic sulfenophthalimides onto isolated or conjugated alkenes affords 2,3-disubstituted benzopyrans and benzoxepins. The reaction is catalyzed by a BINAM-based phosphoramide Lewis base catalyst which assists in the highly enantioselective formation of a thiiranium ion intermediate. The influence of nucleophile electron density, alkene substitution pattern, tether length and Lewis base functional groups on the rate, enantio- and site-selectivity for the cyclization is investigated. The reaction is not affected by the presence of substituents on the phenol ring. In contrast, substitutions around the alkene strongly affect the reaction outcome. Sequential lengthening of the tether results in decreased reactivity, which necessitated increased temperatures for reaction to occur. Sterically bulky aryl groups on the sulfenyl moiety prevented erosion of enantiomeric composition at these elevated temperatures. Alcohols and carboxylic acids preferentially captured thiiranium ions in competition with phenolic hydroxyl groups. An improved method for the selective C(2) allylation of phenols is also described.
Introduction
One of the simplest benzofused heterocycles, the chroman core, is a privileged scaffold for bioactive compounds, with representatives displaying antioxidant, antitumor, antibacterial, and other therapeutic properties (Chart 1).1 Its presence in pharmaceutically relevant targets has led to a variety of methods for its enantioselective construction.
Chart 1. Chroman-Containing Therapeutic Agents.
The importance of the chroman motif in organic molecules is reflected in the myriad protocols that have been developed for its synthesis. Five major disconnections have been identified, each of which leads to a different starting material (Scheme 1). These are (a) cyclization of a 2-allylphenol, (b) C–H functionalization of an O-alkyl phenol, (c) intermolecular double Michael reaction of a phenol with an unsaturated carbonyl derivative, (d) intramolecular Friedel–Crafts-type cyclization of an O-allylphenol, and (e) direct functionalization of the 2-position of the parent chroman.
Scheme 1. Retrosynthetic Disconnections for Construction of Chromans.
To date, for each of the pathways (a)–(c), enantioselective versions have been developed, whereas pathway (d) is diastereoselective due to the presence of a stereogenic center. The enantioselective variant of pathway (b) has been accomplished under Rh(II) catalysis,2 pathway (c) is amenable to enantioselective catalysis by secondary amines,3 whereas pathway (d) can be accessed either as a two-step epoxidation–ring-opening process or in a single step using transition-metal catalysis.4 Each of these pathways have distinct substitution requirements that are reflected in the products they afford. Notably, none of these approaches directly lead to the 2- or 2,3-difunctionalized chromans that are accessible through pathway (a).5 Selected examples of enantioselective reactions that set the stereocenter at C(2) through pathway (a) include: (1) asymmetric allylic substitution, which proceeds through capture of an allylpalladium intermediate by the phenol oxygen (Scheme 2a);6 (2) tandem oxidative functionalization/Heck coupling, wherein a similar allylpalladium intermediate is generated from an isolated alkene (Scheme 2b);7 (3) oxidative functionalization of a skipped diene precursor to form an allylpalladium complex (Scheme 2c);8 and (4) Lewis base catalyzed cyclofunctionalization of the γ-position of an ynoate with a phenolic hydroxyl group (Scheme 2d).9
Scheme 2. Enantioselective Construction of Chromans.
Despite the impressive selectivities and obvious utility of these methods, they are not applicable to the synthesis of chromans bearing an additional substituent at the 3-position. Hence, direct synthesis of enantioenriched, anti-2,3-difunctionalized chromans is usually accomplished diastereoselectively from an acyclic epoxide or diol precursor (Scheme 3a).10 The difunctionalization of γ-substituted 2-allylphenol to afford chromans with stereocenters at both the 2- and 3-positions remains rare.11 A recent example involves the stereocontrolled generation and intramolecular opening of a seleniranium ion by a phenolic hydroxyl group to form a 2-seleno-3-arylchroman (Scheme 3b).12 The reaction proceeds via a DYKAT mechanism, since the seleniranium ion in question is not stable under the reaction conditions. Only aryl substituents have been incorporated at the 2-position. The product could be functionalized further by formation of a C–C bond through the intermediacy of a C-centered radical with poor diastereoselectivity. The stereocenter adjacent to the oxygen atom remained unaffected.
Scheme 3. Synthesis of 2,3-Disubstituted Chromans.
As part of our ongoing program on enantioselective sulfenofunctionalization of alkenes, we were interested in extending the scope of this transformation to the synthesis of chromans. Sulfenofunctionalization of alkenes is a longstanding strategy for the efficient introduction of sulfur moieties into organic molecules.13 The introduction of diverse, electrophilic sulfenylating reagents allows for tuning of both reactivity and selectivity in the desired application. Furthermore, the intermediate thiiranium ion is a strong electrophile that which undergoes facile reaction with nucleophiles resulting in a net anti-sulfenofunctionalization of alkenes (eq 1).14
![]() |
1 |
In recent years, the extension of the concept of Lewis base activation of Lewis acids developed in these laboratories has enabled the enantioselective sulfenofunctionalization of alkenes and enol ethers.13a Early studies identified three key racemization processes that could lead to the erosion of enantioenriched thiiranium ions: (1) C–S bond scission to afford a configurationally unstable carbocation, (2) reversible transfer of the sulfenium ion to the nucleophile, thereby creating an achiral sulfenylating agent, and (3) olefin-to-olefin transfer of the thiiranium ion.14,15 Subsequent investigations identified that both carbocation formation and olefin-to-olefin transfer could be suppressed by lowering the reaction temperature to −20 °C. The configurational stability of the thiiranium ions is maintained in the presence of hard nucleophiles, but not in the presence of weak Lewis bases, demonstrating that Lewis bases intimately interact with thiiranium ions. Intramolecular capture of thiiranium ions by C-, N-, and O-nucleophiles have all been successful. The reactions of tethered alcohols led to the formation of 2,3-difunctionalized pyrans in high yields and with good enantioselectivities (Scheme 4a).16 Lactones were accessible from the intramolecular cyclization of carboxylic acids.16 Tosyl-protected amines efficiently captured thiiranium ions to afford pyrrolidine and piperidine derivatives (Scheme 4b).17 Friedel–Crafts-type capture by electron-rich arenes allowed access to substituted tetralins (Scheme 4c).18 Finally, silyl enol ethers produce enantioenriched α-sulfenylated ketones in high selectivity without the intermediacy of thiiranium ions (Scheme 4d).19 The catalyst exhibited complete control over the absolute configuration of the product irrespective of nucleophile. Comparable enantioselectivities with the same absolute configuration were observed for products from all nucleophiles tested so far. The broad nucleophile scope and high stereochemical control observed in both the formation and capture of thiiranium ions are hallmarks of this Lewis base catalyzed sulfenofunctionalization reaction.
Scheme 4. Lewis Base Catalyzed Sulfenofunctionalization of Alkenes.
The enantioselective olefin sulfenylation reaction relies on the principle of Lewis base activation of Lewis acids extensively developed for main group chemistry in these laboratories.20 Comprehensive kinetic and spectroscopic studies have led to the formulation of a detailed catalytic cycle (Figure 1).21 The cycle begins with protonation of N-phenylthiophthalimide (1a) by methanesulfonic acid acting as a cocatalyst. Displacement of the S-aryl group by chiral Lewis base catalyst 2 leads to the formation of active complex i. The rate of formation of i is not turnover-limiting, and i serves as the resting state of the catalyst. The subsequent reaction of complex i with an alkene leads to enantioenriched thiiranium ion ii. The formation of ii is both the turnover-limiting and the stereodetermining step. Inter- or intramolecular nucleophilic capture of the thiiranium ion and subsequent deprotonation affords the final product iv as well as regenerates 2 to continue the catalytic cycle.
Figure 1.
Catalytic cycle for the enantioselective, intramolecular sulfenylation.
The intermediates involved in the catalytic cycle have been investigated both spectroscopically and crystallographically. Active complex i, a competent intermediate in stoichiometric reactions, has been independently synthesized and extensively characterized.21 Investigation of the reaction mixture by 31P NMR spectroscopy revealed that 2 is rapidly and completely converted to i under the reaction conditions. Interestingly, the equimolar amounts of phthalimide and methanesulfonate formed as a byproduct of the initial reaction of 2 with 1 play important roles in the reaction by acting as buffers for the remaining methanesulfonic acid and suppressing the background reaction.22
Initial-rate kinetic experiments determined that the reaction is first-order in catalyst and substrate but zero-order in electrophile 1a. These results are consistent with turnover-limiting thiiranium ion formation.21 Two further pieces of evidence corroborate the formation of ii as the slow step: (1) complex i is the resting state of the catalyst, and (2) the rate of the reaction is sensitive to changes in alkene electron density. Electron-poor alkenes react slower than electron-rich alkenes.
Formation of the thiiranium ion ii is also stereodetermining. Product enantioselectivity was insensitive to identity (C-, N-, O-nucleophiles), electron density, or steric bulk of the nucleophile but was very sensitive to alkene substitution pattern. Studies investigating the configurational stability of thiiranium ions in sulfenoetherification reactions also confirmed that no racemization occurs at the reaction temperature.
The transition state from i to ii was investigated computationally to formulate a stereochemical model that explains the observed enantioselectivity. Distortion/interaction analysis23 identified the degree of distortion experienced by complex i to achieve optimal bond overlap with the alkene substrate to be the primary contributor to the energy difference between the competing diastereomeric transition states.21 Computational and experimental determination of the activation energy revealed that both the enthalpy (ΔH⧧ = 11.9 kcal/mol, calculated; 8.9 kcal/mol, experimental) and the entropy term (ΔS⧧ = 12 kcal/mol, calculated; 13.3 kcal/mol, experimental) contribute substantially to the overall reaction barrier (ΔG⧧ = 23.9 kcal/mol, calculated; 22.3 kcal/mol, experimental at −20 °C). The stereochemical model identified a van der Waals interaction between the arylsulfenyl moiety and the binaphthyl backbone. Gratifyingly, increased steric bulk at this position in the electrophile leads to improved selectivity overall, which substantiated predictions made by the current model. The absolute configurations of the sulfenofunctionalized products wholly depend on the absolute configuration of the catalyst and are in agreement with predictions made by the calculated model, which supported thiiranium formation as the enantiodetermining step.
Nucleophilic attack at either carbon of thiiranium ion ii is possible, raising the issue of site-selectivity.24 In electronically biased thiiranium ions, capture follows Markovnikov selectivity.16,25 If the thiiranium ion is sterically and electronically unbiased, mixtures of constitutional isomers are obtained.26 Thiiranium ions whose constituent carbon atoms are sterically differentiated also afford mixtures of isomers.16 Site-selectivity is further influenced by the nature of the nucleophile, as alcohols, carboxylic acids and protected amines display dissimilar levels of Markovnikov selectivity. It is worth noting that reversibility of capture has been demonstrated under the reaction conditions for electronically activated thiiranium ions, such as those derived from isolated trans-alkenes. Products of thiiranium ion capture by both tethered alcohols and tethered tosylamides are capable of undergoing exo/endo isomerization. The product distribution of sulfenofunctionalization therefore represents a composite of intrinsic kinetic selectivity and a substrate-dependent thermodynamic equilibration process.
In extension of these findings, we sought to apply the expertise gained in the study of enantioselective oxysulfenylation of alkenes to the synthesis of difunctionalized chroman derivatives. If both the 2- and the 3-positions of the newly formed ring system are functionalized, the final products can be transformed into a variety of useful compounds, thus constituting a general and selective method for the synthesis of chroman derivatives.
Results
1. Synthesis of C(2) Allylic Phenols
A prerequisite for this investigation was the availability of the C(2)-functionalized phenols. A number of different routes were employed that varied according to the number of intervening methylene groups and the substituents on the terminus of the alkene. Most of those routes are derived from literature precedent and are detailed in the Supporting Information without need for additional comment. However, one important class of substrates, C(2) allylic phenols, presented a number of special challenges, the solutions to which merit a brief prelude.
Although many methods exist for the site-selective O-allylation of phenols, a corresponding general method for the C-selective allylation of phenols has not been described.27 Because phenols are ambident nucleophiles (at O, C(2), and C(4)) and allylating agents are ambident electrophiles (leading to products of SN2 or SN2′ displacement), the formation of a single product represents challenges of site-selectivity and chemoselectivity. Moreover, the products of C-allylation are also competent nucleophiles that can lead to over-allylation. In a single study on the cinnamylation of phenols using sodium as the base, the C- vs O-selectivity was shown to be highly solvent dependent; C-selectivity dominated in diethyl ether, whereas O-selectivity dominated in dioxane.28 Unfortunately, the site-selectivity at the cinnamyl moiety was not reported.
Following from this precedent, the selectivity of cinnamylation of phenol was examined with respect to the counterion and the solvent (Table 1). Repeating the previously reported conditions did in fact afford a predominance (15:1) of C- vs O-alkylation products 3 and 3′ in reasonable yield, but unfortunately, the product of SN2′ reaction at C(2) (3″) was formed in significant quantities as well (entry 1). Changing the solvent to THF afforded a lower yield and a predominance of isomer 3′, whereas dichloromethane gave results similar to those of diethyl ether (entries 2 and 3). Changing the counterion by using lithium or potassium metal in dichloromethane solvent provided no improvement (entries 4 and 5). In all of these cases, the formation of the phenolate was observed to be slow in dichloromethane, prompting a change to sodium hydride as the base. Under these conditions, the phenolate formed almost instantaneously (as judged by vigorous evolution of hydrogen). Warming the mixture to 40 °C led to a favorable increase in the formation of 3 with respect to the other isomers as did a switch to carbon tetrachloride or benzene and heating at 80 °C (entries 6–8).
Table 1. Optimization of the C-Cinnamylation of Phenol.
| entry | solvent | base | temp (°C) | ratioa3/3′/3″ | yield of 3 + 3″b (%) |
|---|---|---|---|---|---|
| 1 | Et2O | Na | rt | 4.5:0.3:1 | 65 |
| 2 | THF | Na | rt | 1:2.5:trace | 12 |
| 3 | CH2Cl2 | Na | rt | 4:0:1 | 37 |
| 4 | CH2Cl2 | Li | rt | c | 0 |
| 5 | CH2Cl2 | K | rt | 2:0.4:1 | 29 |
| 6 | CH2Cl2 | NaH | 40 | 7:trace:1 | 66 |
| 7 | CCl4 | NaH | 80 | 9.5:0.4:1 | 68 |
| 8 | benzene | NaH | 80 | 9:1.5:1 | 74 |
Determined by 1H NMR spectroscopic analysis of the crude reaction mixtures.
Yield of isolated product.
Complex mixture.
The generality of this process was then evaluated by cinnamylation of a number of 2- and 4-substituted phenols under the optimized conditions. Thus, phenol itself afforded 3a in 71% yield (Table 2, entry 1). Both o- and p-cresol could be alkylated under the same conditions in 47 and 62% yield, respectively (entries 2 and 3). Cinnamylation of 4-hydroxyanisole afforded 3e in 49% yield (entry 4). Modestly electron-poor phenols such as 2f–h were also reactive under these conditions, albeit with extended reaction times (entries 5–7). The highly electron poor 4-CF3-substituted phenol 2i required refluxing toluene to effect complete conversion (entry 8). 2-Naphthol was alkylated at the 1-position selectively in 79% yield (entry 9). The reaction was not limited to cinnamyl chlorides: (E)-5-phenyl-1-pent-3-enyl chloride also reacted with phenol to afford 3l in 51% yield (entry 9). Finally, isoprenyl chloride could also be used in a similar fashion to afford the desired trisubstituted alkene 3m in 65% yield (entry 11).29
Table 2. Allylation of Substituted Phenols with Cinnamyl Chloride.
Yield of isolated, purified product.
Toluene was used as the reaction solvent.
2. Sulfenoetherification Reactions
In the course of previous investigations from these laboratories, the dependence of rate-, enantio-, and site-selectivity of sulfenoetherification on the substitution pattern and electron density of the alkene component was studied.16 However, changes in the reaction outcome as a function of structural variations at the nucleophile were not determined. Furthermore, the tether length was kept constant across the different substrates. The primary goals of this study were to evaluate the influence of (1) the steric and electronic properties of the nucleophile, in isolation and in competition, (2) the tether length, and (3) the presence of other Lewis basic functional groups for the sulfenoetherification of alkenes with phenolic hydroxyl groups as nucleophiles
2.1. Optimization of the Sulfenoetherification Reaction
The use of a phenolic hydroxyl group as the nucleophile afforded a unique opportunity to systematically vary both the steric and the electronic properties of the nucleophile. (E)-Cinnamylphenol (3a)12 was selected as a representative substrate for initial reaction optimization. The reaction temperature was chosen as −20 °C to avoid any potential enantiomeric erosion of the thiiranium ion.14b Previous studies showed that only 1.0 equiv of 1a was necessary for the reaction.16 The initial rate experiments revealed that excess acid was detrimental to the reaction rate; thus, 0.75 equiv was chosen as the starting point for optimization. Solvent and concentration were unchanged from the previous conditions for sulfenoetherification reactions. For catalyst 2, the exocyclic amine substituent strongly affects the enantioselectivity of the sulfenofunctionalization process. Thus, catalyst 2a (used in the first study) afforded the desired product with poor selectivity (Table 3, entry 1). Catalyst 2b formed product 4a in 46% yield and with an er of 95.1:4.9 (entry 2). Changing to catalyst 2c resulted in slightly lower enantioselectivity of 93.1:6.9 er (entry 3). Reducing the concentration of the reaction using catalyst 2b allowed the product to be obtained in 95% yield (entry 4).
Table 3. Optimization of the Sulfenocyclization Reactiona.
| entry | [3] (M) | acid (equiv) | catalyst | yieldb (%) | erc |
|---|---|---|---|---|---|
| 1 | 0.4 | 0.75 | 2a | 35d | 65.6:34.4 |
| 2 | 0.4 | 0.75 | 2b | 46e | 95.1:4.9 |
| 3 | 0.4 | 0.75 | 2c | 27f | 93.1:6.9 |
| 4 | 0.15 | 0.75 | 2b | 95 | g |
| 5 | 0.15 | 0.5 | 2b | 93 | 95.3:4.7 |
| 6 | 0.15 | 0.25 | 2b | 93 | 95.7:4.3 |
| 7 | 0.15 | 0.1 | 2b | 32h | 94.9:5.1 |
| 8 | 0.15 | 0.5i | 2b | 96 | 94.3:5.7 |
Reactions run on 0.1 mmol scale.
Yield of isolated, purified product.
Determined by CSP-SFC.
Isolated product contaminated with 2a.
Isolated product contaminated with 2b.
Isolated product contaminated with 2c.
Not determined.
Incomplete conversion was observed.
EtSO3H was used.
In all preceding sulfenofunctionalization studies, the loading of the Brønsted acid greatly affected the rate and selectivity of the reaction.21 In the sulfenoetherification with alcohols, maximum reactivity was reached at 0.6 equiv of methanesulfonic acid. Cyclization of substrate 3a using 0.75 equiv of acid was complete within 24 h. Decreasing the amount of acid to 0.5 equiv or even 0.25 equiv did not decrease the yield in the same time frame (entries 5 and 6). In all cases, high selectivity (>30:1) for endo capture to form the chroman was observed. Further decrease in the acid loading resulted in incomplete conversion and reduced yield (entry 7). The use of ethanesulfonic acid did not affect the enantioselectivity and was not pursued further (entry 8).
2.2. Sulfenocyclizations of Substituted (E)-2-Cinnamylphenols: Influence of Phenol Ring Substituents
The nucleophilicity of phenolic hydroxyl groups is influenced by both steric and electronic properties of ring substituents.30 Accordingly, a series of substituted (E)-2-cinnamylphenols was prepared and evaluated (Table 4). The parent substrate, 3a, which afforded 4a in 84% yield, 94.9:5.1 er, and >30:1 endo-selectivity was used as a benchmark (Table 4, entry 1). Methyl substituents at the 4- and 6-positions on the ring did not alter the reaction outcome meaningfully (entries 2 and 3). The presence of an extended π-system resulted in no change in yield and a very small decrease in er (entry 4). In all cases, high (>30:1) constitutional selectivity was observed.
Table 4. Sulfenocyclizations of Substituted (E)-2-Cinnamylphenolsa.
Reactions run on 1.0 mmol scale.
Yield of isolated, purified product.
Determined by CSP-SFC.
Electrophile 1c was used, AriPr = 2,6-(i-Pr)-C6H3.
Reaction run at 22 °C.
Determined after oxidation to the sulfone.
Next, the influence of heteroatom substituents on reaction outcome was evaluated. Electron-donating groups had little influence; for example, 3e bearing a 4-methoxy group cyclized to form 4e in 84% yield and 94.4:5.6 selectivity (entry 5). Bromophenol 3f cyclized to afford 4f in 81% yield and 93.8:6.2 er (entry 6), albeit with slightly extended reaction time. The more electronegative chloro- and fluoro-substituted substrates reacted in the same time frame, with 4g and 4h being produced in 70 and 82% yields, respectively (entries 7 and 8). The enantioselectivity of the reactions remained high with these substrates.
Phenol 3i, bearing a highly electron-withdrawing 4-CF3 group, was insufficiently reactive at −20 °C. Increasing the reaction temperature to 22 °C caused significant erosion of enantioselectivity (er 70.7:29.3, SI). Sterically bulky electrophile N-2,6-diisopropylphenylthiophthalimide (1c) prevents erosion at elevated reaction temperatures by shielding the intermediate thiiranium ion.21 Cyclization of 3i at room temperature using 1c proceeded smoothly, and 4i was isolated with 89% yield and 95.2:4.8 er (entry 9).
2.3. Sulfenocyclization of 2-Substituted Phenols: Influence of Alkene Substituent and Tether Length
Changes in the alkene substitution pattern have been documented to dramatically alter selectivity for the sulfenofunctionalization process.16 (E)-Disubstituted alkenes are the most selective substrates for sulfenoetherification, whereas terminal alkenes are only slightly less so. Trisubstituted, (Z)-, and 1,1-disubstituted alkenes reacted with poor selectivity. Thus, primarily (E)- and terminal alkenes were employed in this study. Initially, the (E)-phenyl substituent was varied. 2-Furyl-substituted benzopyran 4j was produced in 88% yield and 92.5:7.5 er, whereas 2-thienyl-substituted substrate 3k produced the desired product in 86% yield and 93.9:6.1 er (Table 5, entries 1 and 2). Changing the alkene substituent to an aliphatic group as in substrate 3l led to a 74% combined yield of a 1.5:1.0 mixture of isomers 4l and 5l with 96.6:3.4 er for 4l (entry 3). Trisubstituted alkenes generally led to less selective cyclizations with 1a.16 To increase selectivity, electrophile 1c, which has an improved selectivity profile, was tested with substrate 3m.21 In this case, use of 1c led to the formation of gem-disubstituted benzopyran 4m in 93% yield and 95.4:4.6 er (entry 4).
Table 5. Sulfenocyclizations of 2-Substituted Phenolsa.
Reactions run on 1.0 mmol scale.
Yield of isolated, purified product.
AriPr = 2,6-(i-Pr)-C6H3.
Determined by 1H NMR analysis of crude reaction mixtures.
Determined by CSP-SFC.
0.25 equiv MsOH was used.
Determined after oxidation to the sulfone.
endo/exo ratio for alcohol capture.
The site-selectivity of thiiranium capture during intramolecular sulfenocyclization is strongly influenced by the relative rates of formation of different size rings. The preparation of substrates with varying tether lengths enabled a systematic study of ring size effects (Table 5). Substrate 3n, which contains an (E)-2-styryl group at the end of a two-carbon tether, afforded the 7-endo cyclization product benzoxepane 4n in 92% yield and 94.4:5.6 er (entry 5). Further extending the tether to three methylene groups in substrate 3o proved problematic: under the optimized conditions using electrophile 1a, no desired product was observed. Gratifyingly, use of electrophile 1c led to the surprising formation of exo cyclization product 5o in 76% yield and 92.6:7.4 er (entry 6). Next, the electronic bias imparted by the phenyl group was removed to evaluate the site-selectivity of closure with a terminal alkene in the reaction with electrophile 1c. Substrate 3p reacted via a 6-exo-mode cyclization to afford 5p with high site-selectivity, 91% yield, and 97.2:2.8 er (entry 7). Extension of the tether length by one more methylene group, as in substrate 3q, was gratifyingly successful, as the cyclization proceeded in a 7-exo mode to afford product 5q, with 84% yield and 97.7:2.3 er (entry 8).
The Lewis basic nature of the selenophosphoramide moiety prompted an investigation into the compatibility of the reaction conditions with other Lewis basic functional groups in the substrate. Substrate 3r, containing a carboxylic ester group three carbons removed from the reacting olefin, afforded 5r in good yield albeit with somewhat diminished enantioselectivity compared to 3l (cf. entry 9 and Table 5, entry 3). Replacement of the ester by the corresponding ether in 3s restored the enantioselectivity in comparable yield (entry 10). The relative reactivity of other oxygen nucleophiles with respect to phenolic hydroxyl groups was also tested. Both carboxylic acids and alcohols outcompeted phenols for thiiranium capture. Substrate 3t, bearing a carboxylic acid moiety, preferentially afforded lactone 8t in 92% yield and 92.2:7.8 er (entry 11). In the presence of a remote hydroxyl group, such as in substrate 3u, saturated oxacycles 8u and 9u were formed as a 1.1:1 mixture of constitutional isomers in 88% combined yield and with 96.9:3.1 er and 97.1:2.9 er respectively (entry 12).
2.4. Transformations of Sulfenofunctionalization Products
The sulfenyl moiety in the product thioether can act as a locus for further transformations. Thus, a series of manipulations to explore the reactivity of the thioether group were carried out (Scheme 5). Reductive cleavage of 4a with nickel boride formed 2-phenylchroman in 71% yield. Oxidation of 4a with sodium metaperiodate led to sulfoxide 6 in 85% yield and in a 2:1 diastereomer ratio. Both diastereomers underwent thermal elimination in toluene, leading to the formation of 2-phenylchromene in 92% yield. Attempts to engage the sulfoxide in a Pummerer rearrangement were not successful. Instead, vinyl thioether 7, which results from loss of a proton from the thiocarbenium intermediate, was formed. In the presence of trifluoroacetic anhydride and pyridine, 7 was obtained in 94% yield. Unfortunately, 7 proved resistant to Ni-catalyzed cross coupling with Grignard reagents.
Scheme 5. Manipulations of 3-Phenylthiochroman.
Discussion
The systematic variation of reaction conditions, phenol substituents, tether length, and functional groups enabled a more thorough understanding of the factors governing the sulfenofunctionalization process. In this section, the influences of each of these components on observable reaction outcomes such as rate, enantioselectivity, and site-selectivity will be discussed in turn.
1. Optimization of the Sulfenofunctionalization Reaction
1.1. Catalyst
The optimization of the sulfenofunctionalization reaction focused on two main variables, the catalyst and the loading of the Brønsted acid. Exhaustive catalyst optimization for the sulfenofunctionalization process has been detailed elsewhere and was not repeated for this reaction.16 Of the three best catalysts for sulfenofunctionalization, optimum selectivity was achieved with 2b for reasons previously noted.21 Conversion across all catalysts was comparable.
1.2. Brønsted Acid
Previous kinetic studies established that for an alcohol nucleophile the υmax was reached with 0.6 equiv of methanesulfonic acid (MsOH).21 Further increases in the Brønsted acid loading led to decreases in reaction rate. Two major factors need to be considered for optimal MsOH loading: (1) the amount of acid necessary to fully transform the catalyst into active complex i and (2) the effective acidity of the reaction mixture as a result of solvation effects in nonpolar reaction media. In the proposed mechanistic cycle, the acid is present only in cocatalytic amounts; therefore, only 1.0 equiv of acid with respect to catalyst should be necessary. However, titration studies with ethanesulfonic acid together with 1a and 2c established that up to 4 equiv of acid is needed before full conversion to the sulfenylated species is observed.22 In the case of cyclizations of phenolic hydroxyl groups, high conversion could be achieved with as little as 2.5 equiv of MsOH with respect to catalyst. In contrast to alcohols, the phenolic hydroxyl group does not appear to act as a proton buffer.
The cyclization of 3a was complete within 24 h at −20 °C, compared to 93% after 24 h at the same temperature for the corresponding alcohol substrate.21 Thus, the rate of phenol cyclization is comparable to that of the alcohols. In the prior set of experiments, a large excess (10 equiv with respect to catalyst) of MsOH was employed, which led to rates slower than υmax. The decrease in rate at high MsOH concentrations was ascribed to protonation of the substrate by excess acid.21 In the case of phenols, no substantial changes in rate were observed as a result of increased acid concentration in the range of 2.5–7.5 equiv of MsOH with respect to catalyst. The substantially lower Brønsted basicity of phenols (pKa of PhOH2+, −6.5; pKa EtOH2+, −2.2)31 implies that a much smaller fraction of substrate is protonated even in the presence of an excess of acid. Thus, similar reaction rates are observed over a much broader range of acid stoichiometry.
2. Structural Effects on Rate and Selectivity
2.1. Influence of the Nucleophile
The rate, enantio-, and site-selectivity of sulfenofunctionalization of any alkene with a pendant nucleophile is dependent on a multitude of structural factors. Preceding studies showed a substantial impact of alkene environment on all three of these observables.13a However, no such systematic investigation for the nucleophile was undertaken. In an isolated example, the cyclization of a tertiary alcohol was comparable with that of a primary alcohol (eq 2).16 A previous study regarding the rate of sulfenocyclization of a number of protected amines did not identify specific reactivity trends.17 Thus, the cyclization of (E)-2-cinnamylphenols provided an opportunity to understand how the aforementioned observables are impacted by the steric and electronic properties of the nucleophile.
![]() |
2 |
2.1.1. Reaction Rate
The turnover-limiting step of the sulfenofunctionalization reaction for alcohols is thiiranium ion formation; hence, for these substrates thiiranium ion capture is fast.21 As mentioned previously, phenols are substantially weaker nucleophiles than alcohols.31 However, the rates of cyclization of 3a, 3b, 3c, and 3e were comparable. Thus, the turnover-limiting step does not change for electron-neutral or -rich phenol nucleophiles. Naphthols are slightly stronger nucleophiles than phenols, and in agreement with the aforementioned turnover-limiting thiiranium ion formation, the rate of cyclization of 3d was not affected.31
Introduction of weakly electron-withdrawing substituents led to slightly slower overall rates. The electron-withdrawing property of the substituents on phenols is a composite effect of the inductive (σI) and resonance (σR) contributions of the substituent to the electron density on the phenol.32 Chlorine and bromine both strongly withdraw electron density inductively (σI Br, 0.49; Cl, 0.43) but also donate electron density through π-resonance (σR Br, −0.16; Cl, −0.16).32 Fluorine is a strongly withdrawing substituent inductively, but also a much better π-donor (σI F, 0.57; σR F, −0.33) such that its overall effect is comparable. In contrast, a trifluoromethyl group is both inductively and mesomerically electron withdrawing (σI CF3, 0.46; σR CF3, 0.09). The reaction of Br-, Cl-, and F-substituted phenols (3f, 3g, and 3h, respectively) were all only slightly slower at −20 °C compared to parent substrate 3a. The reaction does not appear to be sensitive to either of these parameters. However, for CF3-bearing substrate 3i the reaction needed to be performed at room temperature.
The substantial difference in rate between 3a and 3i (cf. Table 4, entries 1 and 9) suggests that the turnover-limiting step has changed from formation of the thiiranium ion to capture for electronically deactivated nucleophiles. Although the lifetime of the thiiranium ion intermediate derived from 3i likely increases as a result of slow capture, the high chemical yield implies that the thiiranium ion is stable when 1c is used as the electrophile.
2.1.2. Enantioselectivity
Because thiiranium ions are configurationally stable in dichloromethane at −20 °C,14b their enantiomeric composition should be retained throughout the remaining reaction steps.21 Notably, capture of thiiranium ions derived from styrenes by C-, N-, and O-nucleophiles results in the same absolute configuration and comparable levels of product enantioenrichment (eq 3).16,17
![]() |
3 |
For the participation of phenolic hydroxyl groups, the enantioselectivity of sulfenocyclization remained uniformly high for electron-rich phenols. However, the change in mechanism from turnover-limiting formation to turnover-limiting capture raises the possibility of erosion of enantioselectivity as a consequence of increased thiiranium ion lifetime and attendant racemization. No decrease in enantioselectivity is observed for substrates bearing halogen substituents, confirming the overall stereochemical stability of the thiiranium ion for slightly extended lifetimes at −20 °C For the trifluoromethyl-substituted phenol, the lack of reactivity required that the reaction be run at 23 °C, leading to decreased product enantioselectivity with electrophile 1a (eq 4).
![]() |
4 |
To attenuate the racemization, electrophile 1c, bearing a bulky 2,6-diisopropylphenyl group, was used. The 2,6-substituents impart both slightly higher intrinsic selectivity to 1c as well as increased stability to the resulting thiiranium ions as was seen with alcohol 10 (eq 5).21 The use of 1c in the reaction of 3i resulted in a dramatic increase in selectivity (eq 4). Thus, configurational erosions of thiiranium ions can be ameliorated through increased steric shielding of the sulfur atom.
![]() |
5 |
2.1.3. Site-Selectivity
The site-selectivity for the sulfenoetherification follows the established Markovnikov rule.25 Reaction of (E)-2-cinnamylphenols can proceed through either a 5-exo cyclization to afford a benzofuran or a 6-endo cyclization to afford a chroman. Only chromans were observed as reaction products in the cyclization of (E)-2-cinnamylphenols. Changes in the electron density or steric bulk of the nucleophile had no effect on site-selectivity. Opening of the thiiranium ion through a Friedel–Crafts-type process (i.e., C-aryl cyclization) was not observed, demonstrating that the chemoselectivity of capture is high, irrespective of arene electron density.4c,18
2.2. Influence of Alkene Environment
The alkene environment represents the most important variable that can influence both the rate and the selectivity of the sulfenocyclization process.21 This sensitivity has been evident in numerous sulfenofunctionalizations.16−19 In general, higher alkene electron density leads to increased reactivity. Enantioselectivity is most sensitive to the alkene substitution pattern, whereas site-selectivity is governed by the aforementioned Markovnikov selectivity, albeit complicated by the potential for isomerization of certain sets of constitutional isomers under the reaction conditions.
2.2.1. Rate
The rate of cyclization was expected to follow a well-defined trend of alkene electron density. The reaction times for substrates with disubstituted alkenes demonstrated that the reactivity difference between heteroaryl, aryl and alkyl substituents was not substantial for disubstituted alkenes (3a,k,l,s; 24 h at −20 °C). However, because both mono- and trisubstituted alkenes required electrophile 1c for high selectivity, direct comparison of the rate of cyclization for terminal alkene 3p and trisubstituted alkene 3m with their respective analogs 3s and 3l is not possible.
The strongly acidic nature of the reaction conditions raised the possibility of cationic alkene cyclization or polymerization as a competitive side reaction, especially for substrates with electron-rich alkenes.33 For example, in the cyclization of a 4-tolyl-substituted alkene in the Friedel–Crafts alkylation process, a proton-initiated cyclization was observed (eq 6).22 No evidence of acid-catalyzed polymerization or cyclization was observed for the current set of styrenes.
![]() |
6 |
Conjugated electron-rich heteroarenes are significantly more susceptible to polymerization. Thus, when MsOH was added to a mixture of 2-furylalkene 3j, 2b, and 1a in dichloromethane at −20 °C, rapid polymerization was observed and no identifiable product was obtained. If the order of addition was changed to introduce 3j last, the desired reaction pathway was restored. The effective acid concentration in solution clearly has a substantial impact on the rate of polymerization for sensitive alkenes.22
2.2.2. Enantioselectivity
The enantiomeric composition of the final products in sulfenofunctionalizations is determined by the enantioenrichment of their precursor thiiranium ions.16,17 The enantioselectivity of thiiranium ion formation is, in turn, determined by the transition-state complex consisting of alkene and intermediate i. Computation of the energies of the diastereomeric transition states revealed that catalyst distortion is the most important contributor to the difference in transition-state free energies.21 Thus, changes in alkene substitution pattern and consequently the degree of distortion that the catalyst experiences to accommodate the substituents are expected to substantially impact the stereoselectivity of the process. Indeed, foregoing studies have demonstrated that the enantiotopic faces of (Z)- and 1,1-disubstituted alkenes are poorly differentiated by the active sulfenylating agent derived from 2b.16,21
The enantioselectivity of the sulfenoetherifications herein was consistent among aryl-, heteroaryl-, and alkyl-substituted (E)-alkenes (4a, 94.9:5.1; 4k, 93.9:6.1; 4l, 96.6:3 4k). The nature of the oxygen nucleophile played only a minor role as phenols, alcohols, and carboxylic acids cyclized with comparable enantioselectivities (4a, 94.9:5.1; 8u, 96.9:3.1; 8t, 92.2:7.8). The high enantioselectivities observed independent of nucleophile parameters are in good agreement with the current hypothesis of stereodetermining thiiranium formation.
Terminal alkenes are usually difficult substrates for enantioselective alkene functionalizations due to the absence of steric differentiation at the terminus.34 Lower enantioselectivities have been observed previously for sulfenofunctionalization with this class of substrates (eq 7).16 Therefore, more selective electrophile 1c was employed for the cyclization of terminal alkenes 3p and 3q. Thus, the use of 1c in the cyclization of 3p afforded an enantioselectivity of 97.2:2.8. (cf. Table 5, entries 5 and 7). Similarly, cyclization of 3q proceeded with high enantioselectivity even at elevated temperature (97.7:2.3).
![]() |
7 |
Trisubstituted alkenes are challenging substrates for selective sulfenofunctionalization. In the cyclization of pendant alcohols, both (E)- and (Z)-trisubstituted alkenes afford the corresponding products with poor enantioselectivities (60:40 and 70:30 respectively, eq 8).16 The higher intrinsic selectivity of sulfenylating agent 1c was beneficial to this class of substrates as well, as benzopyran 4m was produced with 95.4:4.6 er.
![]() |
8 |
2.2.3. Site-Selectivity
The Markovnikov rule for site-selectivity holds well for the cyclization of alkenes wherein the nucleophile is three atoms removed (cf. 2.1.3). The investigation of constitutional site-selectivity of the reaction alcohols to thiiranium ions derived from biased alkenes demonstrated that cyclization preferentially occurs at the stabilized position. For unbiased alkenes, a mixture of isomers is obtained, although an in situ isomerization process from the 5-exo isomer to the 6-endo isomer precluded analysis of kinetically controlled selectivity.16 In contrast, high 5-exo selectivity is observed for carboxylic acid cyclizations. The cyclization of phenolic hydroxyl groups proceeds similarly to the alcohols, with high Markovnikov site-selectivity. The influence of resonance stabilization (presence of a Ph substituent, cf. Table 5, entry 5) or inductive stabilization (disubstituted carbon atom of the thiiranium ion, Table 5, entry 4) is sufficient for high selectivity. Moreover, a mixture of isomers is observed in the absence of electronic bias (Table 5, entry 3). The presence of a phenolic hydroxyl group did not otherwise impact selectivity, as the cyclization of 3u proceeded to give a mixture of isomers, whereas carboxylic acid 3t displayed very high 5-exo selectivity, confirming previous trends (Table 5, entries 11 and 12).16
For capture of an electronically unbiased thiiranium ion by a phenolic hydroxyl group three atoms away, the Markovnikov rule predicts poor selectivity. Instead, the controlling factor is the relative rate of 5-exo to 6-endo cyclization. Indeed, in the case of substrate 3l, a 1.5:1.0 ratio of 4l/5l from endo vs exo cyclization, respectively, was obtained (Table 5, entry 3). Direct comparison to the corresponding aliphatic alcohol, which afforded a 5:1 ratio of endo:exo isomers, is not warranted due to the presence of Csp2 atoms in the tether.16 Instead, comparisons can be drawn to intramolecular phenolic opening of other tethered three-membered electrophiles. The opening of a disubstituted alkyl epoxide by a phenolic hydroxyl group proceeds exclusively exo, whereas the iodine-mediated cyclization of 2-crotylphenol,35a which proceeds through an iodonium intermediate, affords solely the endo product35b (eqs 9 and 10). The intrinsic selectivity of phenol capture is therefore highly dependent on the nature of the electrophilic moiety, wherein increased charge and larger atoms in the three-membered ring result in higher formation of the endo product. Thiiranium ions are between these two extremes, and consequently, low selectivity is observed.
![]() |
9 |
The ratio 4l/5l is independent of conversion. In this particular case, the reduced basicity of a benzopyran oxygen compared to a pyran as well as the reduced MsOH loading likely retard isomerization, leading to poor site-selectivity that represents kinetic control.
2.3. Influence of Tether Length
On the basis of the observed characteristics of the sulfenofunctionalization reaction, changes in the tether length were primarily expected to affect the rate- and site-selectivity of the process. As the alkene environment is constant among the various substrates, the enantioselectivity was not expected to vary. Indeed, comparable substrates displayed similar enantioselectivities irrespective of tether length (3a and 3n, 3p and 3q).
2.3.1. Rate
The free energy barrier to cyclization for medium-sized rings is highly dependent on ring size.36 Consequently, the relative rates of endo and exo capture of the thiiranium ions are dependent on the sizes of the rings being formed. The rate of cyclization of substrate 3n, bearing one more atom in the tether than 3a, is similar to the rate of 3a (cf. Table 4, entry 1, and Table 5, entry 5, Scheme 6a). Similarly, the rates of cyclization of dialkyl-substituted substrates 3l and 3s are comparable (Table 5, entries 3 and 10, Scheme 6b,c). Overall, for 5-exo, 6-endo, 6-exo, and 7-endo capture, thiiranium ion formation appears to be turnover-limiting, and no effect on rate as a function of tether length is observed. In contrast, substantially different rates are observed for the cyclization of 3p and 3q (12 h vs 48 h) which have, respectively, two and three methylene units in their tethers (Table 5, entries 7 and 8, Scheme 6d). The cyclization of 3o, also bearing a three-carbon tether, with 1c, required elevated temperature compared to the shorter 3n (22 °C vs −20 °C, Table 5, entries 5 and 6). Attempts to cyclize 3o with 1a for comparison purposes failed, with primarily decomposition products being formed (Scheme 6a). Thus, both 7-exo and 8-endo cyclizations are generally disfavored in comparison to the aforementioned modes. The overall relative rates as a function of cyclization mode can then be expressed as 8-endo ≪ 7-exo < 7-endo ∼ 6-exo ∼ 6-endo ∼ 5-exo. In conjunction with these rates, a structural feature for change of the rate-determining step can be established. For 7-endo and more facile closures, thiiranium formation remains turnover-limiting; however, for less favored closures such as 7-exo and 8-endo, capture becomes turnover-limiting. The importance of sterically shielding the thiiranium ion reactions with turnover-limiting capture is clearly illustrated by the failure of 1a to promote the cyclization of 3o.
Scheme 6. Influence of Tether Length and Substituents on Constitutional Site Selectivity.
2.3.2. Site-Selectivity
Changing the tether length introduces substantial bias into the cyclization due to the higher energy associated with forming 7-membered and larger rings.36,37 The cyclization of electronically unbiased alkenes with two-carbon tethers (3s and 3r) shows that the intrinsic selectivity for 6-exo over 7-endo highly favors the 6-exo product. However, 3n, which bears a phenyl substituent, cyclized selectively to the benzoxepane 4n. Thus, a kinetic preference exists for cyclization following the Markovnikov rule. Surprisingly, the cyclization of 3o did not follow the expected trend. Under standard reaction conditions, decomposition was observed. The increased kinetic barrier to either 8-endo or 7-exo cyclization extends the lifetime of the thiiranium ion such that decomposition processes intervene. The use of the electrophile 1c led to preferential 7-exo cyclization. In this case, the increased stability imparted to the thiiranium ion is sufficient to prevent decomposition, whereupon successful capture can take place. The observed site-selectivity is dominated by the kinetic preference for formation of a seven- vs eight-membered ring. The subtle interplay between enthalpic and entropic contributions is similar to that exhibited with epoxide substrates wherein the cyclization of an electronically unbiased epoxide affords the 5-exo isomer vs the 6-endo isomer with high selectivity whereas an electronically biased epoxide opens with opposite selectivity (eq 11).38
![]() |
11 |
2.4. Influence of Lewis Basic Functional Groups
The sulfenofunctionalization process relies on a moderately Lewis basic selenophosphoramide to promote the catalytic process. Therefore, the sensitivity of the reaction to other Lewis basic functional groups that may be present in the reaction was of interest. In comparison with the reaction of 3a, no effect on rate was observed for any of the four Lewis basic groups tested (alcohol, acid, ester, ether), although in these cases 0.5 equiv of acid was used to counteract any potential buffering effects.
The enantioselectivity of the reactions was consistently high except for 4r and 8t, which showed slight erosion. The interaction of the carbonyl group either directly with the thiiranium ion during its formation or with the complex during its capture may lead to this erosion. Given the small magnitude of the change, the interaction appears to be weak. The site-selectivity for ester 4r was slightly lower than for 3s, which also suggests an interaction not present with the ether functional group.
If two competent nucleophiles are present in the molecule, such as in 3t and 3u, capture with either nucleophile is possible. The chemoselectivity of the reaction is then dependent on, in addition to the ring size as discussed, the relative rates of cyclization for either nucleophile. Both a carboxylic acid and an alcohol outcompeted the phenolic hydroxyl group for thiiranium capture.39 Clearly, the lesser nucleophilicity of the phenolic hydroxyl group with respect to other oxygen nucleophiles is sufficient to disfavor aryl ether formation.30 Interestingly, the chemoselectivity does not correlate with proton affinity, as the pKa of a protonated carboxylic acid is somewhat higher than that for a protonated phenol (pKa,aq: PhCO2H2+ −7.8 vs PhOH2+ −6.5).31 The discrepancy suggests that the kinetic preference for formation of a five-membered ring via 5-exo closure dominates the reaction of 3t.16 In contrast, alcohol 3u formed 8u and 9u in almost equimolar ratio, compared to previous results where a 5:1 isomer ratio favoring the pyran was observed (Schemes 7a,b).16 There appears to be no intrinsic kinetic preference for 5-exo vs 6-endo cyclization for alcohols with three carbon tethers, though the product ratio for the aliphatic alcohol may not represent kinetic control.
Scheme 7. Constitutional Site Selectivity for 4-Pentenols.
Conclusions
A highly enantioselective sulfenocyclization of alkenes with tethered phenolic hydroxyl groups to afford substituted chromans has been developed. A systematic variation of the nucleophile component and tether length allowed further trends in sulfenofunctionalization to be identified. The reaction was insensitive to changes in the steric properties of the nucleophile. The nucleophile electron density only made a difference for highly electron-deficient phenols. The reaction rate did not change for one- and two-methylene tethers, and both benzopyrans and benzoxepanes were readily prepared, whereas further increases in tether length resulted in slower reactions. Enantioselectivity was unaffected by changes in the nucleophile component or tether length. Nucleophilic capture occurred at the more electronically biased location of the thiiranium ion. In the absence of electronic bias, the intrinsic site-selectivity of sulfenofunctionalization was low for one-methylene tethers but high for two-methylene tethers. Carboxylic acids and alcohols were more reactive toward thiiranium ions than phenolic hydroxyl groups, and high chemoselectivity was observed in competition experiments. Substrates which displayed low reactivity at −20 °C were amenable to sulfenofunctionalization with hindered electrophile 1c at higher temperatures. The increased thiiranium ion stability as a result of shielding prevented erosion of enantioselectivity that had previously plagued reactions at such temperatures. The effects and influences identified here are predicted to be general for capture of thiiranium ions by other nucleophiles. Expansion of both scope and selectivity to other nucleophiles will be reported in due course.
Experimental Section
General Experimental Methods
All reactions were performed in oven- (160 °C) and/or flame-dried glassware under an atmosphere of dry argon unless otherwise noted. All reaction temperatures correspond to internal temperatures measured with Teflon-coated thermocouples. A ThermoNesLab CC-100 or a ThermoNesLab IBC-4A Cryocool with an attached Cryotrol was used for reactions at subambient temperatures.
1H and 13C NMR spectra were recorded on Varian Unity (400 MHz, 1H; 101 MHz, 13C) or Inova (500 MHz, 1H; 126 MHz, 13C) spectrometers. 31P and 19F NMR spectra were recorded on Inova (202 MHz) and Inova (470 MHz) spectrometers, respectively. Acquisition times were 4.096 s for 1H NMR, 1.024 s for 13C NMR, 0.655 s for 31P NMR, and 0.328 s for 19F NMR. Spectra are referenced to residual chloroform (δ = 7.26 ppm, 1H; 77.0 ppm, 13C). Chemical shifts are reported in parts per million; multiplicities are indicated by s (singlet), d (doublet), t (triplet), q (quartet), p (pentet), h (hextet), sept (septet), m (multiplet), and br (broad). Coupling constants, J, are reported in hertz, integration is provided, and assignments are indicated. Assignments were confirmed through 2-D COSY and HMQC experiments. Elemental analysis for was performed by the University of Illinois Microanalysis Laboratory or Robertson Microlit Laboratories. Mass spectrometry (MS) was performed by the University of Illinois Mass Spectrometry Laboratory. Electron Impact (EI) spectra were performed at 70 eV using methane as the carrier gas on a Finnegan-MAT C5 spectrometer. Chemical Ionization (CI) spectra were performed with methane reagent gas on a Micromass 70-VSE spectrometer. Electrospray Ionization (ESI) spectra were performed on a Micromass Q-Tof Ultima spectrometer. Data are reported in the form of m/z (intensity relative to the base peak = 100). Infrared spectra (IR) were recorded on a PerkinElmer FT-IR system, and peaks are reported in cm–1 with indicated relative intensities: s (strong, 0–33% T); m (medium, 34–66% T), w (weak, 67–100% %), and br (broad). Melting points (mp) were determined on a Thomas-Hoover capillary melting point apparatus in sealed tubes under vacuum and are corrected.
Analytical thin-layer chromatography (TLC) was performed on Merck silica gel 60 F254 or Merck silica gel 60 RP-18 F254s plates. Silver-impregnated silica was prepared by first dissolving 5 g of AgNO3 in 30 mL of deionized water. The resulting homogeneous solution was added to 50 g of SiO2 in a mortar. The clumpy silica paste was ground with a pestle until free-flowing. The mortar was then covered in aluminum foil and placed in an oven (160 °C) for 3 h. The vessel was then removed from the oven and allowed to cool in a desiccator. No special precautions were necessary during the chromatography process; however, prolonged (>6 h) exposure to visible light resulted in the formation of black Ag nanoparticles and a loss of column separation power. Visualization was accomplished with UV light and/or ceric ammonium molybdate (CAM) solution. Rf values reported were measured using a 10 × 2 cm TLC plate in a developing chamber containing the solvent system described. Flash chromatography was performed using Merck silica gel 60 230–400 mesh (60–63 μ, 60 Å pore size). Analytical chiral stationary phase supercritical fluid chromatography (CSP-SFC) was performed on an Agilent 1100 HPLC equipped with an Aurora Systems A-5 supercritical CO2 adapter for supercritical fluid chromatography and a UV detector (220 or 254 nm) using Daicel Chiralcel OD, OJ, OB or Chiralpak AD, and AS columns as well as a Regis Whelk-O1 column. Normal-phase HPLC was performed on an Agilent 1100 HPLC equipped with AD-H, OJ-H, IB-3, naphthylleucine, and R,R-Beta-Gem columns. Reversed-phase HPLC was performed on an Agilent 1100 HPLC using a Chiralpak AD-RH or Chiralcel OJ-RH column.
Literature Preparations
Synthesis of Reagents
The following compounds were prepared according to literature procedures: N-(phenylthio)phthalimide (1a),16N-[(2,6-diisopropylphenyl)thio]phthalimde (1c),21 4-(N-azepano)-3,5-dimethyl-3,5-dihydrodinaphtho[2,1-d:1′,2′][1,3,2]diazaphosphepine 4-selenide (2a),16 4-(diisopropylamino)-3,5-dimethyl-3,5-dihydrodinaphtho[2,1-d:1′,2′-f][1,3,2]diazaphosphepine 4-selenide (2b),17 and 4-(diisobutyl-1-amino)-3,5-dimethyl-3,5-dihydrodinaphtho[2,1-d:1′,2′-f][1,3,2]diazaphosphepine 4-selenide (2c).18 Methanesulfonic acid and ethanesulfonic acid were dried as described in the literature.22 Substrates 2-((E)-3-thiophene-ylprop-2-en-1-yl)phenol (3k),40 2-(but-3-en-1-yl)phenol (3p)41 and 2-(pent-4-en-1-yl)phenol (3q)42 were prepared as described. Intermediates (E)-3-(furan-2-yl)-1-(2-hydroxyphenyl)prop-2-en-1-one (S2)43 and diethyl (E)-2-(5-(2-hydroxyphenyl)pent-2-en-1-yl)malonate (S3)44 were prepared as described.
Preparation of 2-Substituted Phenols with One Methylene Tether
General Procedure 1
To a 50 mL, oven-dried Schlenk
flask was added washed, dry NaH (1.05 equiv) in a glovebox. The flask
was transferred to a Schlenk line. Solvent (0.5 M) was added to afford
a cloudy mixture. The mixture was placed in an ice bath and the corresponding
phenol (1 equiv) was added portion wise. During this phase, substantial
gas evolution was observed. The insoluble material appeared to change
in texture from an amorphous, cloudy particulate matter to a finely
distributed crystallized solid. The reaction was removed from the
ice bath and then allowed to stir at rt for 30 min. Subsequently,
cinnamyl chloride (1.1 equiv) was added dropwise via syringe. After
the addition was complete, the reaction was placed in an oil bath
and then heated to reflux for the specified amount of time. After
completion of the reaction as judged by TLC, the flask was removed
from the heat source and allowed to cool to rt. The mixture was then
transferred to a separatory funnel, diluted with water (20 mL) and
dichloromethane (20 mL), and then acidified to pH < 1 with slow
addition of a 6 M HCl solution. The aqueous layer was separated and
then back-extracted with a further 30 mL of dichloromethane. The combined
organic layers were then washed with brine, dried over MgSO4, and then filtered through glass wool. The filtrate was dried under
reduced pressure (∼3 mmHg, rotary evaporator). The residue
was then taken up in 10 mL of dichloromethane. Celite was added, and
the mixture was concentrated to afford a white powder, which was then
subjected to flash column chromatography. A second flash column chromatography
operation was then performed using silica impregnated with 10% AgNO3 (w/w).
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)phenol (3)
Following general procedure
1, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), phenol
(0.94 g, 10 mmol), and cinnamyl chloride (1.53 mL, 11 mmol) were combined
in a 50 mL Schlenk flask. The reaction was worked up according to
the general procedure. Silica gel flash column chromatography (3:1
hexanes/toluene, 30 mm diameter, 14 cm of SiO2) followed
by a second silica gel flash column chromatography (9:1, hexanes/ethyl
acetate, 30 mm diameter, 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.49 g of 3 (71%) as a pale oil that solidified upon standing. The spectroscopic
data matched those reported in the literature.45 Data for 3: 1H NMR (500 MHz, CDCl3) δ 7.39–7.35 (m, 2H), 7.33–7.28 (m, 2H),
7.25–7.14 (m, 3H), 6.92 (td, J = 7.4, 1.2
Hz, 1H), 6.83 (dd, J = 7.9, 1.2 Hz, 1H), 6.52 (d, J = 15.9 Hz, 1H), 6.40 (dt, J = 15.9, 6.5
Hz, 1H), 3.59 (d, J = 6.0 Hz, 1H); 13C
NMR (126 MHz, CDCl3) δ 154.2, 137.3, 131.8, 130.7,
128.8, 128.2, 128.1, 127.6, 126.5, 125.9, 121.3, 116.0, 34.4; MS (EI,
70 eV, m/z) 210 (100, M+), 119 (33), 115 (38),104 (66), 91 (82), 69 (45).
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-methylphenol (3b)
Following general
procedure 1, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), p-cresol (1.08 g, 10 mmol), and cinnamyl chloride (1.53
mL, 11 mmol) were combined in a 50 mL Schlenk flask. The reaction
was worked up according to the general procedure. Silica gel flash
column chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 cm
of SiO2) followed by a second silica gel flash column chromatography
(9:1, hexanes/ethyl acetate, 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.05 g of 3b (47%) as a pale oil that solidified upon standing. The
spectral data matched those reported in the literature.46 Data for 3b: 1H NMR
(500 MHz, CDCl3) δ 7.40–7.35 (m, 2H), 7.32
(td, J = 7.6, 1.1 Hz, 2H), 7.26–7.21 (m, 1H),
7.06 (t, J = 8.3 Hz, 1H), 6.84 (t, J = 7.5 Hz, 1H), 6.56 (d, J = 16.0 Hz, 0H), 6.41
(dtd, J = 15.8, 6.6, 1.0 Hz, 1H), 4.96 (s, 1H), 3.59
(dd, J = 6.7, 1.6 Hz, 2H), 2.28 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 149.7, 135.1, 129.3, 128.9,
128.2, 126.5, 126.2, 126.1, 125.2, 124.2, 124.1, 123.4, 113.6, 32.1,
18.5; MS (EI, 70 eV, m/z) 224 (100,
M+), 209 (30), 133 (55), 115 (30), 104 (35), 91 (69), 77
(22).
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-6-methylphenol (3c)
Following general
procedure 1, NaH (252 mg, 10.5 mmol), CCl4 (20 mL), o-cresol (1.08 g, 10 mmol), and cinnamyl chloride (1.53
mL, 11 mmol) were combined in a 50 mL Schlenk flask. The reaction
was worked up according to the general procedure. Silica gel flash
column chromatography (3:1 hexanes/toluene, 30 mm diameter, 14 cm
of SiO2) followed by a second silica gel flash column chromatography
(9:1, hexanes/ethyl acetate, 30 mm diameter 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded
1.38 g of 3c (62%) as a pale oil that solidified upon
standing. The spectral data matched those reported in the literature.47 Data for 3c: 1H NMR
(500 MHz, CDCl3) δ 7.41–7.35 (m, 2H), 7.34–7.30
(m, 2H), 7.23 (ddd, J = 12.8, 6.5, 1.7 Hz, 1H), 7.06
(t, J = 8.7 Hz, 1H), 6.90–6.80 (m, 1H), 6.56
(d, J = 16.0 Hz, 0H), 6.41 (ddd, J = 15.9, 8.0, 5.6 Hz, 1H), 3.59 (dd, J = 6.6, 1.7
Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 152.5,
136.9, 131.6, 129.4, 128.5, 128.1, 127.9, 127.4, 126.2, 124.9, 124.0,
120.4, 34.6, 15.9; MS (EI, 70 eV, m/z) 224 (100, M+), 209 (33), 168 (26), 141 (28), 120 (29),
115 (52), 105 (47), 91 (71), 77 (76), 69 (41).
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-methoxyphenol (3e)
Following general
procedure 1, NaH (252 mg, 10.5 mmol), CCl4 (20 mL),
4-methoxyphenol (1.24 g, 10 mmol), and cinnamyl chloride (1.53 mL,
11 mmol) were combined in a 50 mL Schlenk flask. The reaction was
worked up according to the general procedure. Silica gel flash column
chromatography (3:1, hexanes/toluene, 30 mm diameter, 14 cm of SiO2) followed by a second silica gel flash column chromatography
(9:1 hexanes/ethyl acetate, 30 mm diameter, 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded
1.17 g of 3e (49%) as a pale oil that solidified upon
standing. The spectral data matched those reported in the literature.48 Data for 3e: 1H NMR
(500 MHz, CDCl3) δ 7.39–7.14 (m, 5H), 6.81–6.65
(m, 3H), 6.48 (d, 1H, J = 15.9 Hz), 6.35 (dt, J = 15.9, 6.5 Hz, 1H), 3.74 (s, 3H), 3.52 (d, J = 5.7 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ
153.8, 147.9, 137.0, 131.5, 128.5, 127.7, 127.3, 126.8, 126.2, 116.4,
116.0, 112.6, 55.7, 34.3; MS (EI, 70 eV, m/z) 240 (100, M+), 149 (66), 136 (99), 121 (25),
115 (31), 108 (44), 91 (79), 77 (21).
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-bromophenol (3f)
Following general
procedure 1, NaH (252 mg, 10.5 mmol), CCl4 (20 mL),
4-bromophenol (1.73 g, 10 mmol), and cinnamyl chloride (1.53 mL, 11
mmol) were combined in a 50 mL Schlenk flask. The reaction was worked
up according to the general procedure. Silica gel flash column chromatography
(3:1 hexanes/toluene, 30 mm diameter, 16 cm of SiO2) followed
by a second silica gel flash column chromatography (9:1, hexanes/ethyl
acetate, 30 mm diameter, 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.62 g of 3f (56%) as a pale oil that solidified upon standing. The
spectroscopic data matched those reported in the literature.49 Data for 3f: 1H NMR
(500 MHz, CDCl3) δ 7.42–7.19 (m, 5H), 6.74
(ddd, J = 9.9, 8.5, 1.3 Hz, 1H), 6.53 (dd, J = 15.9, 1.7 Hz, 1H), 6.36 (dt, J = 15.9,
6.6 Hz, 0H), 4.99 (d, J = 1.3 Hz, 0H), 3.55 (dd, J = 6.6, 1.6 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 153.4, 150.1, 137.1, 133.2, 132.4, 130.8, 128.8,
128.3, 127.8, 127.1, 126.5, 117.7, 113.2, 34.1; MS (EI, 70 eV, m/z) 290 (71, M+ + 2), 288 (76,
M+), 209 (93), 131 (24), 118 (39), 115 (45), 104 (100),
91 (82), 77 (41).
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-chlorophenol (3g)
Following general
procedure 1, NaH (252 mg, 10.5 mmol), CCl4 (20 mL),
4-chlorophenol (1.28 g, 10 mmol), and cinnamyl chloride (1.53 mL,
11 mmol) were combined in a 50 mL Schlenk flask. The reaction was
worked up according to the general procedure. Silica gel flash column
chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 cm of SiO2) followed by a second silica gel flash column chromatography
(9:1, hexanes/ethyl acetate, 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 1.49 g of 3g (61%) as a yellow oil that solidified upon standing. The
spectroscopic data matched those reported in the literature.50 Data for 3g: 1H NMR
(500 MHz, CDCl3) δ 7.43–7.07 (m, 5H), 6.77
(d, J = 8.5 Hz, 1H), 6.57–6.49 (m, 1H), 6.36
(dt, J = 15.9, 6.6 Hz, 1H), 4.97 (s, 1H), 3.60–3.47
(m, 2H); 13C NMR (126 MHz, CDCl3) δ 159.4,
152.8, 137.1, 132.4, 130.3, 128.8, 127.8, 127.7, 127.1, 126.5, 117.2,34.1;
MS (EI, 70 eV, m/z) 246 (33, M++2), 244 (96, M+), 209 (75), 165 (19), 153 (42),
115 (42), 105 (60), 104 (100), 91 (87), 81 (40), 77 (59), 69 (81).
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-fluorophenol (3h)
Following general
procedure 1, NaH (252 mg, 10.5 mmol), CCl4 (20 mL),
4-fluorophenol (1.12 g, 10 mmol), and cinnamyl chloride (1.53 mL,
11 mmol) were combined in a 50 mL Schlenk flask. The reaction was
worked up according to the general procedure. Silica gel flash column
chromatography (3:1 hexanes/toluene, 30 mm diameter, 16 cm of SiO2) followed by a second silica gel flash column chromatography
(9:1, hexanes/ethyl acetate, 30 mm diameter, 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded
1.73 g of 3h (76%) as a yellow oil that solidified upon
standing.51 Data for 3h: bp
100 °C (ABT, 3 × 10–5 mm Hg); 1H NMR (500 MHz, CDCl3) δ 7.40–7.32 (m, 2H,
HC(12)), 7.29 (ddd, J = 7.9, 6.2, 1.3 Hz, 2H, HC(11)),
7.24–7.18 (m, 1H, HC(13)), 6.88 (dd, J = 9.0,
3.0 Hz, 1H, HC(5)), 6.82 (td, J = 8.3, 3.1 Hz, 1H,
HC(3)), 6.74 (dd, J = 8.7, 4.7 Hz, 1H, HC(2)), 6.49
(dt, J = 15.7, 1.5 Hz, 1H, HC(9)), 6.33 (dt, J = 15.9, 6.6 Hz, 1H, HC(8)), 3.52 (dd, J = 6.6, 1.5 Hz, 2H, HC(7)); 13C NMR (126 MHz, CDCl3) δ 157.2 (d, J = 232 Hz, C4), 149.8
(C1), 136.9 (C10), 132.0 (C9), 128.6 (C12), 127.5 (C13), 127.3 (d, J = 7 Hz, C6), 126.9 (C9), 126.2 (C11), 116.6 (d, J = 23 Hz, C5)), 116.5 (d, J = 8.5 Hz,
C2), 113.9 (d, J = 25 Hz, C3), 34.0 (C7); 19F NMR (470 MHz, CDCl3) δ −123.9 (m); IR (ATR,
cm–1) 3429 (br), 3027 (w), 1619 (w), 1598 (w), 1494
(s), 1438 (s), 1327 (w), 1254 (w), 1176 (s), 1141 (m), 1090 (w), 1028
(w), 958 (m), 928 (w), 872 (w), 809 (m), 748 (s), 731 (m), 716 (w),
692 (s); MS (EI, 70 eV, m/z) 228
(100, M+), 137 (46), 115 (21), 109 (21), 104 (85), 91 (57)
HRMS calcd for C15H13OF 228.0950, found 228.0952,
error 0.7; TLC Rf 0.30
(4:1, hexanes/ethyl acetate) [UV,CAM].
Preparation of (E)-2-(3-Phenyl-2-propen-1-yl)-4-(trifluoromethyl)phenol (3i)
Following general
procedure 1, NaH (126 mg, 5.25 mmol), toluene (10 mL), 4-(trifluoromethyl)phenol
(810 mg, 5 mmol), and cinnamyl chloride (715 μL, 5.5 mmol) were
combined in a 50 mL Schlenk flask. The reaction was worked up according
to the general procedure. Silica gel flash column chromatography (3:1
hexanes/toluene, 30 mm diameter, 16 cm of SiO2) followed
by a second silica gel flash column chromatography (9:1, hexanes/ethyl
acetate, 30 mm diameter, 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 885 mg of 3i (64%) as a clear oil that solidified upon standing. Data
for 3i: bp 120 °C (ABT, 3.2 × 10–5 mm Hg); 1H NMR (500 MHz, CDCl3) δ 7.47–7.28
(m, 5H, HC(aryl)), 7.28–7.21 (m, 2H, HC(11)), 6.88 (d, J = 8.2 Hz, 1H, HC(2)), 6.54 (dt, J = 15.8,
1.6 Hz, 1H, HC(9)), 6.36 (dt, J = 15.9, 6.6 Hz, 1H,
HC(8)), 5.26 (s, 1H, OH), 3.61 (d, J = 6.6 Hz, 2H,
HC(7)); 13C NMR (126 MHz, CDCl3) δ 156.9
(C1), 136.9 (C10), 132.5 (C9), 128.9 (C-aryl), 127.9 (q, J = 3.8 Hz, C5), 127.8 (C-aryl), 126.9, (C8), 126.50 (C-aryl), 125.5
(q, J = 3.9 Hz, C3), 116.0 (C2), 34.3 (C7); 19F NMR (470 MHz, CDCl3) δ −61.56 (s);
IR (ATR, cm–1) 3498 (br), 3027 (w), 2923 (w), 1614
(w), 1496 (w), 1485 (w), 1448 (w), 1355 (s), 1335 (s), 1250 (w), 1201
(s), 1152 (s), 1114 (s), 1028 (w), 967 (m), 928 (w), 889 (w), 805
(w), 743 (m), 692 (s); MS (EI, 70 eV, m/z) 278 (4, M+), 260 (83), 223 (30),184 (23), 168 (60),
156 (35), 149 (40), 141 (60), 128 (51), 115 (74), 104 (40), 91 (69),
77 (100); HRMS calcd for C16H13OF3 278.0919, found 278.0912, error −2.4; TLC Rf 0.33 (4:1, hexanes/ethyl acetate) [UV,CAM].
Preparation of (E)-1-(3-Phenyl-2-propen-1-yl)naphthalen-2-ol (3d)
Following general
procedure 1, NaH (252 mg, 10.5 mmol), CCl4 (20 mL),
2-naphthol (1.44g, 10 mmol), and cinnamyl chloride (1.53 mL, 11 mmol)
were combined in a 50 mL Schlenk flask. The reaction was worked up
according to the general procedure. Silica gel flash column chromatography
(3:1 hexanes/toluene, 30 mm diameter, 16 cm of SiO2) followed
by a second silica gel flash column chromatography (9:1, hexanes/ethyl
acetate, 30 mm diameter, 50 g of SiO2 (10% AgNO3 w/w)) afforded 2.05 g (79%) of 3d as a pale pink solid.
The spectroscopic data matched those reported in the literature.52 Data for 3d: mp 62–64 °C
(hexanes); 1H NMR (500 MHz, CDCl3) δ 8.00
(d, J = 8.6 Hz, 1H), 7.82 (d, J =
8.1 Hz, 1H), 7.72 (d, J = 8.8 Hz, 1H), 7.52 (ddt, J = 8.2, 6.9, 1.3 Hz, 1H), 7.39–7.35 (m, 1H), 7.34–7.29
(m, 2H), 7.30–7.24 (m, 2H), 7.22–7.18 (m, 1H), 7.16–7.09
(m, 2H), 6.47 (p, J = 1.9 Hz, 2H), 4.01 (dd, J = 3.1, 1.4 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 151.1, 137.2, 133.3, 130.9, 129.4, 128.6, 128.4,
128.3, 127.6, 127.1, 126.6, 126.1, 126.0, 123.2, 123.1, 117.9, 117.1,
28.43; MS (EI, 70 eV, m/z) 260 (100,
M+), 169 (59), 156 (36), 128 (38), 117 (25), 115 (24),
104 (44), 91 (38).
Preparation of (E)-2-(5-Phenylpent-2-en-1-yl)phenol (3l)
Following general
procedure 1, NaH (126 mg, 5.25 mmol), toluene (10 mL), phenol
(470 mg, 5 mmol), and (E)-(5-chloro-3-penten-1-yl)benzene53 (990 mg, 5.5 mmol) were combined in a 50 mL
Schlenk flask. The reaction was worked up according to the general
procedure. Silica gel flash column chromatography (3:1, hexanes/toluene,
30 mm diameter, 16 cm of SiO2) followed by a second silica
gel flash column chromatography (9:1, hexanes/ethyl acetate, 30 mm
diameter SiO2 (10% AgNO3 w/w)) afforded a pale
oil. Distillation afforded 940 mg of 3l (79%) as a clear
oil. Data for 3l: bp 160 °C (ABT, 0.05 mmHg); 1H NMR (500 MHz, CDCl3) δ 7.30–7.26
(m, 2H, HC(aryl)), 7.21–7.10 (m, 5H, HC(aryl)), 7.05 (dd, J = 7.5, 1.7 Hz, 1H, HC(5)), 6.87 (td, J = 7.4, 1.2 Hz, 1H, HC(4)), 6.82 (dd, J = 8.0, 1.2
Hz, 1H, HC(2)), 5.64 (ddd, J = 5.5, 3.9, 1.7 Hz,
2H, HC(8), HC(9)), 5.01 (s, 1H, OH), 3.35 (dd, J =
4.5, 1.8 Hz, 2H, HC(7)), 2.70 (dd, J = 8.8, 6.7 Hz,
2H, HC(11)), 2.42–2.32 (m, 2H, HC(10)); 13C NMR
(126 MHz, CDCl3) δ 154.2 (C1), 141.7 (C12), 131.9
(C9), 130.2 (C5), 128.4 (C13), 128.3 (C8), 128.2 (C14), 127.8 (C15),
125.8 (C3, C6), 120.8 (C4), 115.8 (C2), 35.7 (C11), 34.2 (C10), 34.0
(C7); IR (ATR, cm–1) 3531 (br), 3083 (w), 3062 (w),
3026 (w), 2922 (w), 2852 (w), 1602 (w), 1591 (w), 1585 (w), 1489 (m),
1453 (s), 1435 (w), 1328 (w), 1254 (m), 1212 (m), 1169 (m), 1152 (w),
1097 (m), 1038 (w), 1030 (w), 970 (m), 936 (w), 916 (w), 842 (w),
798 (w), 749 (s), 697 (s); MS (EI, 70 eV, m/z) 238 (95, M+), 147 (100), 131 (21), 107 (42),
91 (62); TLC Rf 0.27
(4:1, hexanes/ethyl acetate) [UV,CAM]. Anal. Calcd for C17H18O (238.33): C, 85.67; H, 7.61. Found: C, 85.31; H,
7.63.
Preparation of 2-(3-Methylbut-2-en-1-yl)phenol (3m)
Following general
procedure 1, NaH (126 mg, 5.25 mmol), CCl4 (10 mL),
phenol (470 mg,
5 mmol), and prenyl chloride (605 μL, 5.5 mmol) were combined
in a 50 mL Schlenk flask. The reaction was worked up according to
the general procedure. Silica gel flash column chromatography (3:1,
hexanes/toluene, 30 mm diameter, 16 cm of SiO2) followed
by a second silica gel flash column chromatography (9:1, hexanes/ethyl
acetate, 30 mm diameter, 50 g of SiO2 (10% AgNO3 w/w)) afforded a pale oil. Distillation afforded 525 mg (65%) of 3m as a clear oil. The spectroscopic data matched those reported
in the literature.54 Data for 3m: 1H NMR (500 MHz, CDCl3) δ 7.14 (t, J = 7.4 Hz, 1H), 6.89 (td, J = 7.5, 1.2
Hz, 1H), 6.83 (dt, J = 7.6, 1.3 Hz, 1H), 5.35 (dddd, J = 7.3, 5.8, 2.9, 1.5 Hz, 1H), 5.09 (s, 1H), 3.38 (d, J = 7.2 Hz, 2H), 1.80 (dd, J = 5.1, 1.4
Hz, 6H); 13C NMR (126 MHz, CDCl3) δ 154.1,
129.8, 127.3, 121.8, 120.6, 115.5, 29.4, 25.7, 17.7; MS (EI, 70 eV, m/z) 162 (21, M+), 145 (39),
133 (38), 115 (33), 107 (100), 91 (77), 77 (47).
Preparation of (E)-2-(3-(Furan-2-yl)allyl)phenol (3j)
To a 5 mL Schlenk flask equipped with a stir bar were added, under argon, (E)-3-(furan-2-yl)-1-(2-hydroxyphenyl)prop-2-en-1-one S2 (749 mg, 3.5 mmol), THF (3.5 mL), and triethylamine (535 μL, 3.85 mmol, 1.1 equiv). To this solution was added with vigorous stirring ethyl chloroformate (370 μL, 3.85 mmol, 1.1 equiv). The color of the solution changed from dark brown to light gold with concomitant precipitation of solid triethylammonium chloride. The mixture was stirred for a further 30 min, and the reaction was assayed for completion by TLC. To a separate 50 mL flask, under argon and equipped with a stir bar, were added ethanol (15 mL) and cerium chloride heptahydrate (1.56 g, 4.2 mmol, 1.2 equiv), and the resulting clear solution was stirred for 20 min. The solution containing the ethyl carbonate of the starting material was then filtered into the second flask through glass wool. THF (2 × 5 mL) was used to wash the flask and filter cake. To the resulting light yellow solution was added NaBH4 (160 mg, 4.2 mmol, 1.2 equiv), and the solution was stirred for a further 1 h. Water (1 mL) was added to quench the reaction, and the solution was then stirred for a further 15 min. The resulting heterogeneous mixture was transferred to a 125 mL separatory funnel and diluted with water (15 mL) and CH2Cl2 (30 mL). The layers were separated, and the aqueous layer was extracted with CH2Cl2 (2 × 30 mL). The organic layers were combined, dried over MgSO4, and concentrated by rotary evaporation (30 °C, 3 mmHg). The crude material thus obtained was redissolved in 10 mL of CH2Cl2 and adsorbed onto Celite. Purification by silica gel flash column chromatography (12:1 hexanes/ethyl acetate, 20 mm diameter, 18 cm of SiO2) followed by bulb-to-bulb diffusion pump distillation afforded 112 mg (16%) of 3j as a pale yellow oil. Data for 3j: bp 70 °C (ABT, 2 × 10–4 mm Hg); 1H NMR (500 MHz, CDCl3) δ 7.33 (d, J = 1.8 Hz, 1H, HC(11)), 7.17 (m, 2H, HC(3), HC(5)), 6.93 (t, J = 7.5 Hz, 1H, HC(4)), 6.83 (d, J = 7.9 Hz, 1H, HC(6)), 6.41–6.31 (m, 2H, HC(8), HC(12)), 6.28 (d, J = 15.9 Hz, 1H, HC(9)), 6.18 (d, J = 3.3 Hz, 1H, HC(13)), 4.87 (s, 1H, OH), 3.55 (d, J = 6.3 Hz, 2H, HC(7)); 13C NMR (126 MHz, CDCl3) δ 154.1 (C1), 141.9 (C2), 130.8 (C3), 128.2 (C5), 127.0 (C8), 121.3 (C9), 120.2 (C4), 115.9 (C6), 111.4, 107.3 (C13), 33.9 (C7); IR (ATR, cm–1) 3409 (br), 1593 (w), 1489 (m), 1455 (s), 1232 (m), 1095 (w), 1012 (m), 964 (m), 753 (s); MS (EI, 70 eV, m/z) 200 (100, M+), 171 (16), 131 (19), 107 (16), 94 (54), 81 (24); HRMS calcd for C13H12O2 200.0837, found 200.0842, error 2.3; TLC Rf 0.36 (4:1, hexanes/ethyl acetate) [UV,CAM].
Preparation of 2-Substituted Phenols with Two or More Methylene Tethers
Preparation of (E)-2-(4-Phenylbut-3-en-1-yl)phenol55 (3n)
To a 50 mL Schlenk
flask under argon was added BuLi (2.23 M in hexanes, 9.5 mL, 21 mmol,
2.1 equiv) followed by a further 4 mL of hexanes. Tetramethylethylenediamine
(TMEDA, 2.44 g, 21 mmol, 2.1 equiv) was added via syringe, and the
flask was placed in a −78 °C bath (dry ice/i-PrOH). The internal temperature was monitored until it dropped below
−40 °C. Cresol (1.08 g, 10 mmol) was dissolved in hexanes
(6 mL) and added to the cold mixture as a solution. To this cold mixture
was then added solid KO-t-Bu (2.36 g, 21 mmol, 2.1
equiv). The formation of a yellow suspension was observed. The flask
was then removed from the −78 °C bath and placed in a
−20 °C bath (i-PrOH, IBC-4A Cryocool),
and the solution within was allowed to stir for 30 min. The flask
was then removed and allowed to warm to rt over 15 min. THF (10 mL)
was added. The flask was then returned to the aforementioned −78
°C bath, and the internal temperature was monitored until it
was below −60 °C and then allowed to equilibrate for a
further 20 min. Cinnamyl chloride (1.98 g, 13 mmol, 1.3 equiv) was
dissolved in THF (2 mL) and added to the mixture. The solution was
then allowed to warm to rt and stirred for 1 h. The reaction was quenched
by the addition of aq satd NH4Cl (10 mL). The mixture was
transferred to a 250 mL separatory funnel and the pH adjusted to <1
with 6 M HCl. The layers were separated, and the aqueous layer was
extracted with ether (2 × 30 mL). The organic layers were combined,
dried over MgSO4, filtered, and concentrated (30 °C,
3 mmHg). The product was purified by two successive silica gel flash
column chromatography operations (1, 9:1 hexanes/ethyl acetate, 30
mm diameter, 15 cm of SiO2; 2, 50:1 toluene/ethyl acetate,
30 mm diameter, 14 cm of SiO2) and then distilled under
vacuum to afford 330 mg (15%) of 3n as a clear oil. The
spectroscopic data match those reported in the literature.55 Data for 3n: 1H NMR:
(400 MHz, CDCl3) δ 7.38 (d, J =
6.9 Hz, 2H, HC(12)), 7.33 (t, J = 7.7 Hz, 2H, HC(13)),
7.24 (t, J = 7.2 Hz, 1H, HC(14)), 7.20 (dd, J = 7.5, 1.6 Hz, 1H, HC(3)), 7.14 (td, J = 7.7, 1.7 Hz, 1H, HC(5)), 6.93 (td, J = 7.4, 1.1
Hz, 1H, HC(4)), 6.81 (dd, J = 8.0, 1.2 Hz, 1H, HC(6)),
6.48 (dt, J = 15.9, 1.4 Hz, 1H, HC(10)), 6.33 (dt, J = 15.8, 6.9 Hz, 1H, HC(9)), 4.69 (s, 1H, OH), 2.84 (dd, J = 8.8, 6.6 Hz, 2H, HC(7)), 2.62–2.54 (app q, J = 7.5 Hz, 2H, HC(8)); 13C NMR (126 MHz, CDCl3) δ 153.7, 137.9, 130.7, 130.6, 130.4, 128.7, 127.5,
127.2, 126.2, 121.1, 115.5, 115.1, 33.5, 30.4; MS (EI, 70 eV, m/z) 224 (59, M+), 117 (100),
115 (26), 107 (97), 91 (20), 77 (20).
Preparation of (E)-2-(5-Phenylpent-4-en-1-yl)phenol (3o)
Dichloromethane was degassed by being purged
with argon for 30 min. To a 10 mL flask was added Grubbs-I-indenylidene
catalyst (46 mg, 0.05 mmol, 0.033 equiv) in a glovebox. The flask
was transferred to a Schlenk line, and degassed dichloromethane (3
mL), 3q (241 mg, 1.5 mmol) and styrene (890 μL,
7.5 mmol, 5 equiv) were added in order. The solution was stirred for
24 h, whereupon a second portion of catalyst (23 mg, 0.025 mmol, 0.016
equiv) was added. The solution was then stirred for a further 24 h.
The solution was then transferred to a 100 mL RB flask, and the volatiles
were removed by rotary evaporation (30 °C. Three mm Hg). The
material was redissolved in 10 mL of CH2Cl2 and
adsorbed onto Celite. Purification by silica gel flash column chromatography
(12:1 hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) followed by distillation afforded 150 mg (42%) of 3o as a clear oil. Data for 3o: bp 150 °C (ABT, 0.05
mmHg); 1H NMR (400 MHz, CDCl3) δ 7.35
(d, J = 8.1 Hz, 2H, HC(13)), 7.30 (t, J = 7.6 Hz, 2H, HC(14)), 7.20 (t, J = 7.2 Hz, 1H,
HC(15)), 7.14 (d, J = 7.4 Hz, 1H, HC(3), 7.09 (t, J = 7.7 Hz, 1H, HC(5)), 6.88 (t, J = 7.4
Hz, 1H, HC(4)), 6.76 (d, J = 8.0 Hz, 1H, HC(6)),
6.42 (d, J = 16.1 Hz, 1H, HC(11), 6.26 (dt, J = 15.9, 6.7 Hz, 1H, HC(10), 4.65 (s, 1H, OH), 2.68 (t, J = 7.7 Hz, 1H, HC(7), 2.29 (q, J = 6.9
Hz, 1H, HC(9)), 1.82 (p, J = 7.4 Hz, 1H, HC(8)); 13C NMR (126 MHz, CDCl3) δ 153.8 (C1), 138.1
(C12), 130.9 (C3), 130.6 (C11), 130.5 (C10), 128.8 (C14), 128.6 (C2),
127.4 (C5), 127.2 (C15), 126.3 (C13), 121.1 (C4), 115.6 (C6), 33.0
(C9), 29.7 (C7), 29.6 (C8); IR (ATR, cm–1) 3401
(br), 3059 (w), 3025 (w), 2926 (w), 2857 (w), 1650 (w), 1592.1 (w),
1490 (m), 1454 (s), 1327 (m), 1234 (m), 1169 (w), 1104 (w), 1068 (w),
1042 (w), 1028 (w), 963 (s), 933 (w), 911 (w), 842 (w), 747 (s), 691
(s); MS (EI, 70 eV, m/z) 238 (100,
M+), 147 (45), 131 (34), 117 (42), 107 (74), 91 (43), 77
(25); TLC Rf 0.44 (4:1
hexanes/ethyl acetate) [UV,CAM]. Anal. Calcd for C16H16O (224.34): C, 85.67; H, 7.61. Found: C, 85.27; H, 7.43.
Preparation of Ethyl (E)-7-(2-Hydroxyphenyl)hept-4-enoate (3r)
To a 50 mL RB flask equipped with a stir
bar were added, under argon, LiI (1.87 g, 14 mmol, 4 equiv) and NaCN
(189 mg, 3.85 mmol, 1.1 equiv). To this was added DMSO (10 mL), and
the solution was stirred for 15 min. The diester S3 (1.12
g, 3.5 mmol) was then dissolved in DMSO (10 mL) and added to the stirring
solution. The solution was heated to 160 °C (internal temperature,
oil bath) for 3 h. Consumption of starting material was monitored
by TLC. The flask was then removed from the heat source and allowed
to cool to rt. The solution was transferred to a 125 mL separatory
funnel and diluted with water (50 mL) and ethyl acetate (50 mL). Use
of other solvent ratios occasionally resulted in persistent emulsions.
The layers were separated, and the aqueous layer was extracted with
ethyl acetate (50 mL). The organic layers were washed thoroughly (5
× 30 mL water) and then washed with brine (15 mL), dried over
MgSO4, filtered, and concentrated by rotary evaporation
(30 °C, 3 mmHg). The material was then redissolved in 10 mL of
diethyl ether and adsorbed onto Celite. Purification by silica gel
flash chromatography (7:1 hexanes/ethyl acetate, 20 mm diameter, 18
cm of SiO2) followed by bulb-to-bulb vacuum distillation
afforded 476 mg (57%) of 3r as a clear oil. Data for 3r: bp 130 °C (ABT, 0.05 mmHg); 1H NMR (500
MHz, CDCl3) δ 7.15–7.05 (m, 2H, HC(3), HC(5)),
6.87 (t, J = 7.4 Hz, 1H, HC(4)), 6.78 (d, J = 7.9 Hz, 1H, HC(6)), 5.57 (dt, J = 15.3,
6.7 Hz, 1H, HC(9)), 5.47 (dt, J = 15.3, 6.0 Hz, 1H,
HC(10)), 5.24 (s, 1H, OH), 4.16 (q, J = 7.1 Hz, 2H,
HC(14)), 2.68 (dd, J = 8.7, 6.7 Hz, 2H, HC(11)),
2.42–2.26 (m, 6H, HC(7), HC(8), HC(10)), 1.28 (t, J = 7.1 Hz, 3H, HC(15)); 13C NMR (126 MHz, CDCl3) δ 173.8 (C13), 153.9 (C1), 131.2 (C9), 130.5 (C3), 129.1
(C10), 128.2 (C2), 127.4 (C5), 120.9 (C4), 115.6 (C6), 60.7 (C14),
34.5 (C7/C8/C10), 32.9 (C7/C8/C10), 30.4(C11), 28.1 (C7/C8/C10), 14.5
(C15); IR (ATR, cm–1) 3416 (br), 2981 (w), 2926
(w), 2854 (w), 1706 (s), 1608 (w), 1593 (w), 1504 (w), 1490 (w), 1455
(s), 1372 (m), 1344 (w), 1299 (w), 1232 (s), 1176 (s), 1150 (s), 1101
(m), 1033 (m), 968 (m), 850 (m), 751 (s); MS (EI, 70 eV, m/z) 248 (29, M+), 107 (100); TLC Rf 0.31 (4:1, hexanes/ethyl
acetate) [UV,CAM]. Anal. Calcd for C15H20O3 (248.32): C, 72.55; H, 8.12. Found: C, 72.43; H, 8.14.
Preparation of (E)-7-(2-Hydroxyphenyl)hept-4-enoic Acid (3t)
To a 10 mL Schlenk flask under argon were added ester 3r (447 mg, 1.8 mmol) and THF (10 mL). Water was added via syringe (2.5 mL) followed by solid LiOH·H2O (272 mg, 6.48 mmol, 3.6 equiv). The solution was allowed to stir 16 h at rt. The mixture was transferred to a 60 mL separatory funnel and diluted with ether (30 mL) and water (20 mL). The biphasic mixture was acidified with 1 M HCl to pH < 2, whereupon a white precipitate formed, which disappeared upon thorough shaking. The layers were separated, and the aqueous layer was extracted with ether (2 × 15 mL). The organic layers were combined, washed with brine (15 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation (30 °C, 3 mmHg). The material was redissolved in 10 mL of diethyl ether and then was adsorbed onto Celite. Purification by silica gel flash column chromatography (4:1 hexanes/ethyl acetate, 30 mm diameter, 16 cm of SiO2) followed by recrystallization from hexanes (5 mL) afforded 326 mg (83%) of 3t as white spindles. Data for 3t: mp 108–110 °C (hexanes); 1H NMR (500 MHz, CDCl3) δ 7.17–7.08 (m, 2H, HC(3), HC(5)), 6.91 (t, J = 7.4 Hz, 1H, HC(4)), 6.80 (d, J = 7.9 Hz, 1H, HC(2)), 5.60 (dt, J = 15.6, 6.5 Hz, 1H, HC(9)), 5.50 (dt, J = 15.4, 6.3 Hz, 1H, HC(10)), 2.70 (dd, J = 8.5, 6.6 Hz, 2H, HC(8)), 2.45 (t, J = 7.1 Hz, 2H, HC(11)), 2.35 (app p, J = 6.8 Hz, 4H, HC(7), HC(12)); 13C NMR (126 MHz, CDCl3) δ 179.0 (C13), 153.6 (C1), 131.4 (C10), 130.6 (C5), 128.8 (C9), 128.0 (C2), 127.4 (C3), 121.1 (C4),115.6 (C6), 34.1 (C11), 32.9 (C7), 30.3 (C8), 27.8 (C12); IR (ATR, cm–1) 3184 (br), 3042 (w), 2934 (w), 2908 (w), 1703 (s), 1613 (w), 1591 (m), 1503 (w), 1455 (s), 1441 (m), 1425 (m), 1409 (m), 1373 (m), 1280 (m), 1262 (w), 1236 (s), 1192 (s), 1109 (w), 1041 (w), 990 (w), 974 (s), 930 (w), 909 (w), 845 (w), 821 (m), 747 (s), 688 (w); MS (EI, 70 eV, m/z) 220 (16, M+), 137 (16), 107 (100); TLC Rf 0.06 (4:1, hexanes/ethyl acetate) [UV,CAM]. Anal. Calcd for C13H16O3 (220.27): C, 70.89; H, 7.32. Found: C, 71.12; H, 7.24.
Preparation of (E)-2-(7-Hydroxyhept-3-en-1-yl)phenol (3u)
To a 50 mL Schlenk flask under argon were
added lithium aluminum hydride (126 mg, 3.3 mmol, 1.5 equiv) and THF
(4 mL). The flask was placed in an ice bath for 10 min. Ester 3r (520 mg, 2.2 mmol) was dissolved in THF (4 mL) and added
dropwise to the cold solution. The solution was then allowed to stir
at 0 °C for 2 h. The flask was then once again placed in an ice
bath for 15 min. The reaction was quenched by the addition of water
(2 mL, dropwise) with substantial gas evolution and the formation
of copious amounts of solids. After addition of water was complete,
a further 5 mL of water was added, followed by dropwise addition of
6 M HCl to pH < 2. The resulting biphasic mixture was transferred
to a 125 mL separatory funnel and then shaken well. The layers were
separated, and the aqueous layer was extracted with diethyl ether
(3 × 20 mL). The organic layers were combined, washed with brine
(15 mL), dried over MgSO4, filtered, and concentrated by
rotary evaporation (30 °C, 3 mmHg). The resulting material was
dissolved in 10 mL of ether and adsorbed onto Celite. Purification
by silica gel flash column chromatography (3:1 hexanes/ethyl acetate,
20 mm diameter, 17 cm of SiO2) followed by bulb-to-bulb
distillation afforded 416 mg (91%) of 3u as a clear oil.
Data for 3u: bp 140 °C (ABT, 0.05 mmHg); 1H NMR (500 MHz, CDCl3) δ 7.17–7.07 (m, 2H,
HC(3), HC(5)), 6.90 (t, J = 8.0 Hz, 1H, HC(4)), 6.79
(d, J = 8.2 Hz, 1H, HC(6)), 5.56 (dt, J = 15.1, 6.5 Hz, 1H, HC(9)), 5.48 (dt, J = 15.6,
6.5 Hz, 1H, HC(10)), 3.65 (t, J = 6.5 Hz, 2H, HC(13)),
2.71 (dd, J = 8.3, 6.8 Hz, 2H, HC(7)), 2.35 (q, J = 7.4 Hz, 2H, HC(8)), 2.12 (q, J = 6.8
Hz, 2H, HC(11)), 1.65 (p, J = 6.8 Hz, 2H, HC(12)); 13C NMR (126 MHz, CDCl3) δ 154.2 (C1), 130.8
(C10), 130.5 (C5), 130.3 (C9), 128.5 (C2), 127.3 (C3), 120.7 (C4),
115.7 (C6), 62.6 (C13), 33.1 (C8), 32.2 (C12), 30.3 (C7), 29.0 (C11);
IR (ATR, cm–1) 3307 (br), 3033 (w), 2932 (w), 2851
(w), 1607 (w), 1592 (w), 1504 (w), 1489 (w), 1455 (m), 1354 (w), 1238
(m), 1178 (w), 1153 (w), 1094 (w), 1042 (m), 1015 (w), 968 (w), 929
(w), 847 (w), 750 (s); MS (EI, 70 eV, m/z) 206 (20, M+), 120 (14), 107 (100); TLC Rf 0.1 (4:1 hexanes/ethyl acetate) [UV,CAM].
Anal. Calcd for C13H18O2 (206.29):
C, 75.69; H, 8.80. Found: C, 75.48; H, 8.56.
Preparation of (E)-2-(7-Methoxyhept-3-en-1-yl)phenol (3s)
This compound was prepared in two ways. Method A: To a 10 mL Schlenk flask in a glovebox was added NaH (27 mg, 1.1 mmol, 2.1 equiv). The flask was transferred to the Schlenk line, and THF (1.5 mL) was added. To this was added the alcohol 3u (103 mg, 0.5 mmol) in THF (0.5 mL). The solution was stirred for 15 min at rt, and MeI (34 μL, 0.55 mmol, 1.1 equiv) was added dropwise. The solution was then allowed to stir at rt for 16 h. The reaction was quenched by the addition of water (1 mL) and 1 M HCl (0.5 mL). The mixture was transferred to a 60 mL separatory funnel and diluted with ether (10 mL) and water (10 mL) and the pH adjusted to <2 with 3 M HCl. The layers were separated, and the aqueous layer was extracted with ether (2 × 10 mL). The organic layers were combined, washed with brine (15 mL), dried over MgSO4, and concentrated by rotary evaporation (30 °C, 3 mmHg). Purification by silica gel flash column chromatography (12:1 hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) afforded 63 mg (57%) of 3s as a clear oil. Method B: To a 10 mL Schlenk flask were added S4 (368 mg, 1.3 mmol) and THF (15 mL). The flask was cooled to −76 °C (internal temperature, dry ice/i-PrOH). BuLi (2.3 M, 620 μL, 1.43 mmol, 1.1 equiv) was added via syringe, and the solution was allowed to stir for 1 h. Triisopropyl borate (489 mg,2.6 mmol, 2.0 equiv) was added via syringe, and the solution was allowed to warm to rt. After the solution was stirred for 6 h at rt, the flask was placed in an ice bath. In a separate 25 mL RB flask, a basic hydrogen peroxide solution was prepared by combining 20 mL of 30% H2O2 with 2 g of NaOH. A portion of this solution (2 mL) was then added dropwise to the flask containing the borate (strong exotherm) followed by the remaining 8 mL of basic peroxide, and the solution was allowed to stir for 5 h at rt. The excess peroxide solution was quenched with satd aq Na2S2O3. After the allotted time had passed, the mixture was transferred to a 125 mL separatory funnel, and satd aq Na2S2O3 was added until no more peroxide was evident (Quantifix test strip). The mixture was then diluted with ether (15 mL) and water (15 mL) and acidified with 1 M HCl to pH < 2. The layers were separated, and the aqueous layer was extracted with ether (3 × 10 mL). The organic layers were combined, dried over MgSO4, filtered, and concentrated by rotary evaporation (30 °C, 3 mmHg). Purification by silica gel flash column chromatography (12:1 hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) followed by bulb-to-bulb vacuum distillation afforded 213 mg (76%) of 3s as a clear oil (76%). Data for 3s: bp 100 °C (ABT, 0.05 mmHg); 1H NMR: (500 MHz, CDCl3) δ 7.15–7.05 (m, 2H, HC(3), HC(5)), 6.88 (t, J = 7.6 Hz, 1H, HC(4)), 6.77 (d, J = 8.0 Hz, 1H, HC(6)), 5.62–5.38 (m, 2H, HC(9), HC(10)), 3.45–3.32 (m, 5H, HC(13), HC(14)), 2.68 (dd, J = 8.6, 6.7 Hz, 2H, HC(7)), 2.32 (app q, J = 7.8 Hz, 2H, HC(8)), 2.11–2.01 (app q, J = 7.7 Hz, 2H, HC(11)), 1.64 (app p, J = 7.2, 6.8 Hz, 2H, HC(12)); 13C NMR (126 MHz, CDCl3) δ 153.8 (C1), 130.7 (C9), 130.5 (C5), 130.3 (C10), 128.2 (C2), 127.4 (C3), 120.9 (C4), 115.6 (C6), 72.4 (C13), 58.7 (C14), 33.0 (C8), 30.5 (C7), 29.5 (C11), 29.3 (C12); IR (ATR, cm–1) 3308 (br), 2930 (w), 2852 (w), 1607 (w), 1593 (w), 1504 (w), 1489 (w), 1455 (s), 1353 (w), 1234 (m), 1179 (m), 1099 (m), 1042 (w), 968 (m), 931 (w), 847 (w), 750 (s); MS (EI, 70 eV, m/z) 220 (17, M+), 149 (15), 107 (100), 81 (35); TLC Rf 0.33 (4:1 hexanes/ethyl acetate) [UV,CAM]. Anal. Calcd for C14H20O2 (220.31): C, 76.33; H, 9.15. Found: C, 76.10; H, 8.91.
Sulfenocyclizations of Substituted (E)-2-Cinnamylphenols
General Procedure 2
To a 10 mL, oven-dried flask equipped
with a magnetic stir bar under an argon atmosphere were added substrate
and CH2Cl2. The catalyst and the electrophile
were added as solids and allowed to dissolve to obtain a clear or
pale yellow solution. The reaction vessel was placed in an i-PrOH bath kept at constant temperature by means of a Neslab
IBC-4A Cryocool with probe. The reaction mixture was cooled to the
appropriate reaction temperature, and the internal temperature was
checked. After the temperature stabilized to ±2 °C, MsOH
was added to the stirring reaction mixture via syringe. (Note: It
is important to not let the acid touch the walls of the reaction vessel
as it may immediately freeze.) After addition of the acid, rapid formation
of a yellow color was observed. The reaction mixture was then stirred
for the appropriate time. Over the course of the reaction, white crystals
of phthalimide precipitate out of the mixture. After the reaction
was complete as judged by TLC and 1H NMR spectroscopy,
Et3N was added directly to the cold reaction mixture. The
flask was then allowed to warm to rt, whereupon the white crystals
slowly dissolved to afford a homogeneous solution. This solution was
then either (1) poured into a separatory funnel containing 1 M NaOH
solution, shaken well, extracted with dichloromethane, dried, and
concentrated or (2) directly concentrated. Subsequently, 1H NMR spectra of the crude residue were recorded. Products were purified
by silica flash chromatography, and analytically pure samples were
obtained by recrystallization or distillation as specified.
Preparation of (2S,3R)-2-Phenyl-3-(phenylthio)chromane (4a)
Following general
procedure 2, 3a (210 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv) and catalyst (S)-2b (52 mg, 0.1
mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After equilibration
(ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv) was added
directly via syringe. The solution was allowed to stir for 24 h at
constant temperature during which time phthalimide precipitated. Upon
consumption of the starting material (TLC, 1H NMR), the
reaction was quenched with triethylamine (300 μL) and allowed
to warm to rt, whereupon the white solid dissolved. The solution was
transferred to a 60 mL separatory funnel and then was diluted with
CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases
were separated, and the aqueous layer was extracted with 15 mL of
CH2Cl2. The organic phases were combined, dried
over MgSO4, filtered, and concentrated by rotary evaporation
(30 °C, 3 mmHg). Purification by silica gel flash column chromatography
(40:1 hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) followed by recrystallization from hexanes (3 mL) afforded, in
two crops, 268 mg (84%) of 4a as white needles. Data
for 4a: mp 121–122 °C (hexanes); 1H NMR (500 MHz, CDCl3) δ 7.41–7.32 (m, 5
H, HC(aryl)), 7.30 (m, 2H, HC(aryl)), 7.26 (m, 3 H, HC(aryl)), 7.20
(t, J = 7.8 Hz, 1H, HC(7)), 7.08 (d, J = 7.5 Hz, 1H, HC(5)), 6.97 (d, J = 8 Hz, 1H, HC(8)),
6.94 (t, J = 8 Hz, 1H, HC(6)), 5.09 (d, J = 7.8 Hz, 1H, HC(2)), 3.81 (ddd, J = 9.5, 7.7,
5.2 Hz, 1H, HC(3)), 3.15 (dd, J = 16.6, 5.1 Hz, 1H,
HC(4)), 2.99 (dd, J = 16.6, 9.1 Hz, 1H, HC(4)); 13C NMR (126 MHz, CDCl3) δ 154.3 (C9), 139.4
(C15), 133.7 (C11), 133.3 (C17), 129.5 (C5), 129.1 (C13), 128.6 (C12),
128.6 (C14), 128.1 (C7), 127.7 (C18), 127.3 (C16), 121.0 (C6), 120.7
(C10), 116.8 (C8), 81.2 (C2), 47.2 (C3), 31.8 (C4); IR (ATR, cm–1) 2912 (w), 1583 (w), 1487 (m), 1449 (w), 1439 (w),
1427 (w), 1306 (w), 1277 (w), 1222 (m), 1205 (w), 1193 (w), 1150 (w),
1111 (w), 1086 (w), 1069 (w), 1024 (w), 1000 (m), 969 (w), 904 (w),
851 (w), 831 (w), 797 (w), 757 (s), 750 (s), 727 (w), 716 (m), 700
(s); MS (EI, 70 eV, m/z) 318 (36,
M+), 208 (40), 200 (100), 199 (98), 119 (19); TLC Rf 0.48 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −40.0 (c = 0.87, CHCl3); CD,
(−), Cotton sign, 230–280 nm; CSP-SFC, (2R,3S)-4atmin 13.4 min, (5.1%), (2S,3R)-4atmaj 18.5 min, (94.9%) (Chiralpak
AD, 220 nm, 200 bar, 40 °C, 95:5, sCO2/MeOH, 2 mL/min).
Anal. Calcd for C21H18OS (318.43): C, 79.21;
H, 5.70. Found: C, 78.91; H, 5.62.
Preparation of (2S,3R)-6-Methyl-2-phenyl-3-(phenylthio)chromane (4b)
Following general
procedure 2, 3b (224 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv)
was added directly via syringe. The solution was allowed to stir for
24 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL), and the
mixture was then allowed to warm to rt, whereupon the white solid
dissolved. The solution was transferred to a 60 mL separatory funnel
and then was diluted with CH2Cl2 (10 mL) and
1 M NaOH (15 mL). The phases were separated, and the aqueous layer
was extracted with 15 mL of CH2Cl2. The organic
phases were combined, dried over MgSO4, filtered, and concentrated
by rotary evaporation (30 °C, 3 mmHg). Purification by silica
gel flash column chromatography (4:1 hexanes/CHCl3 to 3:1
hexanes/CHCl3, 20 mm diameter, 20 cm of SiO2) followed by recrystallization from hexanes (3 mL) afforded, in
two crops, 272 mg (82%) of 4b as white needles. Data
for 4b: mp 114–115 °C (hexanes); 1H NMR (500 MHz, CDCl3) δ 7.40–7.29 (m, 7H,
HC(aryl)), 7.27–7.23 (m, 3H, HC(aryl))), 7.00 (d, J = 8.5 Hz, 1H, HC(7)), 6.88, (s, 1H, HC(5)), 6.87 (d, J = 8.5 Hz, 1H, HC(8)), 5.06 (d, J = 7.7 Hz, 1H,
HC(2)), 3.80 (ddd, J = 8.8, 7.6, 5.2 Hz, 1H, HC(3)),
3.09 (dd, J = 16.6, 5.2 Hz, 1H, HC(4)), 2.95 (dd, J = 16.6, 8.9 Hz, 1H, HC(4)), 2.31 (s, 3H, HC(19)); 13C NMR (126 MHz, CDCl3) δ 152.1 (C9), 139.6
(C15), 133.8 (C11), 133.2 (C17), 130.2 (C6), 129.9 (C5), 129.1 (C13),
128.7 (C7), 128.6 (C12), 128.5 (C14), 127.7 (C18), 127.3 (C16), 120.3
(C10), 116.5 (C8), 81.1 (C2), 47.3 (C3), 31.7 (C4), 20.8 (C19); IR
(ATR, cm–1) 2923 (w), 1588 (w), 1497 (m), 1474 (w),
1457 (w), 1436 (w), 1301 (w), 1239 (m), 1227 (s), 1148 (w), 1127 (w),
1027 (w), 988 (m), 937 (w), 909 (w), 880 (w), 852 (w), 831 (m), 818
(w), 798 (w), 745 (s), 729 (w), 691 (s); MS (EI, 70 eV, m/z) 332 (60, M+), 200 (88), 199 (80),133
(60),91 (100); TLC Rf 0.67 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −32.9 (c = 0.88 in
CHCl3); CD, (−), Cotton sign, 230–280 nm;
CSP-SFC, (2R,3S)-4btmin 10.2 min (5.0%), (2S,3R)-4btmaj 14.3 min (95.0%) (Chiralpak AD, 220 nm, 200 bar, 40 °C, 85:15
sCO2/MeOH, 2 mL/min). Anal. Calcd for C22H20OS (332.46): C, 79.48; H, 6.06. Found: C, 79.15; H, 5.97.
Preparation of (2S,3R)-8-Methyl-2-phenyl-3-(phenylthio)chromane (4c)
Following general
procedure 2, 3c (224 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv)
was added directly via syringe. The solution was allowed to stir for
24 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL), and the
mixture was allowed to warm to rt, whereupon the white solid dissolved.
The solution was transferred to a 60 mL separatory funnel and diluted
with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The
phases were separated, and the aqueous layer was extracted with 15
mL of CH2Cl2. The organic phases were combined,
dried over MgSO4, filtered, and concentrated by rotary
evaporation (30 °C, 3 mmHg). Purification by silica gel flash
column chromatography (60:1 hexanes/ethyl acetate then 40:1 hexanes/ethyl
acetate, 30 mm diameter, 16 cm of SiO2) afforded a white
solid. Recrystallization from hexanes (3 mL) afforded, in two crops,
259 mg (78%) of 4c as white needles. Data for 4c: mp 89–90 °C (hexanes); 1H NMR (500 MHz,
CDCl3) δ 7.38–7.30 (m, 5H, HC(aryl)), 7.28
(d, J = 2.1 Hz, 2H, HC(aryl)), 7.25–7.19 (m,
3H, HC(aryl)), 7.05 (d, J = 7.5 Hz, 1H, HC(5)), 6.88
(dd, J = 7.7, 1.9 Hz, 1H, HC(7)), 6.81 (t, J = 7.4 Hz, 1H, HC(6)), 5.11 (d, J = 7.6
Hz, 1H, HC(2)), 3.75 (ddd, J = 8.9, 7.5, 5.0 Hz,
1H, HC(3)), 3.08 (dd, J = 16.6, 5.1 Hz, 1H, HC(4)),
2.95 (dd, J = 16.5, 8.8 Hz, 1H, HC(4)), 2.23 (s,
3H, HC(19)); 13C NMR (101 MHz, CDCl3) δ
152.4 (C9), 139.9 (C15), 133.9 (C11), 133.0 (C17), 129.2 (C5), 129.2
(C16), 128.6 (C13), 128.4 (C18), 127.6 (C14), 127.1 (C7, C16), 126.0
(C10), 120.4 (C6), 120.1 (C8), 81.0 (C2),47.3 (C3), 31.8 (C4), 16.4
(C19); IR (ATR, cm–1) 1594 (w), 1467 (m), 1432 (w),
1379 (w), 1304 (w), 1259 (w), 1239 (w), 1204 (s), 1101 (w), 1072 (w),
1026 (w), 985 (m), 959 (w), 924 (w), 910 (w), 828 (w), 798 (w), 757
(s), 744 (s), 728 (m), 699 (s); MS (EI, 70 eV, m/z) 332 (43, M+), 222 (48), 200 (100), 199 (60),
149 (20),133 (41); TLC Rf 0.77 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −4.5 (c = 0.88 in
CHCl3); CD, (−), Cotton sign, 230–280 nm;
CSP-SFC, (2R,3S)-4ctmin 10.5 (4.0%), (2S,3R)-4ctmaj 11.8 (96.0%) (Chiralpak AD, 220 nm, 200 bar, 40 °C, 95:5, sCO2/MeOH, 2 mL/min). Anal. Calcd for C22H20OS (332.46): C, 79.48; H, 6.06. Found: C, 79.54; H, 6.19.
Preparation of (2R,3S)-3-Phenyl-2-(phenylthio)-2,3-dihydro-1H-benzo[f]chromene (4d)
Following general procedure 2, 3d (260 mg, 1.0 mmol) was weighed into a dried 10 mL Schlenk
flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0 equiv), and catalyst (S)-2b (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask
was placed in an i-PrOH bath and cooled to −20
°C (probe). After equilibration (ca. 20 min), MsOH (17 μL,
0.25 mmol, 0.25 equiv) was added directly via syringe. The solution
was allowed to stir for 24 h at constant temperature during which
time phthalimide precipitated. Upon consumption of the starting material
(TLC, 1H NMR), the reaction was quenched with triethylamine
(300 μL) and then was allowed to warm to rt, whereupon the white
solid dissolved. The solution was transferred to a 60 mL separatory
funnel and diluted with CH2Cl2 (10 mL) and 1
M NaOH (15 mL). The phases were separated, and the aqueous layer was
extracted with 15 mL of CH2Cl2. The organic
phases were combined, dried over MgSO4, filtered, and concentrated
by rotary evaporation (30 °C, 3 mmHg). Purification by silica
gel flash column chromatography (60:1 hexanes/ethyl acetate then 40:1
hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) followed
by recrystallization (hexanes, 3 mL, ether, 0.2 mL) afforded, in two
crops, 290 mg (79%) of 4d as pale pink prisms. Data for 4d: mp 136–138 °C (hexanes/ether); 1H NMR (500 MHz, CDCl3) δ 7.83 (d, J = 7.8 Hz, 1H, HC(5)), 7.77 (d, J = 8.5, 1H, HC(8)),
7.72 (d, J = 8.9 Hz, 1H, HC(9)), 7.53 (dd, J = 8.3, 7.0 Hz, 1H, HC(7)), 7.46–7.38 (m, 4H, HC(aryl),
HC(6)), 7.38–7.27 (m, 4H, HC(aryl)), 7.27–7.22 (m, 3H
HC(aryl)), 7.19 (d, 1H, 8.9 Hz, HC(10)), 5.15 (d, J = 8.0 Hz, 1H, HC(2)), 3.95 (ddd, J = 8.9, 8.0,
5.6, 1H, HC(3)), 3.49 (dd, J = 16.8, 5.6 Hz, 1H,
HC(4)), 3.26 (dd, J = 16.8, 8.9 Hz, 1H, HC(4)); 13C NMR (101 MHz, CDCl3) δ 152.0 (C11), 139.1
(C19), 133.9 (C14), 133.3 (C21), 132.9 (C12), 129.4 (C13), 129.2 (C17),
128.8 (C18), 128.7 (C5), 128.7 (C16), 128.6 (C9), 127.8 (C22), 127.5
(C20), 126.9 (C7), 123.8 (C6), 122.0 (C8), 118.9 (C10), 112.7 (C12),
81.2 (C2), 47.4 (C3), 28.9 (C4); IR (ATR, cm–1)
3054 (w), 1621 (w), 1596 (m), 1508 (w), 1466 (m), 1456 (w), 1433 (m),
1397 (m), 1259 (w), 1227 (s), 1166 (m), 1140 (w), 1080 (w), 1066 (m),
1024 (w), 991 (s), 971 (s), 913 (w), 862 (w), 847 (w), 818 (s), 801
(m), 767 (s), 746 (s), 736 (s), 703 (s); MS (EI, 70 eV, m/z) 368 (65, M+), 318 (25), 258 (44),
208 (32), 200 (97), 199 (100), 169 (49), 168 (46); TLC Rf 0.74 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −89.4
(c = 0.86 in CHCl3); CD, (−), Cotton
sign, 230–280 nm; CSP-HPLC, (2R,3S)-4dtmin 11.3 (6.8%), (2S,3R)-4dtmaj 17.6 (93.2%) (Chiralpak AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min). Anal. Calcd for C25H20OS (368.49): C, 81.49; H, 5.47. Found: C, 81.32; H, 5.50.
Preparation of (2S,3R)-6-Methoxy-2-phenyl-3-(phenylthio)chromane (4e)
Following general
procedure 2, 3e (240 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv)
was added directly via syringe. The solution was allowed to stir for
24 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL), and the
mixture was allowed to warm to rt, whereupon the white solid dissolved.
The solution was transferred to a 60 mL separatory funnel and then
was diluted with CH2Cl2 (10 mL) and 1 M NaOH
(15 mL). The phases were separated, and the aqueous layer was extracted
with 15 mL of CH2Cl2. The organic phases were
combined, dried over MgSO4, filtered, and concentrated
by rotary evaporation (30 °C, 3 mmHg). Purification by silica
gel flash column chromatography (60:1 hexanes/ethyl acetate to 40:1
hexanes/ethyl acetate, 30 mm diameter, 18 cm of SiO2) followed
by recrystallization from hexanes (3 mL) afforded, in two crops, 293
mg (84%) of 4e as white needles. Data for 4e: mp 128–129 °C (hexanes); 1H NMR (500 MHz,
CDCl3) δ 7.42–7.26 (m, 7H, HC(aryl)), 7.25–7.19
(m, 3H, HC(aryl)), 6.87 (d, J = 8.9 Hz, 1H, HC(8)),
6.75 (dd, J = 8.9, 2.8 Hz, 1H, HC(7)), 6.58 (d, J = 3.1, 1H, HC(5)), 5.02 (dd, J = 7.7,
1.2 Hz, 1H, HC(2)), 3.83–3.72 (m, 4H, HC(3), HC(19)), 3.09
(dd, J = 16.7, 5.2 Hz, 1H, HC(4)), 2.95 (dd, J = 16.7, 8.9 Hz, 1H, HC(4)); 13C NMR (126 MHz,
CDCl3) δ 153.9 (C9), 148.3 (C6), 139.5 (C15), 133.7
(C11), 133.2 (C17), 129.1 (C13), 128.6 (C12), 128.6 (C14), 127.7 (C18),
127.3 (C16), 121.3 (C10), 117.5 (C8), 114.2 (C7), 113.9 (C5), 81.1
(C2), 56.0 (C19), 47.2 (C3), 32.1 (C4); IR (ATR, cm–1) 2835 (w), 1583 (w), 1496 (m), 1457 (w), 1429 (m), 1293 (w), 1245
(w), 1224 (s), 1209 (s), 1151 (m), 1122 (w), 1086 (w), 1040 (s), 994
(s), 934 (w), 909 (w), 875 (w), 851 (w), 820 (m), 787 (w), 742 (s),
727 (s); MS (EI, 70 eV, m/z) 348
(69, M+), 199 (42), 149 (56), 91 (100); TLC Rf 0.44 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −36.2
(c = 0.96 in CHCl3); CD, (−), Cotton
sign, 230–280 nm; CSP-SFC, (2R,3S)-4etmin 13.9 min (5.6%),
(2S,3R)-4etmaj 16.0 min (94.4%) (Chiralpak AD, 220 nm,
200 bar, 40 °C, 85:15, sCO2/MeOH, 2 mL/min). Anal.
Calcd for C22H20O2S (348.46): C,
75.83; H, 5.79. Found: C, 76.04; H, 5.57.
Preparation of (2S,3R)-6-Bromo-2-phenyl-3-(phenylthio)chromane (4f)
Following general
procedure 2, 3f (289 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv)
was added directly via syringe. The solution was allowed to stir for
36 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL), and the
mixture was allowed to warm to rt, whereupon the white solid dissolved.
The solution was transferred to a 60 mL separatory funnel and then
was diluted with CH2Cl2 (10 mL) and 1 M NaOH
(15 mL). The phases were separated, and the aqueous layer was extracted
with 15 mL of CH2Cl2. The organic phases were
combined, dried over MgSO4, filtered, and concentrated
by rotary evaporation (30 °C, 3 mmHg). Purification by silica
gel flash column chromatography (60:1 hexanes/ethyl acetate, then
40:1 hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) followed by recrystallization (hexanes, 3 mL, ether, 0.2 mL) afforded,
in two crops, 320 mg (81%) of 4f as white needles. Data
for 4f: mp 138–139 °C (hexanes/ether); 1H NMR (500 MHz, CDCl3) δ 7.40–7.24
(m, 11H, HC(aryl), HC(7)), 7.19 (d, J = 2.4 Hz, 1H,
HC(5)), 6.85 (d, J = 8.7 Hz, 1H, HC(8)), 5.10 (d, J = 7.3 Hz, 1H, HC(2)), 3.77 (ddd, J =
8.7, 7.3, 5.1 Hz, 1H, HC(3)), 3.07 (dd, J = 16.8,
5.1 Hz, 1H, HC(4)), 2.92 (dd, J = 16.7, 8.5 Hz, 1H,
HC(4)); 13C NMR (126 MHz, CDCl3) δ 153.4
(C9), 139.1 (C15), 133.4 (C17), 133.3 (C11), 132.1 (C5), 131.0 (C7),
129.2 (C13), 128.7 (C12, C14), 128.0 (C18), 127.0 (C16), 122.8 (C6),
118.6 (C8), 113.0 (C10), 81.0 (C2), 46.7 (C3), 31.0 (C4); IR (ATR,
cm–1) 3037 (w), 1573 (w), 1473 (m), 1432 (w), 1405
(w), 1288 (w), 1232 (s), 1182 (m), 1121 (m), 1088 (w), 1067 (w), 1027
(w), 977 (m), 935 (w), 911 (w), 890 (m), 866 (m), 844 (w), 830 (w),
815 (w), 799 (w), 776 (w), 743 (s), 699 (s); MS (EI, 70 eV, m/z) 397 (18, M+), 395 (18,
M+), 199 (100), 91 (88); TLC Rf 0.44 (1:1, hexanes/CH2Cl2)
[UV,CAM]; [α]D23 = −49.2 (c = 0.84 in CHCl3); CD, (−), Cotton sign,
230–280 nm; CSP-HPLC, (2R,3S)-4f, tmin 9.3 (6.2%), (2S,3R)-4f, tmaj 12.2 (93.8%) (Chiralpak AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min). Anal. Calcd for C21H17BrOS (397.33): C, 63.48; H, 4.31. Found: C, 63.38; H, 4.30.
Preparation of (2S,3R)-6-Chloro-2-phenyl-3-(phenylthio)chromane (4g)
Following general
procedure 2, 3g (245 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv)
was added directly via syringe. The solution was allowed to stir for
36 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL), and the
mixture was allowed to warm to rt, whereupon the white solid dissolved.
The material was transferred to a 250 mL RB flask using 20 mL of CH2Cl2 and concentrated by rotary evaporation (30
°C, 3 mmHg). The material was then redissolved in 10 mL of CH2Cl2 and then adsorbed onto Celite. Purification
by silica gel flash column chromatography (5:1 hexanes/CH2Cl2, 20 mm diameter, 16 cm of SiO2) followed
by recrystallization from hexanes (3 mL) afforded, in two crops, 248
mg (70%) of 4g as white needles. Data for 4g: mp 144–145 °C (hexanes); 1H NMR (500 MHz,
CDCl3) δ 7.38–7.29 (m, 7H, HC(aryl)), 7.29–7.25
(m, 3H, HC(aryl)), 7.15 (dd, J = 8.7, 2.5 Hz, 1H,
HC(7)), 7.04 (d, J = 2.6 Hz, 1H, HC(5)), 6.90 (d, J = 8.7, 1H, HC(8)), 5.09 (d, J = 7.3 Hz,
1H, HC(2)), 3.77 (ddd, J = 8.5, 7.3, 5.1 Hz, 1H,
HC(3)), 3.07 (dd, J = 16.8, 5.1 Hz, 1H, HC(4)), 2.92
(dd, J = 16.8, 8.5 Hz, 1H, HC(4)); 13C
NMR (126 MHz, CDCl3) δ 152.9 (C9), 148.7 (C6) 139.1
(C15), 133.4 (C17), 133.3 (C11), 129.2 (C13), 129.1 (C5), 128.7 (C12),
128.1 (C7), 128.0 (C14/C18), 127.0 (C16), 125.7 (C14/C18), 122.2 (C10),
118.1 (C8), 81.0 (C2), 46.7 (C3), 31.2 (C4); IR (ATR, cm–1) 3059 (w), 1578 (w), 1476 (m), 1432 (w), 1411 (w), 1290 (w), 1235
(s), 1187 (m), 1123 (m), 1068 (w), 1027 (w), 981 (m), 935 (m), 898
(m), 875 (s), 849 (w), 831 (m), 794 (w), 781 (w), 743 (s), 699 (s);
MS (EI, 70 eV, m/z) 354 (12, M+), 352 (20, M+),247 (44),199 (89), 149 (36),133
(41),107 (23), 91 (80); TLC Rf 0.45 (1:1, hexanes/CH2Cl2) [UV,CAM];
[α]D23 = −42.6 (c = 1.12 in CHCl3); CD, (−), Cotton sign, 230–280
nm; CSP-HPLC, (2R,3S)-4gtmin 9.2 (6.2%), (2S,3R)-4gtmaj 12.4 (93.8%) (Chiralpak AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min). Anal. Calcd for C21H17ClOS
(352.88): C, 71.48; H, 4.86. Found: C, 71.73; H, 5.11.
Preparation of (2S,3R)-6-Fluoro-2-phenyl-3-(phenylthio)chromane (4h)
Following general
procedure 2, 3h (228 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv)
was added directly via syringe. The solution was allowed to stir for
36 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL), and the
mixture was allowed to warm to rt, whereupon the white solid dissolved.
The solution was transferred to a 60 mL separatory funnel and diluted
with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The
phases were separated, and the aqueous layer was extracted with 15
mL of CH2Cl2. The organic phases were combined,
dried over MgSO4, filtered, and concentrated by rotary
evaporation (30 °C, 3 mmHg). Purification by silica gel flash
column chromatography (6:1 hexanes/CHCl3 then 4:1 then
3:1 hexanes/CHCl3, 20 mm diameter, 17 cm of SiO2) followed by recrystallization from hexanes (3 mL) afforded, in
two crops, 289 mg (86%) of 4h as white needles. Data
for 4h: mp 111–112 °C (hexanes); 1H NMR (500 MHz, CDCl3) δ 7.38–7.32 (m, 5H,
HC(aryl)), 7.30 (m, 2H, HC(aryl)), 7.28–7.24 (m, 3H, HC(aryl)),
6.93–6.88 (m, 2H, HC(8), HC(5)), 6.81–6.74 (d, J = 8.4 Hz, 1H, HC(7)), 5.07 (d, J = 7.6
Hz, 1H, HC(2)), 3.78 (ddd, J = 8.6, 7.5, 5.2 Hz,
1H, (HC(3)), 3.10 (dd, J = 16.9, 5.2 Hz, 1H, HC(4)),
2.95 (dd, J = 16.8, 8.8 Hz, 1H, HC(4)); 13C NMR (126 MHz, CDCl3) δ 157.2 (d, J = 238.9 Hz, C6), 150.3 (C9), 139.2 (C15), 133.4 (C11), 133.4 (C17),
129.2 (C13), 128.7 (C12,C14), 127.9 (C18), 127.2 (C16), 121.8 (d, J = 7.4 Hz, C10), 117.7 (d, J = 8.1 Hz,
C8), 115.4 (d, J = 22.8 Hz, C7), 114.9 (d, J = 23.2 Hz, C5), 81.1 (C2), 46.8 (C3), 31.7 (C4); 19F NMR (470 MHz, CDCl3) δ −124.03
(app q, J = 7.3 Hz); IR (ATR, cm–1) 3072 (w), 1580 (w), 1491 (s), 1473 (m), 1458 (w), 1438 (w), 1429
(m), 1374 (w), 1332 (w), 1283 (w), 1240 (m), 1222(s), 1203 (s), 1140
(m), 1103 (w), 1087 (w), 1067 (w), 1036 (w), 984 (s), 948 (m), 933
(m), 911 (w), 873 (m), 850 (m), 827 (m), 792 (m), 744 (s), 730 (s);
MS (EI, 70 eV, m/z) 336 (33, M+), 226 (27), 199 (100), 91 (93); TLC Rf 0.49 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −23.4
(c = 0.94 in CHCl3); CD, (−), Cotton
sign, 230–280 nm; CSP-SFC, (2R,3S)-4htmin 9.0 min (6.8%),
(2S,3R)-4htmaj 11.6 min (93.2%) (Chiralpak AD, 220 nm,
95:5, hexanes/i-PrOH, 0.8 mL/min). Anal. Calcd for
C21H17FOS (336.42): C, 74.97; H, 5.09. Found:
C, 74.73; H, 5.02.
Preparation of (2S,3R)-3-((2,6-Diisopropylphenyl)thio)-2-phenyl-6-(trifluoromethyl)chromane (4i)
Following general
procedure 2, 3i (276 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1c (339 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and stirred at rt. MsOH (17 μL, 0.25 mmol,
0.25 equiv) was added directly via syringe. The solution was allowed
to stir for 12 h at constant temperature during which time phthalimide
precipitated. Upon consumption of the starting material (TLC, 1H NMR), the reaction was quenched with triethylamine (300
μL), and the mixture was allowed to warm to rt, whereupon the
white solid dissolved. The material was transferred to a 250 mL RB
flask using 20 mL of CH2Cl2 and concentrated
by rotary evaporation (30 °C, 3 mmHg) to afford a pale yellow
residue. The material was then redissolved in 10 mL of CH2Cl2 and adsorbed onto Celite. Purification by silica gel
flash column chromatography of the adsorbed material (5:1 hexanes/CH2Cl2, 20 mm diameter, 16 cm of SiO2)
followed by recrystallization from hexanes (3 mL) afforded, in two
crops, 416 mg (89%) of 4i as white prisms. Data for 4i: mp 137–140 °C (hexanes); 1H NMR
(500 MHz, CDCl3) δ 7.44 (dd, J =
8.5 Hz, 2.2 Hz, 1H, HC(7)), 7.34 (m, 4H, HC(aryl)), 7.25 (m, 2H, HC(aryl)),
7.22–7.20 (br s, 1H, HC(5)), 7.18 (d, J =
7.7 Hz, 2H, HC(17)), 7.04 (d, J = 8.6 Hz, 1H, HC(8)),
5.19 (d, J = 5.5 Hz, 1H, HC(2)), 3.75 (p, J = 6.9 Hz, 2H, HC(19)), 3.50 (q, J = 5.6
Hz, 1H, HC(3)), 2.77 (d, J = 5.5 Hz, 2H, HC(4)),
1.18 (d, J = 6.9 Hz, 12H, HC(20)); 13C
NMR (126 MHz, CDCl3) δ 156.6 (C15), 154.2 (C9), 139.6
(C11), 130.0 (C14), 128.8 (C13), 128.7 (C16), 128.6 (C18), 127.1 (C5),
126.2 (C12), 125.5 (C7), 124.1 (C17), 120.6 (C4), 117.0 (C8), 79.8
(C2), 47.2 (C3), 31.8 (C19), 29.1 (C4), 24.7 (m, C20); 19F NMR (376 MHz, CDCl3) δ −61.87 (s); IR (ATR,
cm–1) 2961 (w), 2926 (w), 1738(w), 1620 (w), 1594
(w), 1507 (w), 1455 (w), 1380 (w), 1361 (w), 1330 (s), 1292 (m), 1241
(s), 1188 (w), 1159 (s), 1115 (s), 1070 (w), 1050 (w), 1032 (w), 990
(m), 971(m), 936 (w), 905 (m), 889 (m), 846 (m), 799 (m), 781 (w),
748 (m), 740 (m), 696 (s); MS (EI, 70 eV, m/z) 470 (25, M+), 283 (100),276 (21),194 (22),
149 (51); TLC Rf 0.65
(1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −7.0 (c = 0.9 in CHCl3); CD, (−), Cotton sign, 230–280 nm. Anal. Calcd
for C28H29F3OS (470.59): C, 71.46;
H, 6.21. Found: C, 71.38; H, 6.22.
Preparation of (2S,3R)-3-((2,6-Diisopropylphenyl)sulfonyl)-2-phenyl-6-(trifluoromethyl)chromane (S1)
To determine enantiomeric composition, 4i was oxidized to the sulfone S1. To a 4 dram vial under nitrogen was added solid 4i (20 mg, 0.04 mmol, 1 equiv) followed by CH2Cl2 (1 mL) and solid m-CPBA (18 mg, 0.11 mmol, 2.5 equiv). The resulting solution was stirred at rt for 3 h. The solution was then diluted with hexanes (3 mL) and directly purified by silica gel flash column chromatography (9:1 hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) to afford 22 mg of a white solid. The product sulfone was then analyzed by chiral stationary phase HPLC. Data for S1: 1H NMR (500 MHz, CDCl3) δ 7.56–7.44 (m, 2H, HC(7), HC(5)), 7.35 (d, J = 7.7 Hz, 3H, HC(aryl)), 7.31–7.27 (m, 5H, HC(aryl)), 7.19 (dd, J = 6.7, 2.9 Hz, 2H, HC(aryl)), 7.08 (d, J = 8.5 Hz, 1H, HC(8)), 5.82 (d, J = 4.4 Hz, 1H, HC(2)), 4.04 (p, J = 6.7 Hz, 2H, HC(19)), 3.86 (app q, J = 5.8 Hz, 1H, HC(3)), 3.30 (dd, J = 17.5, 5.5 Hz, 1H, HC(4)), 3.03 (dd, J = 17.5, 6.4 Hz, 1H, HC(4)), 1.30 (d, J = 6.7 Hz, 6H, HC(20)), 1.25 (d, J = 6.7 Hz, 6H, HC(21)); 13C NMR (126 MHz, CDCl3) δ 151.2, 138.2, 133.6, 129.1, 128.9, 126.6, 126.4, 126.2, 119.1, 117.4, 74.9, 62.5, 30.0, 25.3, 25.2, 22.6; CSP-HPLC, (2S,3R)-S1tmaj 6.9 min (95.2%) (2R,3S)-S1tmin 7.7 min (4.8%) (Chiralpak AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min).
Sulfenocyclizations of Other Substituted (E)-2-(2-Propenyl)phenols
Preparation of (2S,3R)-2-(Furan-2-yl)-3-(phenylthio)chromane (4j)
For compound 4j, general procedure 2 was modified as follows:
To a dried 10 mL Schlenk flask were added CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0 equiv),
and catalyst (S)-2b (52 mg, 0.1 mmol,
0.1 equiv). The flask was placed in an i-PrOH bath
and cooled to −20 °C (probe). After equilibration (ca.
20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv) was added directly
via syringe, and the solution was allowed to stir for 5 min. Substrate 3j (200 mg, 1.0 mmol) was then added directly to the cold
solution. The solution was allowed to stir for 24 h at constant temperature
during which time phthalimide precipitated. Upon consumption of the
starting material (TLC, 1H NMR), the reaction was quenched
with triethylamine (300 μL) and then was allowed to warm to
rt, whereupon the white solid dissolved. The solution was transferred
to a 60 mL separatory funnel and diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases were separated,
and the aqueous layer was extracted with 15 mL of CH2Cl2. The organic phases were combined, dried over MgSO4, filtered, and concentrated by rotary evaporation (30 °C, 3
mmHg). The material was dissolved in CH2Cl2 (10
mL) and adsorbed onto Celite. Purification by silica gel flash column
chromatography (5:1 hexanes/CH2Cl2, 20 mm diameter,
16 cm of SiO2) followed by recrystallization from hexanes
(3 mL) afforded, in two crops, 271 mg (88%) of 4j as
white needles. Data for 4j: mp 72–73 °C (hexanes); 1H NMR (500 MHz, CDCl3) δ 7.44–7.38
(m, 2H, HC(17)), 7.36–7.26 (m, 4H, HC(14), HC(16), HC(18)),
7.16 (dd, J = 8.4, 7.4, 1H, HC(7)), 7.06 (d, J = 7.2 Hz, 1H, HC(5)), 6.96–6.88 (m, 2H, HC(8),
HC(6)), 6.45–6.39 (m, 1H, HC(12), 6.35 (ddd, J = 3.2, 1.8, 1.0 Hz, 1H, HC(13), 5.09 (dd, J = 8.1,
1.1 Hz, 1H, HC(2)), 3.98 (ddd, J = 9.2, 8.1, 5.4,
1H, HC(3)), 3.21 (dd, J = 16.6, 5.4 Hz, 1H, HC(4)),
3.03–2.89 (dd, J = 16.6, 9.2 Hz, 1H HC(4)); 13C NMR (126 MHz, CDCl3) δ 153.7 (C9), 151.5
(C11), 142.9 (C14), 133.6 (C117), 132.9 (C15), 129.5 (C5), 129.1 (C16),
128.0 (C7), 127.9 (C18), 121.2 (C6), 120.5 (C10), 116.9 (C8), 110.6
(C13), 109.9 (C12), 74.6 (C2), 44.3 (C3), 31.7 (C4); IR (ATR, cm–1) 3058 (w), 1733 (w), 1583 (m), 1504 (w), 1487 (m),
1476 (m), 1453 (m), 1439 (w), 1349 (w), 1331 (w), 1301 (w), 1279 (w),
1234 (s), 1217 (m), 1190 (w), 1170 (w), 1150 (m), 1111 (m), 1079 (w),
1033 (m), 1013 (m), 978 (s), 931 (m), 902 (m), 885 (m), 876 (m), 846
(w), 820 (m), 778 (w), 747 (s), 728 (s), 703 (m); MS (EI, 70 eV, m/z) 308 (31, M+), 199 (29),
190 (46), 81 (100); TLC Rf 0.42 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −55.5 (c = 0.96 in
CHCl3); CD, (−), Cotton sign, 230–280 nm;
CSP-HPLC, (2R,3S)-4jtmin 8.7 min (7.5%), (2S,3R)-4jtmaj 9.7 min (92.5%) (Chiralpak AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min). Anal. Calcd for C19H16O2S (308.40): C, 74.00; H, 5.23. Found: C, 73.83; H, 5.16.
Preparation of (2R,3R)-3-(Phenylthio)-2-(thiophene-2-yl)chromane (4k)
Following general
procedure 2, 3k (216 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv)
was added directly via syringe. The solution was allowed to stir for
24 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL) and then
was allowed to warm to rt, whereupon the white solid dissolved. The
solution was transferred to a 60 mL separatory funnel, diluted with
CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases
were separated, and the aqueous layer was extracted with 15 mL of
CH2Cl2. The organic phases were combined, dried
over MgSO4, filtered, and concentrated by rotary evaporation
(30 °C, 3 mmHg). Purification by silica gel flash column chromatography
(60:1 hexanes/ethyl acetate then 40:1 hexanes/ethyl acetate, 30 mm
diameter, 15 cm of SiO2) afforded 278 mg (86%) of 4k as a white, analytically pure solid. Data for 4k: mp 98–99 °C (hexanes/ethyl acetate); 1H
NMR (500 MHz, CDCl3) δ 7.39 (m, 2H, HC(17)), 7.30
(m, 4H, HC(16), HC(18), HC(7)), 7.19 (t, J = 8.3
Hz, 1H, HC(6)), 7.13 (d, J = 3.5 Hz, 1H, HC(12)),
7.06 (d, J = 7.5 Hz, 1H, HC(5), 6.99 (t, J = 4.0 Hz, 1H, HC(13)), 6.94 (m, 2H, HC(14), HC(8)), 5.36
(d, J = 7.6 Hz, 1H, HC(2)), 3.80 (td, J = 8.1, 5.4 Hz, 1H, HC(3)), 3.21 (dd, J = 16.7,
5.3 Hz, 1H, HC(4)), 2.99 (dd, J = 16.7, 8.7 Hz, 1H,
HC(4)); 13C NMR (126 MHz, CDCl3) δ 153.6
(C9), 142.6 (C15), 133.4 (C17), 133.3 (C11), 129.5 (C13), 129.2 (C16),
128.1 (C12), 127.9 (C18), 126.8 (C6), 126.5 (C5), 126.0 (C7), 121.3
(C14), 120.4 (C10), 117.0 (C8), 77.0 (C2), 47.7 (C3), 31.6 (C4); IR
(ATR, cm–1) 2923 (w), 1582 (w), 1485 (m), 1456 (w),
1437 (w), 1345 (w), 1305 (w), 1275 (w), 1233 (w), 1219 (s), 1191 (m),
1149 (w), 1120 (w), 1104 (w), 1078 (m), 1042 (w), 1026 (w), 991 (m),
965 (m), 900 (w), 846 (m), 839 (m), 757 (s), 747 (s), 710 (s); MS
(EI, 70 eV, m/z) 324 (15, M+), 215 (30), 205 (26), 97 (100); TLC: Rf 0.42 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −49.8
(c = 0.95 in CHCl3); CD, (−), Cotton
sign, 230–280 nm; CSP-HPLC, (2R,3R)-4ktmaj 26.6 min (93.9%),
(2S,3S)-4ktmin 34.2 min (6.1%) (Reverse-Phase Chiralpak
OJ-RH, 220 nm, 65:35, MeCN/H2O, 0.5 mL/min). Anal. Calcd
for C19H16OS2 (324.46): C, 70.33;
H, 4.97. Found: C, 69.93; H, 4.83.
Preparation of (2S,3R)-2-Phenethyl-3-(phenylthio)chromane (4l) and (R)-2-((S)-3-Phenyl-1-(phenylthio)propyl)-2,3-dihydrobenzofuran (5l)
Following general
procedure 2, 3l (238 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (17 μL, 0.25 mmol, 0.25 equiv)
was added directly via syringe. The solution was allowed to stir for
24 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL) and then
was allowed to warm to rt, whereupon the white solid dissolved. The
solution was transferred to a 60 mL separatory funnel and then was
diluted with CH2Cl2 (10 mL) and 1 M NaOH (15
mL). The phases were separated, and the aqueous layer was extracted
with 15 mL of CH2Cl2. The organic phases were
combined, dried over MgSO4, filtered, and concentrated
(30 °C, 3 mmHg). The crude 4l/5l ratio
(1.5:1) was established by 1H NMR spectroscopy. The material
was dissolved in 10 mL of CH2Cl2 and adsorbed
onto Celite. Purification by silica gel flash column chromatography
of this material (60:1 hexanes/ethyl acetate then 40:1 hexanes/ethyl
acetate, 30 mm diameter, 14 cm of SiO2) followed by bulb-to-bulb
distillation afforded 258 mg (74%) of the mixture as a clear oil.
Data for mixture: bp 120 °C (ABT, 0.05 mmHg); 1H NMR
(500 MHz, CDCl3) δ 7.51–7.40 (m, 5H, HC(aryl)),
7.32 (m, 13H, HC(aryl)), 7.25 (m, 7H, HC(aryl)), 7.21–7.09
(m, 4H, HC(aryl)), 7.02 (d, J = 7.6 Hz, 1H, HC(aryl)),
6.97–6.81 (m, 4H), 6.74 (d, J = 8.0 Hz, 1H);
diagnostic for 5l1H NMR (500 MHz, CDCl3) δ 4.86 (dt, J = 9.1, 7.4 Hz, 1H,
HC(2)), 3.35 (dd, J = 15.9, 9.2 Hz, 1H, HC(3)), 3.29
(ddd, J = 10.2, 7.0, 3.6 Hz, 1H, HC(10)), 3.22–3.15
(m, 2H, HC(3), HC(12)), 2.88 (m, HC(12)),2.26 (dddd, J = 14.3, 9.6, 7.1, 3.6 Hz, 1H, HC(11)), 1.95 (dtd, J = 14.4, 9.6, 4.9 Hz, 1H, HC(11)); 13C NMR (126 MHz, CDCl3)
δ 85.1 (C2), 53.9 (C10), 34.2 (C3), 33.1 (C12), 32.7 (C11);
diagnostic for 4l1H NMR (500 MHz, CDCl3) δ 4.06 (td, J = 8.4, 2.9 Hz, 1H,
HC(2)), 3.45 (ddd, J = 9.0, 7.9, 5.3 Hz, 1H, HC(3)),
3.15–3.08 (m, 1H, HC(4)), 3.00–2.91 (m, 1H, HC(4)),
2.91–2.82 (m, 2H, HC(12)), 2.36 (dddd, J =
14.0, 10.0, 7.3, 3.0 Hz, 1H, HC(11)), 2.10 (dtd, J = 14.0, 9.0, 5.0 Hz, 1H, HC(11)); 13C NMR (126 MHz, CDCl3) δ 77.4 (C2), 45.0 (C3), 35.0 (C11), 31.7 (C4), 31.4
(C12); IR (ATR, cm–1) 3025 (w), 2923 (w), 1599 (w),
1584 (m), 1488 (m), 1479 (m), 1455 (m), 1437 (m), 1303 (w), 1231 (s),
1174 (w), 1111 (w), 1088 (w), 1066 (w), 1024 (w), 964 (w), 942 (w),
872 (w), 796 (w), 744 (s); MS (EI, 70 eV, m/z) 346 (73, M+), 145 (30), 131 (41), 117 (65),
91 (100), 69 (29); TLC Rf 0.49 (1:1, hexanes/CH2Cl2) [UV,CAM]; CSP-SFC,
(2R,3S)-4l, tmin 16.2 (3.4%), (2S,3R)-4ltmaj 17.7
(96.6%), (2S,10R)-5l, tmin 13.3 (3.7%), (2S,10R)-5ltmaj 14.7 (96.3%) (Chiralpak AD, 220 nm, 95:5 sCO2/MeOH, 2
mL/min). Anal. Calcd for C23H22OS (346.49):
C, 79.73; H, 6.40. Found: C, 79.87; H, 6.51.
Preparation of (S)-3-((2,6-Diisopropylphenyl)thio)-2,2-dimethylchromane (4m)
Following general
procedure 2, 3m (162 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1c (339 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to 0 °C (probe). MsOH (17 μL,
0.25 mmol, 0.25 equiv) was added directly via syringe. The solution
was allowed to stir for 24 h at constant temperature during which
time phthalimide precipitated. Upon consumption of the starting material
(TLC, 1H NMR), the reaction was quenched with triethylamine
(300 μL) and then was allowed to warm to rt, whereupon the white
solid dissolved. The solution was transferred to a 60 mL separatory
funnel and diluted with CH2Cl2 (10 mL) and 1
M NaOH (15 mL). The phases were separated, and the aqueous layer was
extracted with 15 mL of CH2Cl2. The organic
phases were combined, dried over MgSO4, filtered, and concentrated
(30 °C, 3 mmHg). The material was then dissolved in 10 mL of
CH2Cl2 and adsorbed onto Celite. Purification
by silica gel flash column chromatography of this material (5:1 hexanes/CH2Cl2, 20 mm diameter, 16 cm of SiO2)
followed by recrystallization (EtOH, 5 mL), afforded, in two crops,
330 mg (93%) of 4m as white needles. Data for 4m: mp 74–75 °C (EtOH); 1H NMR (400 MHz, CDCl3) δ 7.35 (t, J = 7.8 Hz, 1H, HC(15)),
7.18 (d, J = 7.7 Hz, 2H, HC(14)), 7.08 (t, J = 8.1 Hz, 1H, HC(7)), 6.89 (d, J = 7.3
Hz, 1H, HC(5)), 6.83–6.75 (m, 2H, HC(6), HC(8)), 3.89 (p, J = 6.8 Hz, 2H, HC(16)), 3.16 (dd, J =
8.1, 6.9 Hz, 1H, HC(3)), 2.72 (d, J = 7.2 Hz, 2H,
HC(4)), 1.55 (s, 3H, HC(11)), 1.49 (s, 3H, HC(11)), 1.24 (d, J = 6.8 Hz, 6H, HC(17)), 1.18 (d, J = 6.8
Hz, 6H, HC(17)); 13C NMR (101 MHz, CDCl3) δ
154.2 (C12), 153.2 (C9), 129.7 (C15), 129.5 (C13), 129.4 (C7), 127.9
(C5), 124.1 (C14), 120.6 (C13), 120.4 (C6), 117.4 (C8), 77.5 (C2),
52.1 (C3), 31.8 (C16), 31.7 (C16), 29.8 (C4), 27.9 (C11), 25.0 (C17),
24.5 (C17), 22.2 (C11); IR (ATR, cm–1) 3058 (w),
2962 (m), 2928 (m), 2867 (w), 1609 (w), 1583 (m), 1489 (s), 1455 (s),
1420 (w), 1382 (m), 1368 (m), 1360 (w), 1315 (w), 1301 (m), 1265 (s),
1252 (m), 1236 (s), 1178 (m), 1150 (s), 1127 (s), 1099 (s), 1052 (m),
1033 (m), 974 (w), 944 (s), 927 (m), 896 (w), 858 (s), 847 (w), 825
(w), 804 (m), 748 (s), 741 (s), 713 (m); MS (EI, 70 eV, m/z) 354 (69, M+),235 (98), 194 (28),
161 (100), 149 (33), 145 (60),119 (71), 91 (41); TLC Rf 0.60 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −104.8
(c = 0.79 in CHCl3); CD, (+), Cotton sign,
230–280 nm. Anal. Calcd for C23H30OS
(354.55): C, 77.92; H, 8.53. Found: C, 77.71; H, 8.31.
Preparation of (S)-3-((2,6-Diisopropylphenyl)thio)-2,2-dimethylchromane (S5)
To determine enantiomeric composition, 4m was oxidized to the sulfone. To a 4 dram vial was added solid 4m (20 mg, 0.055 mmol, 1 equiv), followed by CH2Cl2 (1 mL) and m-CPBA (25 mg, 0.15 mmol, 2.5 equiv). The solution was stirred at rt for 3 h. The solution was diluted with hexanes (3 mL) and then directly purified by silica gel flash column chromatography (9:1 hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) to afford 21 mg of a white solid. The product was analyzed by chiral stationary phase HPLC. Data for S5: 1H NMR (500 MHz, CDCl3) δ 7.55 (t, J = 7.8 Hz, 1H, HC(15)), 7.41 (d, J =7.8 Hz, 2H, HC(14)), 7.14 (t, J = 7.7 Hz, 1H, HC(7), 6.97 (d, J = 7.6 Hz, 1H, HC(6)), 6.91–6.79 (m, 2H, HC(5), HC(8)), 4.26 (q, J = 7.0 Hz, 2H, HC(16)), 3.54 (ddd, J = 13.0, 5.3, 2.0 Hz, 1H, HC(3)), 3.36 (dd, J = 16.2, 12.7 Hz, 1H, HC(4)), 2.73 (dd, J = 16.2, 5.2 Hz, 1H, HC(4)), 1.84 (s, 3H, HC(11)), 1.56 (s, 3H, HC(11)), 1.36 (d, J = 6.9, 6H, HC(17)), 1.29 (d, J = 6.7 Hz, 6H, HC(17)); 13C NMR (126 MHz, CDCl3) δ 151.6, 133.5, 129.2, 128.3, 126.6, 121.0, 118.9, 117.6, 76.5, 66.6, 30.0, 29.3, 25.2, 21.8; CSP-HPLC, (R)-S5tmin 55.9 min (4.6%), (S)-S5tmaj 60.0 min (95.4%) (reversed-phase Chiralpak AD-RH, 220 nm, 45:55, MeCN/H2O, 0.15 mL/min).
Sulfenocyclizations of Substituted (E)-2-(3-Butenyl)phenols and (E)-2-(4-Pentenyl)phenols
Preparation of (2S,3R)-2-Phenyl-3-(phenylthio)-2,3,4,5-tetrahydrobenzo[b]oxepine (4n)
Following general procedure 2, 3n (224 mg,
1.0 mmol) was weighed into a dried 10 mL Schlenk flask. Subsequently,
CH2Cl2 (7 mL), electrophile 1a (255
mg, 1.0 mmol, 1.0 equiv), and catalyst (S)-2b (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was
placed in an i-PrOH bath and cooled to −20
°C (probe). After equilibration (ca. 20 min), MsOH (33 μL,
0.5 mmol, 0.5 equiv) was added directly via syringe. The solution
was allowed to stir for 18 h at constant temperature during which
time phthalimide precipitated. Upon consumption of the starting material
(TLC, 1H NMR), the reaction was quenched with triethylamine
(300 μL) and then was allowed to warm to rt, whereupon the white
solid dissolved. The solution was transferred to a 60 mL separatory
funnel and then was diluted with CH2Cl2 (10
mL) and 1 M NaOH (15 mL). The phases were separated, and the aqueous
layer was extracted with 15 mL of CH2Cl2. The
organic phases were combined, dried over MgSO4, filtered,
and concentrated by rotary evaporation (30 °C, 3 mmHg). The residue
was taken up in 10 mL of CH2Cl2 and then adsorbed
onto Celite. Purification by silica gel flash column chromatography
of this material (5:1 hexanes/CH2Cl2, 20 mm
diameter, 16 cm of SiO2) followed by bulb-to-bulb distillation
afforded 304 mg (92%) of 4n as a clear oil. Data for 4n: bp 150 °C (ABT), 0.05 mmHg; 1H NMR (500
MHz, CDCl3) δ 7.49 (m, 2H, HC(aryl)), 7.43–7.34
(m, 3H, HC(aryl)), 7.25–7.12 (m, 7H), 7.05 (t, J = 7.4, 1H, HC(7)), 6.97 (d, J = 7.9, 1H, HC(9)),
4.61 (dd, J = 10.6, 1H, HC(2)), 3.85 (ddd, J = 10.6, 8.6, 4.2, 1H, HC(3)), 3.05 (dt, J = 6.9, 2.8 Hz, 2H, HC(5)), 2.63 (ddd, J = 12.1,
10.4, 4.2 Hz, 1H, HC(4)), 1.91 (dt, J = 14.5, 8.7
Hz, 1H, HC(4)); 13C NMR (126 MHz, CDCl3) δ
159.25 (C10), 140.66 (C16), 134.32 (C12), 134.25 (C11), 132.92 (C18),
130.22 (C15), 128.96 (C14), 128.49 (C13), 128.44 (C8), 127.68 (C17),
127.64 (C6), 127.36 (C19), 123.99 (C7), 121.62 (C9), 88.36 (C2), 55.46
(C3), 33.38 (C4), 30.88 (C5); IR (ATR, cm–1) 3060
(w), 3031 (w), 2930 (w), 1603 (w), 1581 (w), 1487 (s), 1453 (m), 1438
(m), 1350 (w), 1303 (w), 1260 (w), 1232 (s), 1187 (m), 1155 (w), 1106
(w), 1090 (w), 1042 (m), 1024 (w), 978 (m), 939 (w), 914 (m), 887
(w), 754 (s), 738 (s); MS (EI, 70 eV, m/z) 340 (25, M+), 199 (56), 133 (100), 115 (26), 107 (24);
TLC Rf 0.50 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = +39.6 (0.96 in CHCl3); CD, (−), Cotton sign,
230–280 nm; CSP-SFC, (2R,3S)-4ntmin 7.6 (5.6%), (2S,3R)-4ntmaj 8.1 min (94.4%) (Chiralpak AD, 220 nm, 97:3, hexanes/i-PrOH,
0.8 mL/min). Anal. Calcd for C22H20OS (332.46):
C, 79.48; H, 6.06%; Found: C, 79.53; H, 6.09.
Preparation of (R)-2-((S)-((2,6-Diisopropylphenyl)thio)(phenyl)methyl)-2,3,4,5-tetrahydrobenzo[b]oxepine (5o)
Following general procedure 2, 3o (238 mg,
1.0 mmol) was weighed into a dried 10 mL Schlenk flask. Subsequently,
CH2Cl2 (7 mL), electrophile 1c (339
mg, 1.0 mmol, 1.0 equiv), and catalyst (S)-2b (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask was
placed in an i-PrOH bath and cooled to 0 °C
(probe). After equilibration (ca. 20 min), MsOH (33 μL, 0.5
mmol, 0.5 equiv) was added directly via syringe. The solution was
allowed to stir for 24 h at constant temperature during which time
phthalimide precipitated. Upon consumption of the starting material
(TLC, 1H NMR), the reaction was quenched with triethylamine
(300 μL) and then was allowed to warm to rt, whereupon the white
solid dissolved. The material was transferred to a 250 mL RB flask
using CH2Cl2 (20 mL) and concentrated by rotary
evaporation (30 °C, 3 mmHg). Purification by silica gel flash
column chromatography (5:1 hexanes/CH2Cl2, 20
mm diameter, 17 cm of SiO2) followed by recrystallization
(MeOH, 3 mL) afforded, in two crops, 327 mg (76%) of 5o as white needles. Data for 5o: mp 52–55 °C
(methanol); 1H NMR (500 MHz, CDCl3) δ
7.31–7.29 (m, 1H, HC(20)), 7.28–7.24 (m, 5H, H-aryl),
7.14 (ddd, J = 7.0, 4.2 Hz, 2H, H-aryl, HC(6), HC(8)),
7.11 (d, J = 7.7 Hz, 2H, HC(19)), 7.01 (t, J = 7.4 Hz, 1H, HC(7)), 6.86 (d, J = 8.2
Hz, 1H, HC(9)), 4.15 (ddd, J = 11.0, 6.2, 1.5 Hz,
1H, HC(2)), 3.81–3.67 (m, 3H, HC(12), HC(21)), 2.89 (dd, J = 14.4, 12.1, 1H, HC(5)), 2.78–2.67 (m, 1H, HC(5)),
2.31–2.19 (m, 1H, HC(3)), 2.12–1.98 (m, 1H, HC(4)),
1.76 (dddd, J = 14.2, 12.0, 10.9, 3.6 Hz, 1H, HC(3)),
1.66–1.47 (m, 1H, HC(4)), 1.16 (d, J = 6.9
Hz, 6H, HC(22)), 0.97 (d, J = 6.8 Hz, 6H, HC(22)); 13C NMR (126 MHz, CDCl3) δ 159.62 (C17), 153.91
(C10), 140.17 (C18), 136.01 (C18), 131.07 (C13), 130.25 (C8), 129.37
(C20), 129.27 (C15), 128.06 (C14), 127.53 (C6), 127.26 (C16), 123.84
(C7), 123.77 (C19), 121.83 (C9), 85.71 (C2), 62.24 (C12), 36.19 (C3),
33.96 (C5), 31.70 (C21), 26.28 (C4), 24.77 (C22), 24.16 (C22); IR
(ATR, cm–1) 3057 (w), 3026 (w), 2960 (m), 2924 (m),
2865 (w), 1602 (w), 1580 (w), 1487 (s), 1453 (m), 1382 (w), 1360 (m),
1305 (w), 1231 (s), 1209 (m), 1178 (w), 1107 (w), 1075 (w), 1052 (m),
953 (m), 924 (w), 861 (w), 801 (m), 755 (s), 743 (s), 733 (s), 720
(m); MS (EI, 70 eV, m/z) 430 (39,
M+), 283 (72), 237 (61), 147 (41), 107 (62), 91 (100);
TLC Rf 0.8 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = −144.2 (c = 0.74 in CHCl3);
CD, (−), Cotton sign, 230–280 nm. Anal. Calcd for C29H34OS (430.65): C, 80.88; H, 7.96. Found: C, 80.79;
H, 7.91.
Preparation of (R)-2-((S)-((2,6-Diisopropylphenyl)sulfonyl)(phenyl)methyl)-2,3,4,5-tetrahydrobenzo[b]oxepine (S6)
To determine enantiomeric
composition, 5o was oxidized to the sulfone S6. To a 4 dram vial was added solid 5o (20 mg, 0.05 mmol
1 equiv) followed by CH2Cl2 (1 mL) and m-CPBA (22 mg, 0.13 mmol, 2.7 equiv) The solution was stirred
at rt for 3 h. The solution was diluted with hexanes (3 mL) and then
directly purified by silica gel flash column chromatography (9:1 hexanes/ethyl
acetate, 20 mm diameter, 16 cm of SiO2) to afford 21 mg
of a white solid which was analyzed by chiral stationary phase HPLC.
Data for S6: 1H NMR: (400 MHz, CDCl3) δ 7.40 (t, J = 7.9 Hz, 2H, HC(aryl)), 7.34–7.04
(m, 10H, HC(aryl)), 7.04–6.90 (m, 1H, HC(aryl)), 4.86 (ddd, J = 11.0, 4.3, 1.5 Hz, 1H, HC(2)), 4.19 (d, J = 4.3 Hz, 1H, HC(12)), 2.91–2.78 (m, 1H, HC(5)), 2.68 (dd, J = 14.3, 5.9 Hz, 1H, HC(5)), 1.99 (tdd, J = 10.6, 7.9, 4.3 Hz, 2H, HC(4)), 1.82–1.46 (m, 2H, HC(3)),
1.43–1.00 (m, 12H, HC(22)); 13C NMR: (126 MHz, CDCl3) δ 159.3, 135.8, 134.1, 133.0, 132.3, 130.7, 130.3,
130.1, 129.2, 128.5, 127.9, 126.0, 124.2, 122.5, 80.5, 79.7, 76.6,
36.6, 33.8, 30.0, 26.3; CSP-HPLC, (2S,12R)-S6tmin 6.7 min (7.4%),
(2R,12S)-S6tmaj 7.2 min (92.6%) (BG, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min).
Preparation of (R)-2-(((2,6-Diisopropylphenyl)thio)methyl)chromane (5p)
Following general
procedure 2, 3p (148 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1c (339 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to 0 °C (probe). After equilibration
(ca. 20 min), MsOH (33 μL, 0.5 mmol, 0.5 equiv) was added directly
via syringe. The solution was allowed to stir for 12 h at constant
temperature during which time phthalimide precipitated. Upon consumption
of the starting material (TLC, 1H NMR), the reaction was
quenched with triethylamine (300 μL) and then was allowed to
warm to rt, whereupon the white solid dissolved. The solution was
transferred to a 60 mL separatory funnel and diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases were separated,
and the aqueous layer was extracted with CH2Cl2 (15 mL). The organic phases were combined, dried over MgSO4, filtered, and concentrated by rotary evaporation (30 °C, 3
mmHg). The residue was dissolved in 10 mL of CH2Cl2 and adsorbed onto Celite. Purification by silica gel flash
column chromatography (5:1 hexanes/CH2Cl2, 20
mm diameter, 16 cm of SiO2) followed by bulb-to-bulb distillation
afforded 308 mg (91%) of 5p as a clear oil. Data for 5p: bp 160 °C (ABT, 0.05 mmHg); 1H NMR: (500
MHz, CDCl3) δ 7.37 (t, J = 7.7 Hz,
1H, HC(15)), 7.23 (d, J = 7.7 Hz, 2H, HC(14)), 7.17–7.11
(t, J = 7.6 Hz, 1H, HC(7)), 7.09 (d, J = 7.7, 1H, HC(5)), 6.89 (t, J = 7.4, 1H, HC(6)),
6.85 (d, J = 8.3, 1H, HC(8)), 4.16–3.99 (m,
3H, HC(2), HC(16)), 3.06 (dd, J = 12.9, 6.2 Hz, 1H,
HC(11)), 2.92 (dd, J = 12.9, 6.6 Hz, 1H, HC(11)),
2.90–2.80 (m, 2H, HC(4)), 2.24 (ddd, J = 13.4,
6.0, 3.7 Hz, 1H, HC(3)), 1.88 (dddd, J = 13.4, 10.7,
9.7, 5.7 Hz, 1H, HC(3)), 1.30 (dd, J = 6.9, 3.9 Hz,
12H, HC(17)); 13C NMR (101 MHz, CDCl3) δ
154.8 (C12), 153.6 (C9), 131.6 (C4), 129.7 (C7), 129.5 (C14), 127.5
(C5), 124.0 (C10), 122.0 (C13), 120.5 (C6), 117.1 (C8), 74.8 (C2),
42.6 (C11), 31.8 (C3), 27.1 (C4), 24.8 (C17), 24.7 (C17); IR (ATR,
cm–1) 3054 (w), 2960 (m), 2924 (m), 2866 (w), 1610
(w), 1582 (m), 1487 (s), 1456 (s), 1420 (w), 1382 (w), 1361 (w), 1339
(w), 1301 (m), 1274 (w), 1232 (s), 1113 (m), 1075 (w), 1050 (s), 1029
(w), 996 (m), 930 (w), 886 (w), 842 (w), 800 (m), 750(s), 710 (w);
MS (EI, 70 eV, m/z) 340 (88, M+), 194 (29), 161 (49), 147 (47), 133 (100); TLC Rf 0.61 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = +69.7 (c = 1.01 in CHCl3); CD (−), Cotton sign,
230–280 nm. Anal. Calcd for C22H28OS
(340.53): C, 77.60; H, 8.29. Found: C, 77.54; H, 7.93%.
Preparation of (R)-2-(((2,6-Diisopropylphenyl)sulfonyl)methyl)chromane (S7)
To determine enantiomeric composition, 5p was oxidized to the sulfone. To a 4 dram vial was added
solid 5p (20 mg, 0.06 mmol 1 equiv), followed by CH2Cl2 (1 mL) and m-CPBA (26 mg,
0.15 mmol, 2.5 equiv) The solution was stirred at rt for 3 h. The
material was then diluted with hexanes (3 mL) and directly purified
by silica gel flash column chromatography (9:1 hexanes/ethyl acetate,
20 mm diameter, 16 cm of SiO2) to afford 22 mg of a white
solid. The product was analyzed by chiral stationary phase HPLC. Data
for S7: 1H NMR (500 MHz, CDCl3)
δ 7.53 (t, J = 7.8 Hz, 1H, HC(15)), 7.37 (d, J = 7.8 Hz, 2H, HC(14)), 7.01 (d, J = 7.5,
1H, HC(5)), 6.95 (t, J = 7.8 Hz, 1H, HC(7)), 6.81
(t, J = 7.4, 1H, HC(7)), 6.20 (d, J = 8.2, 1H, HC(8)), 4.77 (dddd, J = 8.8, 7.3, 4.4,
2.7 Hz, 1H, HC(2)), 4.21 (p, J = 6.7 Hz, 2H, HC(16)),
3.74 (dd, J = 14.3, 7.4 Hz, 1H, HC(11)), 3.37 (dd, J = 14.4, 4.4 Hz, 1H, HC(11)), 2.88 (ddd, J = 16.0, 9.5, 6.1 Hz, 1H, HC(4)), 2.77 (dt, J =
16.7, 5.4 Hz, 1H, HC(4)), 2.25 (dddd, J = 13.8, 6.2,
5.1, 2.7 Hz, 1H, HC(3)), 1.90 (dddd, J = 13.5, 9.5,
8.8, 5.7 Hz, 1H, HC(3)), 1.28 (d, J = 6.7 Hz, 6H,
HC(17)), 1.23 (d, J = 6.8 Hz, 6H, HC(17)); 13C NMR (126 MHz, CDCl3) δ 153.3, 151.3, 136.2, 133.1,
129.6, 127.6, 126.2, 121.2, 121.0, 117.0, 70.3, 62.4, 29.9, 27.4,
25.2, 25.0, 23.7; CSP-HPLC, (R)-S7tmaj 8.4 (97.2%), (S)-S7tmaj 9.0 min (2.8%) (Chiralpak
AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min).
Preparation of (R)-2-(((2,6-Diisopropylphenyl)thio)methyl)-2,3,4,5-tetrahydrobenzo[b]oxepine (5q)
Following general procedure 2, 3q (162 mg,
1.0 mmol) was weighed into a dried 10 mL Schlenk flask. Subsequently,
CH2Cl2 (7 mL), electrophile 1a (255
mg, 1.0 mmol, 1.0 equiv), and catalyst 2b (52 mg, 0.1
mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to 0 °C (probe). After equilibration (ca.
20 min), MsOH (33 μL, 0.5 mmol, 0.5 equiv) was added directly
via syringe. The solution was allowed to stir for 48 h at constant
temperature during which time phthalimide precipitated. Upon consumption
of the starting material (TLC, 1H NMR), the reaction was
quenched with triethylamine (300 μL) and then was allowed to
warm to rt, whereupon the white solid dissolved. The solution was
transferred to a 60 mL separatory funnel and diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases were separated,
and the aqueous layer was extracted with 15 mL of CH2Cl2. The organic phases were combined, dried over MgSO4, filtered, and concentrated by rotary evaporation (30 °C, 3
mmHg). Purification by silica gel flash column chromatography (5:1
hexanes/CH2Cl2, 20 mm diameter, 20 cm of SiO2) followed by bulb-to-bulb distillation afforded 296 mg (84%)
of 5q as a clear, viscous oil. Data for 5q: bp 180 °C (ABT, 0.05 mmHg); 1H NMR (500 MHz, CDCl3) δ 7.34 (t, J = 7.7 Hz, 1H, HC(16)),7.21–7.17
(m, 3H, HC(8), HC(15)), 7.17–7.12 (m, 2H, HC(6), HC(9)), 7.03
(ddt, J = 8.9, 7.2 Hz, 1H, HC(7)), 4.02 (p, J = 6.8 Hz, 2H, HC(17)), 3.79 (ddd, J =
10.2, 8.0, 4.0 Hz, 1H, HC(2)), 3.15 (dd, J = 12.0
Hz, 8.0 Hz, 1H, HC(12)), 2.93 (dd, J = 14.4, 12.0
Hz, 1H, HC(5)), 2.74 (ddd, J = 14.9, 12.6, 5.3 Hz,
2H, HC(12), HC(5)), 2.12–1.97 (m, 2H, HC(4), HC(3)), 1.91–1.79
(m, 1H, HC(3)), 1.60–1.48 (m, 1H, HC(4)) 1.28 (d, J = 6.8 Hz, 6H, HC(18)), 1.23 (d, J = 6.8 Hz, 6H,
HC(18)); 13C NMR (126 MHz, CDCl3) δ 159.1
(C13), 153.5 (C10), 135.8 (C14), 132.3 (C14), 130.3 (C6), 129.3 (C16),
127.6 (C8), 123.9 (C15), 123.8 (C7), 121.9 (C9), 110.0 (C11), 82.6
(C2), 44.7 (C12), 37.0 (C3), 33.9 (C5), 31.8 (C17), 25.9 (C4), 24.7
(C18), 24.6 (C18); IR (ATR, cm–1) 3055 (w), 2960
(m), 2924 (m), 2865 (w), 1602 (w), 1579 (w), 1487 (s), 1454 (m), 1382
(w), 1360 (m), 1306 (w), 1231(s), 1194 (w), 1178 (w), 1105 (w), 1065
(m), 1052 (m), 1035 (m), 1019 (m), 955 (s), 926 (m), 864 (w), 830
(w), 799 (s), 762 (s), 736 (s), 718 (w); MS (EI, 70 eV, m/z) 354 (82, M+), 194 (100), 160 (81),
153 (51), 151 (51), 107 (98); TLC Rf 0.56 (1:1 hexanes:CH2Cl2) [UV,CAM];
[α]D23 = +36.9 (c = 1.1
in CHCl3); CD, (+), Cotton sign, 230–280 nm. Anal.
Calcd for C23H30OS (354.55): C, 77.92; H, 8.53.
Found: C, 77.75; H, 8.25.
Preparation of (R)-2-(((2,6-Diisopropylphenyl)sulfonyl)methyl)-2,3,4,5-tetrahydrobenzo[b]oxepine (S8)
To determine enantiomeric composition, 5q was oxidized to the sulfone. To a 4 dram vial was added neat 5q (20 mg, 0.06 mmol 1 equiv) followed by CH2Cl2 (1 mL) and m-CPBA (26 mg, 0.15 mmol, 2.5 equiv). The solution was stirred at rt for 3 h. The material was diluted with hexanes (3 mL) and then directly purified by silica gel flash column chromatography (9:1 hexanes/ethyl acetate, 20 mm diameter, 16 cm of SiO2) to afford 20 mg of a white solid which was analyzed by chiral stationary phase HPLC. Data for S8: 1H NMR (500 MHz, CDCl3) δ 7.54 (t, J = 7.8 Hz, 1H, HC(16)), 7.39 (d, J = 7.7 Hz, 2H, HC(15)), 7.08 (d, J = 7.3 Hz, 1H, HC(6)), 7.02 (t, J = 7.6, 1H, HC(8)), 6.96 (t, J = 7.3, 1H, HC(7)), 6.51 (d, J = 7.8 Hz, 1H, HC(9)), 4.32 (dt, J = 9.0, 3.6, 1H, HC(2)), 4.22 (p, J = 6.7 Hz, 2H, HC(17)), 3.85 (dd, J = 14.4, 7.1 Hz, 1H, HC(12)), 3.32 (dd, J = 14.3, 3.5 Hz, 1H, HC(12)), 2.94–2.80 (m, 1H, HC(5)), 2.80–2.68 (m, 1H, HC(5)), 2.15–1.90 (m, 3H, HC(3), HC(4)), 1.72–1.46 (m, 1H, HC(3), HC(4)), 1.30 (d, J = 6.7 Hz, 6H, HC(18), 1.24 (d, J = 6.7 Hz, 6H, HC(18)); 13C NMR (126 MHz, CDCl3) δ 158.4, 151.4, 136.0, 135.4, 133.2, 130.2, 127.6, 126.4, 126.4, 124.2, 121.9, 76.8, 64.6, 38.2, 33.6, 29.9, 25.9, 25.3, 24.9; CSP-HPLC, (S)-S8tmin 10.5 min (2.3%), (R)-S8tmaj 11.1 min (97.7%) (Chiralpak AD, 220 nm, 95:5, hexanes/i-PrOH, 0.8 mL/min).
Preparation of Ethyl (S)-1-((R)-Chroman-2-yl)-1-(phenylthio)butanoate (5r)
Following general procedure 2, 3r (248 mg, 1.0 mmol) was weighed into a dried 10
mL Schlenk
flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0 equiv), and catalyst (S)-2b (52 mg, 0.1 mmol, 0.1 equiv) were added. The flask
was placed in an i-PrOH bath and cooled to −20
°C (probe). After equilibration (ca. 20 min), MsOH (33 μL,
0.5 mmol, 0.5 equiv) was added directly via syringe. The solution
was allowed to stir for 24 h at constant temperature during which
time phthalimide precipitated. Upon consumption of the starting material
(TLC, 1H NMR), the reaction was quenched with triethylamine
(300 μL) and then was allowed to warm to rt, whereupon the white
solid dissolved. The solution was transferred to a 60 mL separatory
funnel and then was diluted with CH2Cl2 (10
mL) and 1 M NaOH (15 mL). The phases were separated, and the aqueous
layer was extracted with CH2Cl2 (15 mL). The
organic phases were combined, dried over MgSO4, filtered,
and concentrated by rotary evaporation (30 °C, 3 mmHg). The material
was dissolved in ethyl acetate (10 mL) and adsorbed onto Celite. Purification
by silica gel flash column chromatography (20:1 hexanes/ethyl acetate,
20 mm diameter, 16 cm of SiO2) followed by bulb-to-bulb
distillation afforded 286 mg (80%) of 5r as a clear,
viscous oil. Data for 5r: bp 180 °C (ABT, 0.05 mmHg); 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 7.3 Hz, 2H, HC(19)), 7.37–7.31 (m, 2H, HC(16)),
7.30–7.28 (m, 1H, HC(20)), 7.11 (dd, J = 8.2,
7.4, 1H, HC(7)), 7.07 (d, J = 7.5 Hz, 1H, HC(5)),
6.87 (t, J = 7.3 Hz, 1H, HC(6)), 6.81 (d, J = 8.2 Hz, 1H, HC(8)), 4.22–4.07 (m, 3H, HC(2),
HC(15)), 3.38–3.28 (m, 1H, HC(11)), 2.91–2.73 (m, 3H,
HC(13), HC(4)), 2.71–2.63 (m, 1H, HC(13)), 2.42–2.32
(m, 2H, HC(3), HC(12)), 2.06–1.90 (m, 2H, HC(12), HC(3)), 1.28
(t, J = 7.2 Hz, 3H, HC(16)); 13C NMR (101
MHz, CDCl3) δ 173.7 (C14), 154.8 (C9), 135.4 (C17),
132.7 (C19), 129.7 (C5), 129.3 (C18), 127.5 (C7,C20), 122.2 (C10),
120.6 (C6), 117.1 (C8), 78.4 (C2), 60.7 (C15), 53.5 (C11), 32.0 (C13),
26.4 (C3), 25.1 (C4), 24.9 (C12), 14.5 (C16); IR (ATR, cm–1) 2930 (w), 1729 (s), 1609 (w), 1582 (m), 1487 (s), 1457 (m), 1438
(m), 1373 (m), 1302 (m), 1273 (m), 1231 (s), 1183 (s), 1150 (m), 1103
(m), 1067 (m), 1024 (m), 995 (m), 935 (w), 883 (w), 852 (w), 832 (w),
749 (s); MS (EI, 70 eV, m/z) 356
(36, M+), 311 (22), 247 (100), 201 (58), 177 (43), 159
(65), 149 (81), 133 (100), 107 (62); TLC Rf 0.22 (1:1, hexanes/CH2Cl2)
[UV,CAM]; [α]D23 = +92.0 (c = 0.70 in CHCl3); CD, (+), Cotton sign, 230–280
nm; CSP-HPLC, (2S,11R)-5rtmin 16.5 min (6.8%),(2R,11S)-5rtmaj 24.7 min (93.2%) (Chiralcel OJ, 220 nm, 95:5 hexanes/i-PrOH, 0.8 mL/min). Anal. Calcd for C21H24O3S (356.48): C, 70.76; H, 6.79. Found: C, 70.82; H, 6.67.
Preparation of (R)-2-((S)-4-Methoxy-1-(phenylthio)butyl)chromane (5s)
Following general
procedure 2, 3s (220 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv), and catalyst (S)-2b (52 mg,
0.1 mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After
equilibration (ca. 20 min), MsOH (33 μL, 0.5 mmol, 0.5 equiv)
was added directly via syringe. The solution was allowed to stir for
24 h at constant temperature during which time phthalimide precipitated.
Upon consumption of the starting material (TLC, 1H NMR),
the reaction was quenched with triethylamine (300 μL) and then
was allowed to warm to rt, whereupon the white solid dissolved. The
material was transferred to a 250 mL RB flask using 20 mL of CH2Cl2 and concentrated by rotary evaporation (30
°C, 3 mmHg). The material was dissolved in 10 mL of CH2Cl2 and adsorbed onto Celite. Purification by silica gel
flash column chromatography (5:1 hexanes/CH2Cl2, 20 mm diameter, 18 cm of SiO2) followed by bulb-to-bulb
distillation afforded 287 mg (88%) of 5s as a clear,
viscous oil. Data for 5s: bp 150 °C (ABT, 0.05 mmHg); 1H NMR: (500 MHz, CDCl3) δ 7.56–7.48
(m, 2H, HC(18)), 7.32 (t, J = 6.8, 2H, HC(17)), 7.29–7.25
(m, 1H, HC(19)), 7.11 (t J = 7.3 Hz, 1H, HC(7)),
7.06 (d, J = 7.3 Hz, 1H, HC(5)), 6.86 (t, J = 7.4 Hz, 1H, HC(6)), 6.79 (d, J = 8.1
Hz, 1H, HC(8)), 4.12 (ddd, J = 9.9, 6.5, 2.2 Hz,
1H, HC(2)), 3.52–3.41 (m, 2H, HC(14)), 3.37 (s, 3H, HC(15)),
3.33 (ddd, J = 8.9, 6.5, 3.3 Hz, 1H, HC(11)), 2.90–2.81
(m, 1H, HC(4)), 2.80–2.72 (m, 1H, HC(4)), 2.26 (dddd, J = 13.4, 5.8, 3.5, 2.3 Hz, 1H, HC(3)), 2.13–1.92
(m, 3H, HC(3), HC(12), HC(13)), 1.88–1.76 (m, 1H, HC(13)),
1.76–1.67 (m, 1H, HC(12)); 13C NMR (101 MHz, CDCl3) δ 154.9 (C9), 136.1 (C16), 132.4 (C18), 129.7 (C5),
129.2 (C17), 127.5 (C7), 127.2 (C19), 122.3 (C10), 120.4 (C6), 117.0
(C8), 78.5 (C2), 72.9 (C14), 58.9 (C15), 54.1 (C11), 28.0 (C3), 27.5
(C12), 25.0 (C4), 24.9 (C11); IR (ATR, cm–1) 2924
(w), 2855 (w), 1736 (w), 1609 (w), 1582 (m), 1487 (s), 1456 (m), 1438
(m), 1374 (w) 1302 (m), 1273 (w), 1232 (s), 1194(m), 1114 (s), 1051
(m), 1024 (m), 995 (m), 886 (m), 850 (w), 830 (w), 748 (s); MS (EI,
70 eV, m/z) 328 (58, M+), 219 (69), 195 (52), 187 (36), 163 (84), 133 (97), 107 (100), 85
(50), 69 (66); TLC Rf 0.15 (1:1, hexanes/CH2Cl2) [UV,CAM]; [α]D23 = +81.4 (c = 0.68 in CHCl3); CD, (+), Cotton sign, 230–280 nm; CSP-HPLC, (2S,11R)-5stmin 10.4 (3.3%), (2R,11S)-5stmaj 13.4 min (96.7%)
(Chiralcel OJ, 220 nm, 95:5, hexanes/i-PrOH, 0.8
mL/min). Anal. Calcd for C20H24O2S (328.47): C, 73.13; H, 7.37. Found: C, 73.41; H, 7.28.
Preparation of (S)-5-((R)-3-(2-Hydroxyphenyl)-1-(phenylthio)propyl)dihydrofuran-2(3H)-one (8t)
Following general procedure 2, 3t (220 mg,
1.0 mmol) was weighed into a dried 10 mL Schlenk flask. Subsequently,
CH2Cl2 (7 mL), electrophile 1a (255
mg, 1.0 mmol, 1.0 equiv), and catalyst 2b (52 mg, 0.1
mmol, 0.1 equiv) were added. The flask was placed in an i-PrOH bath and cooled to −20 °C (probe). After equilibration
(ca. 20 min), MsOH (33 μL, 0.5 mmol, 0.5 equiv) was added directly
via syringe. The solution was allowed to stir for 24 h at constant
temperature during which time phthalimide precipitated. Upon consumption
of the starting material (TLC, 1H NMR), the reaction was
quenched with triethylamine (300 μL) and then was allowed to
warm to rt, whereupon the white solid dissolved. The solution was
transferred to a 60 mL separatory funnel and then was diluted with
CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases
were separated, and the aqueous layer was extracted with 15 mL of
CH2Cl2. The organic phases were combined, dried
over MgSO4, filtered, and concentrated by rotary evaporation
(30 °C, 3 mmHg). Purification by silica gel flash column chromatography
(6:1 hexanes/ethyl acetate, then 3:1 hexanes/ethyl acetate then 2:1
hexanes/ethyl acetate, 30 mm diameter, 16 cm of SiO2) followed
by bulb-to-bulb distillation afforded 300 mg (92%) of 8t as a clear, viscous oil. Data for 8t: bp 120 °C
(ABT, 2.4 × 10–5 mm Hg); 1H NMR
(500 MHz, CDCl3) δ 7.53–7.48 (m, 2H, HC(17)),
7.37–7.31 (m, 3H, HC(16), HC(18)), 7.17–7.11 (m, 2H,
HC(12), HC(14)), 6.90 (t, J = 7.5 Hz, 1H, HC(13)),
6.82 (d, J = 8.2, 1H, HC(11)), 5.09 (s, 1H, OH)),
4.59 (q, J = 7.3 Hz, 1H, HC(5)), 3.26–3.15
(m, 1H, HC(6)), 3.08 (ddd, J = 13.9, 9.2, 4.9 Hz,
1H, HC(8)), 2.88 (ddd, J = 14.1, 9.1, 7.1 Hz, 1H,
HC(8)), 2.68–2.49 (m, 2H, HC(3)), 2.41 (dddd, J = 13.1, 9.6, 7.1, 4.9 Hz, 1H, HC(4)), 2.28–2.18 (m, 1H, HC(7)),
2.14–2.01 (m, 1H, HC(4)), 1.87 (dtd, J = 14.2,
9.5, 4.9 Hz, 1H, HC(7)); 13C NMR (126 MHz, CDCl3) δ 176.9 (C2), 153.9 (C10), 133.9 (C15), 133.0 (C17), 130.7
(C12), 129.4 (C16), 128.1 (C18), 127.9 (C14), 127.1 (C9), 121.2 (C13),
115.8 (C11), 82.6 (C5), 54.2 (C6), 31.8 (C8), 29.0 (C3), 27.4 (C4),
26.1 (C7); IR (ATR, cm–1) 3360 (br), 2924 (w), 1749
(s), 1582 (w), 1504 (w), 1488 (w), 1455 (s), 1438 (w), 1345 (w), 1303
(w), 1230 (s), 1180 (s), 1100 (w), 1068 (w), 1023 (w), 913 (w), 846
(w), 748 (s); MS (EI, 70 eV, m/z) 328 (9), 249 (21),247 (83), 201 (38),177 (27),159 (44), 149 (60),133
(100), 107 (68); TLC Rf 0.05 (4:1, hexanes/ethyl acetate) [UV,CAM]; [α]D23 = +35.4 (c = 0.68 in CHCl3); CD, (−), Cotton sign, 230–280 nm; CSP-HPLC, (5R,6S)-8ttmin 20.2 min (7.8%), (5S,6R)-8ttmaj 23.5 min (92.2%),
(Chiralpak AD-RH, 220 nm, 48:52, H2O/MeCN, 0.3 mL/min).
Anal. Calcd for C19H20O3S (328.43):
C, 69.49; H, 6.14. Found: C, 69.56; H, 6.08.
Preparation of ((R)-3-(Phenylthio)-3-((S)-tetrahydrofuran-2-yl)propyl)phenol (8u) and 2-((R)-3-(Phenylthio)-3-((S)-tetrahydrofuran-2-yl)propyl)phenol (9u)
Following general
procedure 2, 3u (206 mg, 1.0 mmol) was weighed
into a dried 10 mL Schlenk flask. Subsequently, CH2Cl2 (7 mL), electrophile 1a (255 mg, 1.0 mmol, 1.0
equiv) and catalyst 2b (52 mg, 0.1 mmol, 0.1 equiv) were
added. The flask was placed in an i-PrOH bath and
cooled to −20 °C (probe). After equilibration (ca. 20
min), MsOH (33 μL, 0.5 mmol, 0.5 equiv) was added directly via
syringe. The solution was allowed to stir for 24 h at constant temperature
during which time phthalimide precipitated. Upon consumption of the
starting material (TLC, 1H NMR), the reaction was quenched
with triethylamine (300 μL) and then was allowed to warm to
rt, whereupon the white solid dissolved. The solution was transferred
to a 60 mL separatory funnel and then was diluted with CH2Cl2 (10 mL) and 1 M NaOH (15 mL). The phases were separated,
and the aqueous layer was extracted with 15 mL of CH2Cl2. The organic phases were combined, dried over MgSO4, filtered, and concentrated by rotary evaporation (30 °C, 3
mmHg). The crude ratio of 8u/9u (1.1:1)
was established by 1H NMR spectroscopy. Purification by
silica gel flash column chromatography (12:1 hexanes/ethyl acetate,
30 mm diameter, 16 cm of SiO2) followed by bulb-to-bulb
distillation afforded 276 mg (88%) of the mixture as a clear oil.
Data for 8u: bp 180 °C (ABT, 0.05 mmHg); 1H NMR (500 MHz, CDCl3) δ 7.41–7.37 (m, 2H,
HC(17)), 7.34–7.22 (m, 3H, HC(16), HC(18)), 7.16 (dd, J = 7.9, 7.3 Hz, 1H, HC(12)), 7.07 (dd, J = 7.5 Hz, 1H, HC(14)), 6.89 (d, J = 8.1 Hz, 1H,
HC(11)), 6.85 (t, 7.8 Hz, 1H, HC(13)), 6.82 (br s, 1H, OH), 4.06 (ddd, J = 8.7, 7.7, 6.4 Hz, 1H, HC(2)), 4.01 (dt, J = 8.0, 6.9 Hz, 1H, HC(5)), 3.90 (td, J = 7.9, 6.2
Hz, 1H, HC(5)), 3.12 (dt, J = 8.9, 5.5 Hz, 1H, HC(6)),
2.93 (ddd, J = 13.9, 9.0, 6.8 Hz, 1H, HC(8)), 2.79
(ddd, J = 14.4, 9.1, 6.1 Hz, 1H, HC(8)), 2.21 (dddd, J = 12.6, 7.9, 6.4, 5.0 Hz, 1H, HC(3)), 2.16–1.89
(m, 4H, HC(4), HC(8)), 1.77 (ddt, J = 12.5, 8.4,
7.6 Hz, 1H, HC(7)); 13C NMR (126 MHz, CDCl3)
δ 154.8 (C10), 134.7 (C15), 132.0 (C17), 130.5 (C14), 129.2
(C16), 127.9 (C12), 127.3 (C18), 127.1 (C9), 120.4 (C13), 116.3 (C11),
82.7 (C2), 68.8 (C5), 52.3 (C6), 34.1 (C7), 31.4 (C3), 27.6 (C8),
25.9 (C4); IR (ATR, cm–1) 3306 (br), 2927 (w), 2866
(w), 1737 (w), 1582 (m), 1488 (m), 1455 (s), 1438 (m), 1359 (m), 1232
(s), 1177 (m), 1088 (m), 1041 (s), 921 (m), 843 (w), 746 (s); MS (EI,
70 eV, m/z) 314 (47, M+), 133 (67), 107 (100), 71 (62); TLC Rf 0.25 (4:1, hexanes/ethyl acetate) [UV,CAM]; [α]D23 = −17.3 (c = 0.52 in
CHCl3); CD, (−), Cotton sign, 230–280 nm.
Data for 9u: 1H NMR (400 MHz, CDCl3) δ 7.31 (m, 3H, HC(aryl)), 7.24 (m, 3H, HC(aryl)), 7.17–7.05
(m, 2H, HC(12), H(C14)), 6.86 (m, 2H, HC(11), HC(13)), 4.04 (dd, J = 11.4, 4.0, 1H, HC(2)), 3.41 (td, J =
11.7, 2.7 Hz, 1H, HC(5)), 3.16 (td, J = 9.9, 2.8
Hz, 1H, HC(5)), 2.91–2.67 (m, 2H, HC(3), HC(8)), 2.62 (ddd, J = 14.3, 6.1, 4.2 Hz, 1H, HC(8)), 2.45 (dddd, J = 13.9, 10.9, 6.1, 2.8 Hz, 1H, HC(3)), 2.17–2.01 (m, 1H,
HC(4)), 2.01–1.57 (m, 3H, HC(3), HC(4), HC(7)), 1.53–1.34
(m, 1H, HC(7)); 13C NMR (101 MHz, CDCl3) δ
155.0 (C10), 135.0 (C15), 133.7 (C17), 130.7 (C14), 129.2 (C16), 128.0
(C12), 124.4 (C9), 120.7 (C13), 116.4 (C11), 79.7 (C2), 68.3 (C5),
49.3 (9), 34.6 (C8), 31.7 (C4), 27.0 (C3), 25.2 (C7); CSP-HPLC (2R,6S)-9utmaj 19.2 min (97.1%), (2S,6R)-9utmin 20.83 min (2.9%)
(Chiralpak AD, 220 nm, 90:10, hexanes/i-PrOH, 0.6
mL/min); (2R,3S)-8u, tmaj 14.6 min (96.9%), (2S,3R)-8u, tmin 18.1 min (3.1%) (Chiralpak AD 220 nm, 90:10 hexanes/i-PrOH, 0.6 mL/min). Anal. Calcd for C19H22O2S (314.44): C, 72.58; H, 7.05. Found: C, 72.64; H, 6.95.
Manipulations of 4a
Preparation of (R)-2-Phenylchromane (S9)
To a 50 mL
Schlenk flask under argon was added i-PrOH (20 mL)
followed by solid 4a (238 mg,
0.75 mmol). The solid was dissolved by heating, and the flask was
then cooled in an ice bath (internal temperature <5 °C). Solid
NiCl2·6H2O (600 mg, 2.5 mmol, 3.3 equiv)
was added to form a green solution. In a separate flask, NaBH4 (300 mg, 7.9 mmol, 10.5 equiv) was dissolved in EtOH (20
mL) with stirring. This flask was then also cooled in an ice bath
(internal temperature 3 °C). The cold borohydride solution in
ethanol was cannula transferred into the flask containing the substrate
and the nickel chloride. The solution turned black, and gas evolution
was observed. The flask was maintained in the ice bath for a further
4 h. The resulting black suspension was filtered through Celite while
cold, and the filter cake was washed with CH2Cl2 (2 × 25 mL). The filtrate was then concentrated by rotary evaporation
(30 °C, 3 mmHg). Purification of the residue by silica gel flash
column chromatography (9:1, hexanes/CH2Cl2,
20 mm diameter, 15 cm of SiO2) afforded 111 mg (71%) of S9 as a white solid. The spectroscopic data match those reported
in the literature.56 Absolute configuration
was established by correlation with the known optical rotation.47 Data for S9: 1H NMR
(500 MHz, CDCl3) δ 7.47 (d, J =
7.5 Hz, 2H, HC((11)), 7.43 (t, J = 7.4 Hz, 2H, HC(10)),
7.36 (t, J = 7.2 Hz, 1H, HC(12)), 7.17 (t, J = 7.7 Hz, 1H, HC(7)), 7.13 (d, J = 7.1
Hz, 1H, HC(5)), 6.95 (d, J = 7.5 Hz, 1H, HC(8)),
6.92 (t, J = 7.4 Hz, 1H, HC(6)), 5.11 (dd, J = 10.2, 2.5 Hz, 1H, HC(2)), 3.05 (ddd, J = 17.0, 11.4, 5.9 Hz, 1H, HC(4)), 2.85 (ddd, J =
16.5, 5.3, 3.3 Hz, 1H, HC(4)), 2.26 (dddd, J = 13.7,
5.9, 3.3, 2.4 Hz, 1H, HC(3)), 2.14 (dddd, J = 13.7,
11.2, 10.2, 5.3 Hz, 1H, HC(3)); 13C NMR (126 MHz, CDCl3) δ 155.1, 141.7, 129.5, 128.5, 128.4, 127.8, 127.3,
125.9, 121.8, 120.3, 116.9, 77.7, 29.9, 25.0; MS (EI, 70 eV, m/z) 210 (100, M+), 129 (32),
171 (14), 119 (14), 104 (27), 77 (12); [α]D23 = +16.6 (c = 1.05 in CHCl3).
Preparation of (2S,3R)-2-Phenyl-3-((R,S)-phenylsulfinyl)chromane (6a and 6b)
To a 250 mL RB flask under argon were
added MeOH (100 mL) and 4a (2.23 g, 7.0 mmol). Sodium
periodate (1.65 mg, 7.7 mmol, 1.1 equiv) was added as a solid, resulting
in a heterogeneous solution. The mixture was then heated to 50 °C
for 16 h. TLC analysis showed trace amounts of remaining starting
material; however, formation of the corresponding sulfone was also
observed and the flask then removed from heat. After the solution
cooled to rt, water (100 mL) and CH2Cl2 (100
mL) were added to afford a clear, biphasic mixture. The mixture was
transferred to a 500 mL separatory funnel and shaken thoroughly, and
the layers were separated. The aqueous layer was extracted with further
CH2Cl2 (2 × 50 mL). The organic layers
were combined, washed with water (25 mL) and brine (25 mL), dried
over MgSO4, filtered, and concentrated by rotary evaporation
(30 °C, 3 mmHg). Analysis of the crude material by 1H NMR spectroscopy revealed a 2:1 diastereomeric mixture. Purification
by silica gel flash column chromatography (9:1 hexanes/ethyl acetate,
then 4:1 hexanes/ethyl acetate, 30 mm diameter, 16 cm of SiO2) separated the diastereomers. Recombination of the diastereomers 6a and 6b followed by recrystallization (EtOH,
2 mL) afforded, in two crops, 284 mg (85% combined yield) of the mixture
as white to pale yellow prisms. Data for 6a: mp 138–140
°C (ethanol); 1H NMR (400 MHz, CDCl3) δ
7.59–7.39 (m, 10H, HC(aryl)), 7.12 (t, J =
8.4 Hz, 1H, HC(7)), 7.03 (d, J = 8.4 Hz, 1H, HC(5)),
6.95–6.84 (m, 2H, HC(6), HC(8)), 5.12 (d, J = 9.1 Hz, 1H, HC(2)), 3.50 (dd, J = 16.9, 10.2
Hz, 1H, HC(4)), 3.12 (ddd, J = 10.3, 9.1, 5.4 Hz,
1H, HC(3)), 2.31 (dd, J = 16.8, 5.4 Hz, 1H, HC(4)); 13C NMR (126 MHz, CDCl3) δ 154.2 (C9), 141.4
(C15), 138.2 (C11), 131.3 (C18), 130.2 (C7), 129.5 (C17), 129.4 (C14),
129.3 (C13), 127.9 (C5), 127.6 (C16), 124.6 (C12), 121.5 (C6), 120.2
(C10), 117.0 (C8), 77.7 (C2), 63.5 (C3), 20.4 (C4); IR (ATR, cm–1) 3050 (w), 1609 (w), 1583 (w), 1487 (m), 1455 (m),
1443 (m), 1369 (w), 1298 (w), 1232 (s), 1194 (w), 1177 (w), 1110(w),
1085 (m), 1034 (s), 999 (m), 931 (m), 910 (m), 873 (w), 840 (w), 830
(w), 788 (m), 747 (s), 698 (s), 686 (s); MS (ESI, m/z) 335 (M + H+, 100), 209 (66); TLC Rf0.2 (4:1 hexanes/ethyl acetate)
[UV,CAM]. Anal. Calcd for C21H18O2S (334.43): C, 75.42; H, 5.43. Found: C, 75.06; H, 5.23. Data for 6b: 1H NMR (500 MHz, CDCl3) δ
7.72–7.65 (m, 2H, HC(aryl)), 7.61–7.53 (m, 3H, HC(aryl)),
7.37–7.33 (m, 4H, HC(aryl)), 7.27 (m, 2H, HC(aryl)), 7.10 (d, J = 8.4 Hz, 1H, HC(5)), 6.97–6.92 (m, 2H, HC(6),
HC(8)), 6.09 (dd, J = 3.1, 1.5 Hz, 1H, HC(2)), 3.42
(dt, J = 5.2, 3.2 Hz, 1H, HC(3)), 2.82 (dd, J = 17.7, 5.2 Hz, 1H, HC(4)), 2.38 (ddd, J = 17.7, 2.9, 1.2 Hz, 2H, HC(4)).
Preparation of (S)-2-Phenyl-2H-chromene (S10)
To a 10 mL Schlenk flask under
argon was added a 1:1 diastereomeric mixture of sulfoxides 6a/6b (334 mg, 1.0 mmol) and toluene (10 mL). Trimethyl
phosphite (236 μL, 2.0 mmol, 2 equiv) was added via syringe.
The solution was then refluxed for 4 h. After the reaction was complete
(TLC), the flask was removed from the oil bath and allowed to cool
to rt. The solution was concentrated by rotary evaporation (30 °C,
3 mmHg). Purification by silica gel flash column chromatography (9:1
hexanes/CH2Cl2 then 5:1 hexanes/CH2Cl2, 20 mm diameter, 16 cm of SiO2) afforded
193 mg (92%) of S10 as a clear oil. The spectroscopic
data match those reported in the literature.47 The rotation is in agreement with the absolute configuration shown.47 Data for S10: 1H NMR
(500 MHz, CDCl3) δ 7.53–7.46 (m, 2H, HC(aryl)),
7.47–7.33 (m, 3H, HC(aryl)), 7.16 (t, J =
7.8 Hz, 1H, HC(7)), 7.06 (d, J = 7.5 Hz, 1H, HC(5)),
6.91 (t, J = 7.4 Hz, 1H, HC(6)), 6.84 (d, J = 8.0 Hz, 1H, HC(8)), 6.58 (d, J = 9.8
Hz, 1H, HC(4)), 5.97 (d, J = 2.1 Hz, 1H, HC(2)),
5.85 (dd, J = 9.9, 3.3 Hz, 1H, HC(3)); 13C NMR δ 153.2, 140.9, 129.5, 128.6, 128.3, 127.0, 126.6, 124.8,
124.0, 121.3, 121.2, 116.0, 77.2; MS (EI, 70 eV, m/z) 208 (90, M+), 207 (100), 178 (15),
131 (41); [α]D23 = +97.6 (c = 1.1 in CHCl3).
Preparation of (S)-2-Phenyl-3-(phenylthio)-2H-chromene (7)
To a 50 mL Schlenk flask under argon was added a 1:1 mixture of 6a/6b (334 mg, 1 mmol) and toluene (8 mL). To this was added pyridine (805 μL, 10 mmol, 10 equiv) via syringe followed by trifluoroacetic anhydride (278 μL, 2.0 mmol, 2.0 equiv). The solution was then heated to 80 °C (internal temperature, oil bath) for 4 h. The flask was then removed from the heat source and allowed to cool to rt. The mixture was transferred to a 60 mL separatory funnel and diluted with water (10 mL) and ether (15 mL). The layers were separated, and the aqueous layer was extracted with ether (2 × 10 mL). The organic layers were combined, dried over MgSO4, and concentrated by rotary evaporation (30 °C, 3 mmHg). Purification by silica gel flash column chromatography (9:1 hexanes/CH2Cl2 then 5:1 hexanes/CH2Cl2, 20 mm diameter, 16 cm of SiO2) followed by recrystallization (hexanes, 2 mL) afforded 292 mg (92%) of 7 as white prisms. Data for 7: mp 86–88 °C (hexanes); 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 6.6 Hz, 2H, HC(aryl)), 7.43–7.32 (m, 8H, HC(aryl)), 7.12 (t, J = 7.7 Hz, 1H, HC(7)), 7.00 (d, J = 7.6, Hz, 1H, HC(5)), 6.90 (t, J = 7.5 Hz, 1H, HC(6)), 6.78 (d, J = 8.0 Hz, 1H, HC(8)), 6.66 (s, 1H, HC(4)), 5.75 (s, 1H, HC(2)); 13C NMR (126 MHz, CDCl3) δ 151.8 (C9), 138.5 (C15), 132.5 (C17), 132.3 (C11), 131.4 (C13), 129.7 (C9), 129.6 (C16), 129.1 (C18), 128.7 (C13), 128.3 (C14), 128.0 (C12), 126.3 (C7), 125.4 (C4), 122.4 (C10), 121.8 (C6), 116.5 (C8), 79.6 (C2); IR (ATR, cm–1) 3047 (w), 3028 (w), 2942 (w), 1902 (w), 1736 (w), 1704 (w), 1625 (w), 1600 (w), 1581 (w), 1570 (w), 1483 (m), 1473 (m), 1450 (m), 1437 (m), 1348 (w), 1326 (m), 1301 (w), 1258 (m), 1223 (m), 1206 (m), 1194 (m), 1160 (w), 1148 (w), 1115 (m), 1078 (w), 1065 (m), 1045 (m),1022 (m), 1000 (w), 962 (m), 937 (m), 924 (m), 905 (m), 889 (m), 854 (m), 832 (w), 776 (m), 764 (m), 747 (s), 737 (s), 697 (s), 688 (s); MS (EI, 70 eV, m/z) 316 (40, M+), 207 (100),178 (23); TLC Rf 0.57 (4:1 hexanes/ethyl acetate) [UV,CAM]. Anal. Calcd for C21H16OS (316.42): C, 79.71; H, 5.10. Found: C, 79.31; H, 4.97.
Acknowledgments
D.J.P.K. thanks Dr. Eduard Hartmann, Dr. Pavel Ryabchuk, and Dr. H. M. Chi for valuable discussions. This research was supported by NIH Grant No. R01 GM08525. D.J.P.K. was supported in part by a John M. Witt Jr. Graduate Fellowship and a Seemon H. Pines Graduate Fellowship.
Supporting Information Available
The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.joc.7b00295.
General experimental details, optimization experiments, 1H and 13C spectra for new compounds, LC and SFC chromatograms for enantioenriched compounds, and CD spectra for enantioenriched compounds (PDF)
The authors declare no competing financial interest.
Supplementary Material
References
- a Núñez M. G.; García P.; Moro R. F.; Díez D. Tetrahedron 2010, 66, 2089–2109. 10.1016/j.tet.2009.12.045. [DOI] [Google Scholar]; b Shen H. C. Tetrahedron 2009, 65, 3931–3952. 10.1016/j.tet.2009.02.002. [DOI] [Google Scholar]
- Ye T.; Garcia C. F.; McKervey M. A. J. Chem. Soc., Perkin Trans. 1 1995, 1373–1379. 10.1039/P19950001373. [DOI] [Google Scholar]
- a Poulsen P. H.; Feu K. S.; Paz B. M.; Jensen F.; Jørgensen K. A. Angew. Chem., Int. Ed. 2015, 54, 8203–8207. 10.1002/anie.201503370. [DOI] [PubMed] [Google Scholar]; b Geng Z.-C.; Zhang S.-Y.; Li N.-K.; Li N.; Chen J.; Li H.-Y.; Wang X.-W. J. Org. Chem. 2014, 79, 10772–10785. 10.1021/jo501560m. [DOI] [PubMed] [Google Scholar]
- a Li S.; Li F.; Gong J.; Yang Z. Org. Lett. 2015, 17, 1240–1243. 10.1021/acs.orglett.5b00214. [DOI] [PubMed] [Google Scholar]; b Petrone D. A.; Malik H. A.; Clemenceau A.; Lautens M. Org. Lett. 2012, 14, 4806–4809. 10.1021/ol302111y. [DOI] [PubMed] [Google Scholar]; c Marcos R.; Rodríguez-Escrich C.; Herrerías C. I.; Pericàs M. A. J. Am. Chem. Soc. 2008, 130, 16838–16839. 10.1021/ja8062887. [DOI] [PubMed] [Google Scholar]
- a Uyanik M.; Hayashi H.; Ishihara K. Science 2014, 345, 291–294. 10.1126/science.1254976. [DOI] [PubMed] [Google Scholar]; b Ammann S. E.; Rice G. T.; White M. C. J. Am. Chem. Soc. 2014, 136, 10834–10837. 10.1021/ja503322e. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Taylor R. R. R.; Batey R. A. J. Org. Chem. 2013, 78, 1404–1420. 10.1021/jo302328s. [DOI] [PubMed] [Google Scholar]; d Ward A. F.; Xu Y.; Wolfe J. P. Chem. Commun. 2012, 48, 609–611. 10.1039/C1CC15880E. [DOI] [PMC free article] [PubMed] [Google Scholar]; e Vece V.; Ricci J.; Poulain-Martini S.; Nava P.; Carissan Y.; Humbel S.; Duñach E. Eur. J. Org. Chem. 2010, 2010, 6239–6248. 10.1002/ejoc.201000738. [DOI] [Google Scholar]
- Trost B. M.; Shen H. C.; Dong L.; Surivet J.-P.; Sylvain C. J. Am. Chem. Soc. 2004, 126, 11966–11983. 10.1021/ja048078t. [DOI] [PubMed] [Google Scholar]
- Tietze L. F.; Stecker F.; Zinngrebe J.; Sommer K. M. Chem. - Eur. J. 2006, 12, 8770–8776. 10.1002/chem.200600849. [DOI] [PubMed] [Google Scholar]
- Wang P.-S.; Liu P.; Zhai Y.-J.; Lin H.-C.; Han Z.-Y.; Gong L.-Z. J. Am. Chem. Soc. 2015, 137, 12732–12735. 10.1021/jacs.5b08477. [DOI] [PubMed] [Google Scholar]
- Chung Y. K.; Fu G. C. Angew. Chem., Int. Ed. 2009, 48, 2225–2227. 10.1002/anie.200805377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- a Stadlbauer S.; Ohmori K.; Hattori F.; Suzuki K. Chem. Commun. 2012, 48, 8425–8427. 10.1039/c2cc33704e. [DOI] [PubMed] [Google Scholar]; b Mewett K. N.; Fernandez S. P.; Pasricha A. K.; Pong A.; Devenish S. O.; Hibbs D. E.; Chebib M.; Johnston G. A. R.; Hanrahan J. R. Bioorg. Med. Chem. 2009, 17, 7156–7173. 10.1016/j.bmc.2009.08.062. [DOI] [PubMed] [Google Scholar]; c Urano M.; Kagawa H.; Harigaya Y.; Li S.; Onda M. J. Heterocycl. Chem. 1991, 28, 1845–1847. 10.1002/jhet.5570280807. [DOI] [Google Scholar]
- Chapelat J.; Buss A.; Chougnet A.; Woggon W.-D. Org. Lett. 2008, 10, 5123–5126. 10.1021/ol8019583. [DOI] [PubMed] [Google Scholar]
- Zhang H.; Lin S.; Jacobsen E. N. J. Am. Chem. Soc. 2014, 136, 16485–16488. 10.1021/ja510113s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- a Kalyani D.; Kornfilt D. J. P.; Burk M. T.; Denmark S. E. In Lewis Base Catalysis in Organic Synthesis; Vedejs E., Denmark S. E., Eds.; Wiley-VCH: Weinheim, 2015; pp 1153–1212. [Google Scholar]; b Metzner P.; Thuillier A.. Sulfur Reagents in Organic Synthesis; Academic Press, 1994. [Google Scholar]; c Studies in Organic Chemistry; de la Mare P. B. D., Bolton R., Eds.; Elsevier, 1982; Vol. 9, pp 198–246. [Google Scholar]
- a Schmid G. H.; Garratt D. G. In Double-Bonded Functional Groups (1977); John Wiley & Sons, Ltd.: 2010; pp 725–912. [Google Scholar]; b Denmark S. E.; Vogler T. Chem. - Eur. J. 2009, 15, 11737–11745. 10.1002/chem.200901377. [DOI] [PubMed] [Google Scholar]; c Lucchini V.; Modena G.; Pasquato L. J. Chem. Soc., Chem. Commun. 1994, 1565–1566. 10.1039/c39940001565. [DOI] [Google Scholar]; d Smit V. A.; Zefirov N. S.; Bodrikov I. V.; Krimer M. Z. Acc. Chem. Res. 1979, 12, 282–288. 10.1021/ar50140a003. [DOI] [Google Scholar]
- Denmark S. E.; Collins W. R.; Cullen M. D. J. Am. Chem. Soc. 2009, 131, 3490–3492. 10.1021/ja900187y. [DOI] [PubMed] [Google Scholar]
- Denmark S. E.; Kornfilt D. J. P.; Vogler T. J. Am. Chem. Soc. 2011, 133, 15308–15311. 10.1021/ja2064395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denmark S. E.; Chi H. M. J. Am. Chem. Soc. 2014, 136, 8915–8918. 10.1021/ja5046296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denmark S. E.; Jaunet A. J. Org. Chem. 2014, 79, 140–171. 10.1021/jo4023765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denmark S. E.; Rossi S.; Webster M. P.; Wang H. J. Am. Chem. Soc. 2014, 136, 13016–13028. 10.1021/ja506133z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denmark S. E.; Beutner G. L. Angew. Chem., Int. Ed. 2008, 47, 1560–1638. 10.1002/anie.200604943. [DOI] [PubMed] [Google Scholar]
- Denmark S. E.; Hartmann E.; Kornfilt D. J. P.; Wang H. Nat. Chem. 2014, 6, 1056–1064. 10.1038/nchem.2109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denmark S. E.; Chi H. M. J. Am. Chem. Soc. 2014, 136, 3655–3663. 10.1021/ja413270h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- a Wolters L. P.; Bickelhaupt F. M. Wiley Interdisciplinary Reviews: Computational Molecular Science 2015, 5, 324–343. 10.1002/wcms.1221. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Ess D. H.; Houk K. N. J. Am. Chem. Soc. 2007, 129, 10646–10647. 10.1021/ja0734086. [DOI] [PubMed] [Google Scholar]
- a Dake G. In Comprehensive Heterocyclic Chemistry III; Ramsden C. A., Scriven E. F. V., Taylor R. J. K., Eds.; Elsevier: Oxford, 2008; pp 173–233. [Google Scholar]; b Coxon J.; Hartshorn M.; Swallow W. Aust. J. Chem. 1973, 26, 2521–2526. 10.1071/CH9732521. [DOI] [Google Scholar]
- Rayner C. M. In Organosulfur Chemistry; Philip P., Ed.; Academic Press: 1995; Vol. 1, pp 89–131. [Google Scholar]
- Santi C.; Tidei C. In Comprehensive Organic Synthesis II, 2nd ed.; Elsevier: Amsterdam, 2014; pp 605–637. [Google Scholar]
- a Onitsuka K.; Okuda H.; Sasai H. Angew. Chem., Int. Ed. 2008, 47, 1454–1457. 10.1002/anie.200704457. [DOI] [PubMed] [Google Scholar]; b López F.; Ohmura T.; Hartwig J. F. J. Am. Chem. Soc. 2003, 125, 3426–3427. 10.1021/ja029790y. [DOI] [PubMed] [Google Scholar]
- Yamada S.; Ono F.; Katagiri T.; Tanaka J. Nippon Kagaku Kaishi 1980, 1980, 733–737. 10.1246/nikkashi.1980.733. [DOI] [Google Scholar]
- Removal of 6 by flash column chromatography was only possible with AgNO3-impregnated SiO2 (10% w/w) as the stationary phase.
- Krygowski T. M.; Stȩpień B. T. Chem. Rev. 2005, 105, 3482–3512. 10.1021/cr030081s. [DOI] [PubMed] [Google Scholar]
- Bordwell F. G. Acc. Chem. Res. 1988, 21, 456–463. 10.1021/ar00156a004. [DOI] [Google Scholar]
- Hansch C.; Leo A.; Taft R. W. Chem. Rev. 1991, 91, 165–195. 10.1021/cr00002a004. [DOI] [Google Scholar]
- Buzanowski W. C.; Graham J. D.; Priddy D. B.; Shero E. Polymer 1992, 33, 3055–3059. 10.1016/0032-3861(92)90095-E. [DOI] [Google Scholar]
- a Johnson R. A.; Sharpless K. B. In Catalytic Asymmetric Synthesis; John Wiley & Sons, Inc., 2005; pp 229–280. [Google Scholar]; b Kolb H. C.; VanNieuwenhze M. S.; Sharpless K. B. Chem. Rev. 1994, 94, 2483–2547. 10.1021/cr00032a009. [DOI] [Google Scholar]
- a Lattanzi A.; Scettri A. Synlett 2002, 2002, 942–946. 10.1055/s-2002-31894. [DOI] [Google Scholar]; b Orito K.; Hatakeyama T.; Takeo M.; Suginome H.; Tokuda M. Synthesis 1997, 1997, 23–25. 10.1055/s-1997-1504. [DOI] [Google Scholar]
- Illuminati G.; Mandolini L.; Masci B. J. Am. Chem. Soc. 1975, 97, 4960–4966. 10.1021/ja00850a032. [DOI] [Google Scholar]
- Galli C.; Mandolini L. Eur. J. Org. Chem. 2000, 2000, 3117–3125. . [DOI] [Google Scholar]
- a Gruber K.; Zhou B.; Houk K. N.; Lerner R. A.; Shevlin C. G.; Wilson I. A. Biochemistry 1999, 38, 7062–7074. 10.1021/bi990210s. [DOI] [PubMed] [Google Scholar]; b Janda K. D.; Shevlin C. G.; Lerner R. A. J. Am. Chem. Soc. 1995, 117, 2659–2660. 10.1021/ja00114a035. [DOI] [Google Scholar]
- In the case of 8t, up to 5–8% of phenol capture may have occurred, but this material was not isolable for characterization purposes.
- Yuan H.; Chen H.; Jin H.; Li B.; Yue R.; Ye J.; Shen Y.; Shan L.; Sun Q.; Zhang W. Tetrahedron Lett. 2013, 54, 2776–2780. 10.1016/j.tetlet.2013.02.109. [DOI] [Google Scholar]
- Dzudza A.; Marks T. J. Chem. - Eur. J. 2010, 16, 3403–3422. 10.1002/chem.200902269. [DOI] [PubMed] [Google Scholar]
- Ammann S. E.; Rice G. T.; White M. C. J. Am. Chem. Soc. 2014, 136, 10834–10837. 10.1021/ja503322e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zheng C.-J.; Jiang S.-M.; Chen Z.-H.; Ye B.-J.; Piao H.-R. Arch. Pharm. 2011, 344, 689–695. 10.1002/ardp.201100005. [DOI] [PubMed] [Google Scholar]
- Hosokawa T.; Kono T.; Uno T.; Murahashi S.-I. Bull. Chem. Soc. Jpn. 1986, 59, 2191–2193. 10.1246/bcsj.59.2191. [DOI] [Google Scholar]
- Jeong Y.; Kim D.-Y.; Choi Y.; Ryu J.-S. Org. Biomol. Chem. 2011, 9, 374–378. 10.1039/C0OB00701C. [DOI] [PubMed] [Google Scholar]
- Yamamoto Y.; Itonaga K. Org. Lett. 2009, 11, 717–720. 10.1021/ol802800s. [DOI] [PubMed] [Google Scholar]
- Zhang H.; Lin S.; Jacobsen E. N. J. Am. Chem. Soc. 2014, 136, 16485–16488. 10.1021/ja510113s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malkov A. V.; Davis S. L.; Baxendale I. R.; Mitchell W. L.; Kočovský P. J. Org. Chem. 1999, 64, 2751–2764. 10.1021/jo982178y. [DOI] [PubMed] [Google Scholar]
- Jiménez M. C.; Miranda M. A.; Tormos R. J. Org. Chem. 1998, 63, 1323–1326. 10.1021/jo971621m. [DOI] [Google Scholar]
- Bhadra S.; Akakura M.; Yamamoto H. J. Am. Chem. Soc. 2015, 137, 15612–15615. 10.1021/jacs.5b11429. [DOI] [PubMed] [Google Scholar]
- Joshi A. S.; Bahel J. J. Ind. Chem. Soc. 1961, 38, 768–773. [Google Scholar]
- Kimura M.; Fukasaka M.; Tamaru Y. Synthesis 2006, 2006, 3611–3616. 10.1055/s-2006-950220. [DOI] [Google Scholar]
- Brozek L. A.; Ardolino M. J.; Morken J. P. J. Am. Chem. Soc. 2011, 133, 16778–16781. 10.1021/ja2075967. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grealis J. P.; Müller-Bunz H.; Ortin Y.; Casey M.; McGlinchey M. J. Eur. J. Org. Chem. 2013, 2013, 332–347. 10.1002/ejoc.201201063. [DOI] [Google Scholar]
- Bosch-Montalva M. T.; Domingo L. R.; Jimenez M. C.; Miranda M. A.; Tormos R. J. Chem. Soc., Perkin Trans. 2 1998, 2175–2180. 10.1039/a802625d. [DOI] [Google Scholar]
- a Hodgetts K. J. Tetrahedron 2005, 61, 6860–6870. 10.1016/j.tet.2005.04.047. [DOI] [Google Scholar]; b Liu F.; Evans T.; Das B. C. Tetrahedron Lett. 2008, 49, 1578–1581. 10.1016/j.tetlet.2008.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]; c Antus S.; Baitz-Gács E.; Kajtár J.; Snatzke G.; Tőkés A. L. Liebigs Ann. Chem. 1994, 1994, 497–502. 10.1002/jlac.15619940509. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

































